Days At A Glance Speakers Posters Session Type Search
Type

    09:00 - 17:00 
    Registration
    Strathblane Hall
    10:30 - 12:00 
    Skills 1: Working with the media
    Sidlaw
    Chair: Saffron Whitehead (London)
    SK1.1
    Skills 1: Working with the media
    Why should we engage with the media?
    London, UK
    SK1.2
    Skills 1: Working with the media
    Working with press officers to promote your research
    SK1.3
    Skills 1: Working with the media
    What journalists need from scientists
    SK1.4
    Skills 1: Working with the media
    When hormones hit the headlines
    10:30 - 12:00 
    Symposium 1: Endocrinology meets the environment
    Nutrition and habits meet hormones
    Supported by Endocrine Connections
    Fintry
    Chairs: Matthew Simmonds (Oxford) & Martin Read (Birmingham)
    S1.1
    Symposium 1: Endocrinology meets the environment
    Later life consequences of maternal vitamin D deficiency - MAVIDOS Study
    S1.2
    Symposium 1: Endocrinology meets the environment
    Iodine deficiency
    S1.3
    Symposium 1: Endocrinology meets the environment
    Environmental influences on autoimmunity
    Amsterdam, The Netherlands
    10:30 - 12:00 
    Symposium 2: Zoning in on adrenal tumours
    Illuminating the recent advances in genetic causes of adrenal tumours and hypertension
    Supported by Endocrine-Related Cancer
    Main Hall, Pentland
    Chairs: Marie Freel (Glasgow) & Scott MacKenzie (Glasgow)
    S2.1
    Symposium 2: Zoning in on adrenal tumours
    Somatic mutations and adrenal remodelling in hyperaldosteronism
    S2.2
    Symposium 2: Zoning in on adrenal tumours
    Advances in genetic causes of adrenal Cushing’s
    Zürich, Switzerland
    S2.3
    Symposium 2: Zoning in on adrenal tumours
    The new genetics of phaeochromocytoma
    Paris, France
    10:30 - 12:00 
    Symposium 3: Fanning the flames of mitochondrial function
    Mitochondrial decline and dysfunction is a common theme in many disease states. Identifying strategies that improve mitochondrial function
    Moorfoot & Kilsyth
    Chairs: Paul Chapple (London) & Craig Doig (Birmingham)
    S3.1
    Symposium 3: Fanning the flames of mitochondrial function
    Novel regulation of fat metabolism in cancer
    Boston, USA
    S3.2
    Symposium 3: Fanning the flames of mitochondrial function
    Mitochondrial protein homeostasis in the control of metabolism and aging
    Amsterdam, The Netherlands
    S3.3
    Symposium 3: Fanning the flames of mitochondrial function
    Mitochondrial disease: problems and solutions
    12:15 - 13:00 
    Meet the Expert 1: Cutting edge imaging of whole endocrine organs
    Supported by Clinical Endocrinology
    Sidlaw
    Chair: Julian Davis (Manchester)
    MTE1
    Meet the Expert 1: Cutting edge imaging of whole endocrine organs
    Cutting edge imaging of whole endocrine organs
    12:15 - 13:00 
    Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
    Supported by Clinical Endocrinology
    Main Hall, Pentland
    Chair: Graham Leese (Dundee)
    MTE2
    Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
    T4 vs T4/T3 – evidence vs expectations?
    12:15 - 13:00 
    Futures 1: Branching out with endocrinology
    Making the most out of your degree(s) – matching your skills to academic careers
    Fintry
    Chairs: Ruth Andrew (Edinburgh) & Samantha Mirczuk (London)
    FUT1.1
    Futures 1: Branching out with endocrinology
    Insights into career patterns for graduates of a biological sciences degree
    FUT1.2
    Futures 1: Branching out with endocrinology
    From postdoc to P.I. – transition to independence
    London, United Kingdom
    FUT1.3
    Futures 1: Branching out with endocrinology
    The secret life of a core facilities manager
    Edinburgh, UK
    FUT1.4
    Futures 1: Branching out with endocrinology
    Panel discussion
    12:15 - 13:00 
    Futures 2: Overcoming the consultancy hurdle
    Shaping the future of endocrinology and diabetes
    Moorfoot & Kilsyth
    Chairs: Miles Levy (Leicester) & Sheba Jarvis (London)
    FUT2.1
    Futures 2: Overcoming the consultancy hurdle
    Perspective of a next generation consultant
    Portsmouth, UK
    FUT2.2
    Futures 2: Overcoming the consultancy hurdle
    Perspective of an established consultant
    Leeds, UK
    FUT2.3
    Futures 2: Overcoming the consultancy hurdle
    Research pathways in endocrinology – a UK and global perspective
    London, UK
    FUT2.4
    Futures 2: Overcoming the consultancy hurdle
    Panel discussion
    13:00 - 14:15 
    Lunch & poster viewing
    Exhibition Hall, Lennox Suite
    13:00 - 14:15 
    Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
    Sidlaw
    Chair: Ashley Grossman (Oxford)
    Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
    Current thinking in the management of hyponatraemia and SIADH
    Cardiff University, United Kingdom
    Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
    Interactive case studies
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    13:00 - 14:15 
    Pfizer Satellite: Treatment resistance in Acromegaly
    Moorfoot & Kilsyth
    Chair: John Ayuk (Birmingham)
    Pfizer Satellite: Treatment resistance in Acromegaly
    Challenges in acromegaly - resistance to somatostatin analogues
    Birmingham, UK
    Pfizer Satellite: Treatment resistance in Acromegaly
    Managing treatment resistance in Fimilial Isolated Pituitary Adenomas

    Unknown speaker

    London, UK
    14:15 - 14:45 
    Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
    Main Hall, Pentland
    Chair: Steve O'Rahilly (Cambridge)
    PL1
    Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
    Hyperactive PI-3-Kinase signalling without hormone excess: between cancer and endocrinology
    Edinburgh, UK
    14:45 - 15:15 
    Plenary Lecture 2: Society for Endocrinology Medal Lecture
    Main Hall, Pentland
    Chair: Barbara McGowan (London)
    PL2
    Plenary Lecture 2: Society for Endocrinology Medal Lecture
    Kisspeptin - a vital trigger of puberty with therapeutic potential
    London, UK
    15:30 - 17:00 
    Oral Communications 1:Early Career Prize Session
    Six oral communications from selected abstracts submitted by Early Career endocrinologists
    Moorfoot & Kilsyth
    Chairs: Brian Walker (Edinburgh) & Gerard Conway (London)
    OC1.1
    Oral Communications 1:Early Career Prize Session
    A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901
    OC1.2
    Oral Communications 1:Early Career Prize Session
    Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
    London, UK
    OC1.3
    Oral Communications 1:Early Career Prize Session
    RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
    OC1.4
    Oral Communications 1:Early Career Prize Session
    Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome
    Dublin, Ireland
    OC1.5
    Oral Communications 1:Early Career Prize Session
    Interaction of the MR and GR in the Nucleus and at DNA
    OC1.6
    Oral Communications 1:Early Career Prize Session
    Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
    Munich, Germany
    15:30 - 17:00 
    Clinical Management Workshop 1: How do I do it? (I)
    Clinical tips from the experts
    Supported by Clinical Endocrinology and Endocrinology, Diabetes & Metabolism Case Reports, Thyroid Eye Disease Charitable Trust and British Thyroid Foundation
    Main Hall, Pentland
    Chairs: John Bevan (Aberdeen) & Tristan Richardson (Bournemouth)
    CMW1.1
    Clinical Management Workshop 1: How do I do it? (I)
    How do I report and interpret a DXA scan?
    Sheffield, UK
    CMW1.2
    Clinical Management Workshop 1: How do I do it? (I)
    How do I treat osteoporosis after bisphosphonates?
    Birmingham, United Kingdom
    CMW1.3
    Clinical Management Workshop 1: How do I do it? (I)
    How do I investigate and manage gynaecomastia?
    CMW1.4
    Clinical Management Workshop 1: How do I do it? (I)
    How do I manage adrenal suppression?
    Oxford, UK
    CMW1.5
    Clinical Management Workshop 1: How do I do it? (I)
    How do I prevent thyroid eye disease after radioiodine?
    United Kingdom
    CMW1.6
    Clinical Management Workshop 1: How do I do it? (I)
    How do I manage suspected non compliance for thyroxine replacement?
    15:30 - 17:00 
    Symposium 4: It's all in the timing: rhythms underlying endocrine systems
    Exploring dynamic systems with different timescales and mechanisms
    Supported by Journal of Endocrinology
    Sidlaw
    Chairs: Gordon Hager (Bethesda, MD, USA) & Lorna Smith (Bristol)
    S4.1
    Symposium 4: It's all in the timing: rhythms underlying endocrine systems
    Sleep: what endocrinologists should know about the body clock
    S4.2
    Symposium 4: It's all in the timing: rhythms underlying endocrine systems
    Rhythms of adrenal glucocorticoid secretion
    Bristol, United Kingdom
    S4.3
    Symposium 4: It's all in the timing: rhythms underlying endocrine systems
    Dynamics In Hypothalamic-Pituitary Function Over Multiple Time-scales
    15:30 - 17:00 
    Symposium 5: Premature ovarian insufficiency
    Ovarian follicle reserve: sequelae and management of premature depletion
    Fintry
    Chairs: Stephen Franks (London) & Kim Jonas (London)
    S5.1
    Symposium 5: Premature ovarian insufficiency
    Determinants of ovarian follicle reserve: implications for the ageing ovary
    S5.2
    Symposium 5: Premature ovarian insufficiency
    Neurological and psychological effects of premature ovarian insufficiency
    S5.3
    Symposium 5: Premature ovarian insufficiency
    Management of oestrogen replacement and potential for fertility in young women with premature ovarian insufficiency
    London
    17:00 - 17:30 
    Tea & coffee
    Exhibition Hall, Lennox Suite
    17:30 - 18:30 
    Early Career Prize Lectures
    The Society awards two prizes to Early Career Endocrinologists, one basic science and one clinical
    Main Hall, Pentland
    Chairs: Karen Chapman (Edinburgh) & Wiebke Arlt (Birmingham)
    ECP1.1
    Early Career Prize Lectures
    Basic Science - The Physiology and Pharmacology of the Fasting-Induced Hormone, FGF21
    London, UK
    ECP1.2
    Early Career Prize Lectures
    Clinical: Kisspeptin- A ‘Key Regulator' of Reproductive Physiology, Integrating Limbic Circuits with the Regulation of Reproductive Hormones
    London, UK
    18:30 - 19:00 
    Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
    Main Hall, Pentland
    Chair: David Ray (Manchester)
    PL3
    Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
    An integrated view of nuclear receptor/chromatin interactions
    Bethesda, USA
    19:00 - 19:45 
    Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
    Main Hall, Pentland
    Chair: Mark Vanderpump (London)
    D1.1
    Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
    FOR
    Cardiff, Wales
    D1.2
    Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
    AGAINST
    19:45 - 11:59 
    Welcome Reception
    Exhibition Hall, Lennox Suite
    20:00 - 20:45 
    Futures 3: Why endocrinology and diabetes?
    Drink and nibbles will be available
    Fintry
    Chairs: Karim Meeran (London) & Dominic Cavlan (London)
    FUT3.1
    Futures 3: Why endocrinology and diabetes?
    What endocrinology did for me – from a consultant’s perspective
    Sheffield, UK
    FUT3.2
    Futures 3: Why endocrinology and diabetes?
    Let me tell you how it is – from a trainee’s perspective
    FUT3.3
    Futures 3: Why endocrinology and diabetes?
    An Endocrinology Club in your medical school - from concept to reality
    FUT3.4
    Futures 3: Why endocrinology and diabetes?
    Panel discussion
    20:45 - 11:59 
    Early Career Quiz
    Ticketed event
    Moorfoot & Kilsyth

    08:00 - 17:00 
    Registration
    Strathblane Hall
    09:00 - 09:30 
    Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
    Main Hall, Pentland
    Chair: Graham Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
    Calcium regulation: from rhinos to molecules
    Oxford, United Kingdom
    09:30 - 10:00 
    Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
    Main hall - Pentland
    Chair: Mark Vanderpump (London)
    PL5
    Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
    New insights into thyroid hormone action
    Boston, USA
    10:00 - 10:30 
    Tea & coffee
    Exhibition Hall, Lennox Suite
    10:30 - 12:00 
    Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
    Update on advanced neuroendocrinology
    Main Hall, Pentland
    Chairs: Helen Spoudeas (London) & Andrew Lansdown (Cardiff)
    CMW2.1
    Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
    Weird and wonderful pituitary imaging
    London
    CMW2.2
    Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
    How to improve management of craniopharyngioma
    Manchester, United Kingdom
    CMW2.3
    Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
    Inflammatory and autoimmune pituitary disease
    London, UK
    10:30 - 12:00 
    Symposium 6: Clinical implications of thyroid genomics
    Genome variations in thyroid regulation and disease
    Supported by Journal of Molecular Endocrinology
    Moorfoot & Kilsyth
    Chairs: Mark Gurnell (Cambridge) & Vicki Smith (Birmingham)
    S6.1
    Symposium 6: Clinical implications of thyroid genomics
    Thyroid genomics - relevance to thyroid hormone therapy
    Cardiff, Wales
    S6.2
    Symposium 6: Clinical implications of thyroid genomics
    Genetic underpinning of thyroid function in health and disease
    Rotterdam, The Netherlands
    S6.3
    Symposium 6: Clinical implications of thyroid genomics
    TCGA genomic characterisation of papillary thyroid carcinoma
    Ann Arbor, USA
    10:30 - 12:00 
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Successfully conveying science to the general public
    Supported by Addison’s Disease Self-Help Group
    Sidlaw
    Chairs: Anna Mitchell (Newcastle upon Tyne) & Kate Lines (Oxford)
    SK2.1
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Engaging with the public: conveying the wonders of science
    SK2.2
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    The battles of writing a lay summary
    Southborough, UK
    SK2.3
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Making science cool for kids
    SK2.4
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Making your impact statement pack a punch
    Oxford, United Kingdom
    SK2.5
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Making social media work for promoting and recruiting science
    SK2.6
    Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
    Panel discussion
    10:30 - 12:00 
    Nurse Session 1: Multiple Endocrine Neoplasia
    Holistic approach of the MEN patient
    Supported by AMEND
    Fintry
    Chairs: Morag Middleton (Aberdeen) & Alison Milne (Aberdeen)
    N1.1
    Nurse Session 1: Multiple Endocrine Neoplasia
    Overview of MEN
    Birmingham, UK
    N1.2
    Nurse Session 1: Multiple Endocrine Neoplasia
    Genetics and MEN
    London , UK
    N1.3
    Nurse Session 1: Multiple Endocrine Neoplasia
    Psychological support of the MEN patient
    12:15 - 13:00 
    Meet the Expert 3: Optimising fertility in teenage cancer survivors
    Supported by Clinical Endocrinology
    Main Hall, Pentland
    Chair: Richard Quinton (Newcastle upon Tyne)
    MTE3
    Meet the Expert 3: Optimising fertility in teenage cancer survivors
    Optimising fertility in teenage cancer survivors
    Edinburgh, UK
    12:15 - 13:00 
    Meet the Expert 4: Investigation and management of TSHoma
    Supported by Clinical Endocrinology
    Sidlaw
    Chair: Neil Gittoes (Birmingham)
    MTE4
    Meet the Expert 4: Investigation and management of TSHoma
    Investigation and management of TSHoma

    Unknown speaker

    Cambridge, UK
    12:15 - 13:00 
    Meet the Expert 5: What every endocrine researcher should know about genome editing
    Fintry
    Chair: Vicki Smith (Birmingham)
    MTE5
    Meet the Expert 5: What every endocrine researcher should know about genome editing
    What every endocrine researcher should know about genome editing
    Boston, USA
    12:15 - 13:00 
    Meet the Expert 6: Frontiers in the management of hypoparathyroidism
    Supported by Clinical Endocrinology and Hypopara UK
    Moorfoot & Kilsyth
    Chair: Bill Fraser (Norwich)
    MTE6
    Meet the Expert 6: Frontiers in the management of hypoparathyroidism
    Frontiers in the management of hypoparathyroidism
    Bethesda, USA
    13:00 - 14:15 
    Lunch & poster viewing
    Exhibition Hall, Lennox Suite
    13:00 - 14:15 
    Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
    Moorfoot & Kilsyth
    Chair: Ashley Grossman (Oxford)
    Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
    The experience of acromegaly: patients’ perspectives
    Exeter, UK
    Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
    Somatostatin analogue therapy for acromegaly; what matters to patients?
    Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
    Thyrotropinomas (TSHomas) – do symptoms correlate with disease activity?

    Unknown speaker

    Cambridge, UK
    14:15 - 15:45 
    Oral Communications 2: Translational pathophysiology and therapeutics
    Six oral communications from selected abstracts submitted by delegates
    Sidlaw
    Chairs: Anne White (Manchester) & Jyothis George (Oxford)
    OC2.1
    Oral Communications 2: Translational pathophysiology and therapeutics
    Dual 5-alpha reductase inhibition promotes hepatic lipid accumulation in man as a result of changes to lipid metabolism in adipose tissue and the liver
    Birmingham, United Kingdom
    OC2.2
    Oral Communications 2: Translational pathophysiology and therapeutics
    Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism
    OC2.3
    Oral Communications 2: Translational pathophysiology and therapeutics
    Further advances in diagnosis of adrenal cancer: a high-throughput urinary steroid profiling method using liquid chromatography tandem mass spectrometry (LC-MS/MS)
    OC2.4
    Oral Communications 2: Translational pathophysiology and therapeutics
    Development of a long-acting growth hormone antagonist for the treatment of acromegaly
    OC2.5
    Oral Communications 2: Translational pathophysiology and therapeutics
    Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and one year mortality

    Unknown speaker

    Holbæk, Denmark
    OC2.6
    Oral Communications 2: Translational pathophysiology and therapeutics
    Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1 (MEN1)
    Oxford, UK
    14:15 - 15:45 
    Symposium 7: The rise and rise of the FGFs in endocrinology
    The increasing understanding of FGFs in pathogenesis and treatment of diverse endocrine disease
    Moorfoot & Kilsyth
    Chairs: Steve O'Rahilly (Cambridge) & Andrew Lansdown (Cardiff)
    S7.1
    Symposium 7: The rise and rise of the FGFs in endocrinology
    FGFs and hypogonadism
    Lausanne, Switzerland
    S7.2
    Symposium 7: The rise and rise of the FGFs in endocrinology
    FGF21: Starvation hormone to clinical drug?
    Bloomington, USA
    S7.3
    Symposium 7: The rise and rise of the FGFs in endocrinology
    Targeting FGF23 in bone disease
    Indianapolis, USA
    14:15 - 15:45 
    Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
    Thyroid and metabolic control during pregnancy
    Main Hall, Pentland
    Chairs: Karen Adamson (Edinburgh) & Shareen Forbes (Edinburgh)
    S8.1
    Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
    Revolutionising Type 1 diabetes metabolic control in pregnancy
    Cambridge, UK
    S8.2
    Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
    Pregnancy and obesity
    Edinburgh, United Kingdom
    S8.3
    Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
    Autoimmune thyroid disease before and during pregnancy
    Exeter
    14:15 - 15:45 
    Nurse Session 2: Nurse-led clinics
    Why, how and other considerations of nurse led clinics
    Fintry
    Chairs: Dianne Wright (Bradford) & Sadaf Ulnasah (Birmingham)
    N2.1
    Nurse Session 2: Nurse-led clinics
    Development of a nurse-led hyperparathyroidism clinic
    London, UK
    N2.2
    Nurse Session 2: Nurse-led clinics
    Running a general endocrine nurse-led clinic
    N2.3
    Nurse Session 2: Nurse-led clinics
    Medicolegal aspects of endocrine nursing
    Oxford, UK
    15:45 - 16:15 
    Tea & coffee
    Exhibition Hall, Lennox Suite
    16:15 - 17:45 
    Oral Communications 3: Steroids and adrenal
    Six oral communications from selected abstracts submitted by delegates
    Sidlaw
    Chairs: John Connell (Dundee) & Mick O'Reilly (Birmingham)
    OC3.1
    Oral Communications 3: Steroids and adrenal
    Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
    London, UK
    OC3.2
    Oral Communications 3: Steroids and adrenal
    Glucocorticoids stabilise the microtubule network to inhibit cell migration
    OC3.3
    Oral Communications 3: Steroids and adrenal
    11β-HSD1-mediated decrease in COX-2 expression is abrogated by hypoxia in human dermal fibroblasts
    Leeds, United Kingdom
    OC3.4
    Oral Communications 3: Steroids and adrenal
    Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma
    Birmingham, United Kingdom
    OC3.5
    Oral Communications 3: Steroids and adrenal
    Glucocorticoid pattern-dependent gene regulation in the rat hippocampus
    OC3.6
    Oral Communications 3: Steroids and adrenal
    Female 5β-reductase knockout mice are protected from diet induced obesity, insulin resistance and glucose intolerance
    16:15 - 17:45 
    Oral Communications 4: Diabetes and cardiometabolic complications
    Six oral communications from selected abstracts submitted by delegates
    Fintry
    Chairs: Terence Pang (Dudley) & Jonathan Hazlehurst (Oxford)
    OC4.1
    Oral Communications 4: Diabetes and cardiometabolic complications
    Acute intense exercise restores defective counter-regulation in Type 1 Diabetes through a process of dis-habituation
    OC4.2
    Oral Communications 4: Diabetes and cardiometabolic complications
    Thermal imaging as a novel non-invasive method to measure human brown adipose tissue activity in humans
    London, UK
    OC4.3
    Oral Communications 4: Diabetes and cardiometabolic complications
    5α-Tetrahydrocorticosterone exhibits topical anti-inflammatory action with limited adverse effects on angiogenesis
    OC4.4
    Oral Communications 4: Diabetes and cardiometabolic complications
    Hyperinsulinaemia due to inhibition of 5α-reductases is ameliorated by liver-selective glucocorticoid receptor antagonism in diet-induced obesity
    OC4.5
    Oral Communications 4: Diabetes and cardiometabolic complications
    Glucagon Increases Energy Expenditure Independently of Brown Adipose Tissue Activation in Humans
    OC4.6
    Oral Communications 4: Diabetes and cardiometabolic complications
    Cardiac fibrosis and the balance between glucocorticoid and mineralocorticoid receptor signalling
    16:15 - 17:45 
    Symposium 9: The endocrinology of the thin
    Mechanisms and therapies at unhealthily low body mass states
    Supported by Endocrine Connections
    Moorfoot & Kilsyth
    Chairs: Daniel Morganstein (London) & Clare McFadden (Edinburgh)
    S9.1
    Symposium 9: The endocrinology of the thin
    Endocrine dysfunction in anorexia nervosa
    Boston, USA
    S9.2
    Symposium 9: The endocrinology of the thin
    Paradoxical metabolism neutralizes immunity in cachexia
    S9.3
    Symposium 9: The endocrinology of the thin
    Ghrelin in frailty
    Philadelphia, USA
    16:15 - 17:45 
    Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
    Immunotherapy for the clinical endocrinologist
    Main Hall, Pentland
    Chairs: Paul Newey (Dundee) & Anna Mitchell (Newcastle upon Tyne)
    CMW3.1
    Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
    The thyroid and rituximab
    Alessandria, Itay
    CMW3.2
    Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
    Endocrine sequelae of biological therapies
    Dublin, Ireland
    CMW3.3
    Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
    Biological agents in pancreatic neuroendocrine tumours
    18:00 - 18:30 
    Plenary Lecture 6: Clinical Endocrinology Trust Lecture
    Main Hall, Pentland
    Chair: Steve Ball (Manchester)
    PL6
    Plenary Lecture 6: Clinical Endocrinology Trust Lecture
    Mining the steroid metabolome in adrenal hormone excess
    London, UK
    18:30 - 19:00 
    Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
    Main Hall, Pentland
    Chair: John Connell (Dundee)
    PL7
    Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
    The expanding universe of mineralocorticoids in hypertension
    Michigan, USA
    19:30 - 23:59 
    Conference Dinner
    Ticketed event
    The Hub, Edinburgh

    07:30 - 17:00 
    Registration
    Strathblane Hall
    07:30 - 08:30 
    Breakfast
    Tea, coffee and pastries available
    Main Hall, Foyer
    08:30 - 09:15 
    Society for Endocrinology AGM
    Main Hall, Pentland
    09:15 - 10:45 
    Clinical Management Workshop 4: How do I do it? (II)
    Clinical tips from the experts
    Supported by Clinical Endocrinology and Endocrinology, Diabetes & Metabolism Case Reports
    Main Hall, Pentland
    Chairs: Colin Johnston (London) & Helen Simpson (Cambridge)
    CMW4.1
    Clinical Management Workshop 4: How do I do it? (II)
    How do I prep a thyrotoxic patient for urgent surgery?
    CMW4.2
    Clinical Management Workshop 4: How do I do it? (II)
    How do I manage refractory hypocalcaemia
    CMW4.3
    Clinical Management Workshop 4: How do I do it? (II)
    How far do I investigate chronic fatigue?
    Manchester, UK
    CMW4.4
    Clinical Management Workshop 4: How do I do it? (II)
    How do I manage hirsutism?
    CMW4.5
    Clinical Management Workshop 4: How do I do it? (II)
    How do I manage hormone replacement in teenagers/young adults with learning difficulties?
    CMW4.6
    Clinical Management Workshop 4: How do I do it? (II)
    How do I manage men who have used anabolic steroids?
    09:15 - 10:45 
    Applied Physiology Workshop 1: Evolving model systems for complex tissues
    From cells to organs in the lab
    Sidlaw
    Chairs: Kevin Docherty (Aberdeen) & Shareen Forbes (Edinburgh)
    APW1.1
    Applied Physiology Workshop 1: Evolving model systems for complex tissues
    Modelling human diseases with stem cell derived hypothalamic neurones
    APW1.2
    Applied Physiology Workshop 1: Evolving model systems for complex tissues
    Regeneration in the hypothalamus
    Sheffield, UK
    APW1.3
    Applied Physiology Workshop 1: Evolving model systems for complex tissues
    Cell replacement and regeneration of beta cells as novel therapy for diabetes
    09:15 - 10:45 
    Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
    How does food talk to the gut?
    Supported by Journal of Endocrinology
    Moorfoot & Kilsyth
    Chairs: Robert Semple (Cambridge) & Ben Challis (Cambridge)
    S10.1
    Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
    Incretin hormones as regulators of appetite: from concept to clinical use
    Liverpool, United Kingdom
    S10.2
    Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
    Gut lipid sensing and energy homeostasis
    Toronto, Canada
    S10.3
    Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
    Short chain fatty acids in the regulation of energy homeostasis
    11:00 - 11:30 
    Plenary Lecture 8: Society for Endocrinology European Medal Lecture
    Main Hall, Pentland
    Chair: Karen Chapman (Edinburgh)
    PL8
    Plenary Lecture 8: Society for Endocrinology European Medal Lecture
    Repositioning of the mineralocorticoid receptor antagonists: pathophysiological basis and therapeutic issues 
    Paris, France
    11:30 - 12:00 
    Tea & coffee
    Exhibition Hall, Lennox Suite
    12:00 - 13:30 
    Oral communications 5: Thyroid and parathyroid
    Six oral communications from selected abstracts submitted by delegates
    Sidlaw
    Chairs: Duncan Bassett (London) & Peter Taylor (Cardiff)
    OC5.1
    Oral communications 5: Thyroid and parathyroid
    Functional consequences of germline mutations in a novel non-RET medullary thyroid cancer susceptibility gene
    Birmingham, UK
    OC5.2
    Oral communications 5: Thyroid and parathyroid
    A novel, missense, mutation (P81R) in the thyrotropin-releasing hormone receptor gene in congenital central hypothyroidism
    OC5.3
    Oral communications 5: Thyroid and parathyroid
    Use of 11-C-Methionine PET to loacliase parathyroid adenoma/hyperplasia-a single centre experience
    OC5.4
    Oral communications 5: Thyroid and parathyroid
    A novel modulator of cellular invasion and metastasis in endocrine cancer
    OC5.5
    Oral communications 5: Thyroid and parathyroid
    Investigating the genetic architecture of gland-in-situ congenital hypothyroidism by comprehensive screening of eight known causative genes
    Cambridge, United Kingdom
    OC5.6
    Oral communications 5: Thyroid and parathyroid
    Safety review of liothyronine use: a 20 year observational follow up study
    12:00 - 13:30 
    Oral communications 6: Advances in reproduction and signalling
    Six oral communications from selected abstracts submitted by delegates
    Moorfoot & Kilsyth
    Chairs: Ruth Andrew (Edinburgh) & Konstantinos Manolopoulos (Birmingham)
    OC6.1
    Oral communications 6: Advances in reproduction and signalling
    Neurokinin B receptor antagonist limits kisspeptin-10 induced LH secretion in women
    OC6.2
    Oral communications 6: Advances in reproduction and signalling
    Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)
    London, United Kingdom
    OC6.3
    Oral communications 6: Advances in reproduction and signalling
    Mutations in HS6ST1 are causal in self-limited delayed puberty, as well as idiopathic hypogonadotropic hypogonadism
    London, UK
    OC6.4
    Oral communications 6: Advances in reproduction and signalling
    Calcium-sensing receptor internalisation is impaired in cells expressing FHH3-associated AP2σ mutations
    Birmingham, UK
    OC6.5
    Oral communications 6: Advances in reproduction and signalling
    Pituitary tumor transforming gene binding factor (PBF): a novel modulator of iodide uptake and target for Src phosphorylation in breast cancer
    OC6.6
    Oral communications 6: Advances in reproduction and signalling
    Glucocorticoids induce rapid and persistent chromatin remodelling at a glucocorticoid receptor bound locus in macrophages
    12:00 - 13:30 
    Symposium 11: Epigenetics in endocrine-related cancers
    Evolving manifestations of epigenetic signalling and nuclear hormone receptors in breast, prostate and ovarian tumourigenesis
    Supported by Endocrine-Related Cancer
    Fintry
    Chairs: Simon Langdon (Edinburgh) & James Thorne (Leeds)
    S11.1
    Symposium 11: Epigenetics in endocrine-related cancers
    Oestrogen receptors and epigenetics in breast cancer aetiology and outcome
    London, UK
    S11.2
    Symposium 11: Epigenetics in endocrine-related cancers
    Regulation of androgen receptor function in prostate cancer
    Buffalo, USA
    S11.3
    Symposium 11: Epigenetics in endocrine-related cancers
    Epigenetic signalling and acquired drug resistance in ovarian cancer
    12:00 - 13:30 
    Symposium 12: Corticosteroids - getting to the heart of the matter
    This symposium will address the role of corticosteroids and therapeutic approaches in cardiovascular disease and the potential for cardio-selective therapeutic interventions
    Supported by Journal of Molecular Endocrinology
    Main Hall, Pentland
    Chairs: Frederic Jaisser (Paric France) & Rachel Richardson (Edinburgh)
    S12.1
    Symposium 12: Corticosteroids - getting to the heart of the matter
    Glucocorticoids and the control of cardiac function
    S12.2
    Symposium 12: Corticosteroids - getting to the heart of the matter
    Selective targeting of the mineralocorticoid receptors (MR) and cardiovascular disease
    Clayton, Australia
    S12.3
    Symposium 12: Corticosteroids - getting to the heart of the matter
    MR antagonists - lessons from clinical trials
    Nancy, France
    12:00 - 13:30 
    Senior Endocrinologists Session
    Tinto
    Chairs: Paul Belchetz (Leeds) & Ian Mason (Edinburgh)
    SE1.1
    Senior Endocrinologists Session
    The new tachykinin, endokinin: its role in emesis, sialorrhea and smoking in pregnancy
    SE1.2
    Senior Endocrinologists Session
    What is visual art, why is it made, and for whom?
    SE1.3
    Senior Endocrinologists Session
    Steroid mass spectrometry: a 50 year history
    Oakland, USA
    SE1.4
    Senior Endocrinologists Session
    A crackpot ejection theory about China's unique natural glass
    Rome, Italy
    SE1.5
    Senior Endocrinologists Session
    Understanding the biochemistry underpinning hypoglycaemia of the Insulin Autoimmune Syndrome (IAS) is paramount for diagnosis and management
    13:30 - 14:45 
    Lunch & poster viewing
    Exhibition Hall, Lennox Suite
    13:30 - 14:45 
    Internis Satellite
    Fintry
    13:45 - 14:45 
    Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
    Sidlaw
    Chair: Ashley Grossman (Oxford)
    Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
    Assessing disease burden in AI: data from the real world
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
    Treatment and management of AI: insights from a German cohort
    Berlin, Germany
    Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
    The economics of orphan drugs
    14:45 - 15:30 
    Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
    Supported by Clinical Endocrinology
    Sidlaw
    Chair: Lora Heisler (Aberdeen)
    MTE7
    Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
    Designer receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
    14:45 - 15:30 
    Meet the Expert 8: Updated thyroid cancer guidelines
    Supported by Clinical Endocrinology
    Moorfoot & Kilsyth
    Chair: Graham Williams (London)
    MTE8
    Meet the Expert 8: Updated thyroid cancer guidelines
    Updated thyroid cancer guidelines
    United Kingdom
    14:45 - 15:30 
    Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
    Supported by Clinical Endocrinology
    Fintry
    Chair: Guftar Shaikh (Glasgow)
    MTE9
    Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
    Endocrine and non-endocrine aspects of hypothalamic syndromes

    Unknown speaker

    London, UK
    14:45 - 15:30 
    Meet the Expert 10: Diagnosis and management of SIADH
    Supported by Clinical Endocrinology
    Main Hall, Pentland
    Chair: Maralyn Druce (London)
    MTE10
    Meet the Expert 10: Diagnosis and management of SIADH
    Diagnosis and management of SIADH
    Dublin, Republic of Ireland
    15:45 - 16:15 
    A year in...Type 2 diabetes
    Big breakthroughs over the previous 12 months in the field of Type 2 diabetes research
    Main Hall, Pentland
    Chair: Chris McCabe (Birmingham)
    AYI1
    A year in...Type 2 diabetes
    A year in...Type 2 diabetes
    16:15 - 16:45 
    Plenary Lecture 9: Society for Endocrinology International Medal Lecture
    Main Hall, Pentland
    Chair: Steve O'Rahilly (Cambridge)
    PL9
    Plenary Lecture 9: Society for Endocrinology International Medal Lecture
    Controlling the freedom of steroids in health and disease
    Vancouver, Canada
    16:45 - 17:15 
    Awards Ceremony
    Main Hall, Pentland
    17:15 - 17:30 
    Closing Remarks
    Main Hall, Pentland
Ali Abbara
London, United Kingdom
Wed 04 12:15
OC6.2
Oral communications 6: Advances in reproduction and signalling
Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)
London, United Kingdom
Bo Abrahamsen
Holbæk, Denmark
Tue 03 15:15
OC2.5
Oral Communications 2: Translational pathophysiology and therapeutics
Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and one year mortality

Unknown speaker

Holbæk, Denmark
Simak Ali
London, UK
Wed 04 12:00
S11.1
Symposium 11: Epigenetics in endocrine-related cancers
Oestrogen receptors and epigenetics in breast cancer aetiology and outcome
London, UK
Amit Allahabadia
Wed 04 09:15
CMW4.1
Clinical Management Workshop 4: How do I do it? (II)
How do I prep a thyrotoxic patient for urgent surgery?
Richard Anderson
Edinburgh, UK
Tue 03 12:15
MTE3
Meet the Expert 3: Optimising fertility in teenage cancer survivors
Optimising fertility in teenage cancer survivors
Edinburgh, UK
David Anderson
Rome, Italy
Wed 04 12:54
SE1.4
Senior Endocrinologists Session
A crackpot ejection theory about China's unique natural glass
Rome, Italy
Professor Wiebke Arlt
London, UK
Tue 03 18:00
PL6
Plenary Lecture 6: Clinical Endocrinology Trust Lecture
Mining the steroid metabolome in adrenal hormone excess
London, UK
Richard Auchus
Michigan, USA
Tue 03 18:30
PL7
Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
The expanding universe of mineralocorticoids in hypertension
Michigan, USA
Dr John Ayuk
Birmingham, UK
Tue 03 10:30
N1.1
Nurse Session 1: Multiple Endocrine Neoplasia
Overview of MEN
Birmingham, UK
Steve Ball
Manchester, United Kingdom
Tue 03 11:00
CMW2.2
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
How to improve management of craniopharyngioma
Manchester, United Kingdom
Thomas Barber
Wed 04 10:00
CMW4.4
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hirsutism?
Leela Barham
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
The economics of orphan drugs
Louise Bath
Mon 02 16:00
CMW1.3
Clinical Management Workshop 1: How do I do it? (I)
How do I investigate and manage gynaecomastia?
Paul Beltchetz
Wed 04 12:18
SE1.2
Senior Endocrinologists Session
What is visual art, why is it made, and for whom?
Felix Beuschlein
Zürich, Switzerland
Mon 02 11:00
S2.2
Symposium 2: Zoning in on adrenal tumours
Advances in genetic causes of adrenal Cushing’s
Zürich, Switzerland
John Bevan
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Somatostatin analogue therapy for acromegaly; what matters to patients?
Susan Bird
Mon 02 12:15
FUT1.1
Futures 1: Branching out with endocrinology
Insights into career patterns for graduates of a biological sciences degree
Louise Breen
London, UK
Tue 03 14:15
N2.1
Nurse Session 2: Nurse-led clinics
Development of a nurse-led hyperparathyroidism clinic
London, UK
Antonia Brooke
Exeter, UK
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
The experience of acromegaly: patients’ perspectives
Exeter, UK
Morris Brown
Mon 02 10:30
S2.1
Symposium 2: Zoning in on adrenal tumours
Somatic mutations and adrenal remodelling in hyperaldosteronism
Robert Brown
Wed 04 13:00
S11.3
Symposium 11: Epigenetics in endocrine-related cancers
Epigenetic signalling and acquired drug resistance in ovarian cancer
Federica Buonocore
London, UK
Tue 03 16:15
OC3.1
Oral Communications 3: Steroids and adrenal
Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
London, UK
Moray Campbell
Buffalo, USA
Wed 04 12:30
S11.2
Symposium 11: Epigenetics in endocrine-related cancers
Regulation of androgen receptor function in prostate cancer
Buffalo, USA
James Cannon
Tue 03 11:00
SK2.3
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making science cool for kids
Anne Cappola
Philadelphia, USA
Tue 03 17:15
S9.3
Symposium 9: The endocrinology of the thin
Ghrelin in frailty
Philadelphia, USA
Paul Carroll
London, UK
Tue 03 11:30
CMW2.3
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Inflammatory and autoimmune pituitary disease
London, UK
Ben Challis
Wed 04 12:30
OC5.3
Oral communications 5: Thyroid and parathyroid
Use of 11-C-Methionine PET to loacliase parathyroid adenoma/hyperplasia-a single centre experience
Andrew Childs
London, United Kingdom
Mon 02 12:25
FUT1.2
Futures 1: Branching out with endocrinology
From postdoc to P.I. – transition to independence
London, United Kingdom
Vasileios Chortis
Birmingham, United Kingdom
Tue 03 17:00
OC3.4
Oral Communications 3: Steroids and adrenal
Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma
Birmingham, United Kingdom
Helen Christian
Mon 02 12:15
MTE1
Meet the Expert 1: Cutting edge imaging of whole endocrine organs
Cutting edge imaging of whole endocrine organs
Professor Alexander Comninos
London, UK
Mon 02 18:00
ECP1.2
Early Career Prize Lectures
Clinical: Kisspeptin- A ‘Key Regulator' of Reproductive Physiology, Integrating Limbic Circuits with the Regulation of Reproductive Hormones
London, UK
Becky Conway-Campbell
Tue 03 17:15
OC3.5
Oral Communications 3: Steroids and adrenal
Glucocorticoid pattern-dependent gene regulation in the rat hippocampus
Melanie Davies
London
Mon 02 16:30
S5.3
Symposium 5: Premature ovarian insufficiency
Management of oestrogen replacement and potential for fertility in young women with premature ovarian insufficiency
London
Colin Dayan
Cardiff, Wales
Mon 02 19:00
D1.1
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
FOR
Cardiff, Wales
Tue 03 10:30
S6.1
Symposium 6: Clinical implications of thyroid genomics
Thyroid genomics - relevance to thyroid hormone therapy
Cardiff, Wales
Waljit Dhillo
London, UK
Mon 02 12:35
FUT2.3
Futures 2: Overcoming the consultancy hurdle
Research pathways in endocrinology – a UK and global perspective
London, UK
Mon 02 14:45
PL2
Plenary Lecture 2: Society for Endocrinology Medal Lecture
Kisspeptin - a vital trigger of puberty with therapeutic potential
London, UK
Frank Duca
Toronto, Canada
Wed 04 09:45
S10.2
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Gut lipid sensing and energy homeostasis
Toronto, Canada
Jane Evanson
London
Tue 03 10:30
CMW2.1
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Weird and wonderful pituitary imaging
London
Chona Feliciano
Tue 03 14:45
N2.2
Nurse Session 2: Nurse-led clinics
Running a general endocrine nurse-led clinic
Thomas Flint
Tue 03 16:45
S9.2
Symposium 9: The endocrinology of the thin
Paradoxical metabolism neutralizes immunity in cachexia
Gary Frost
Wed 04 10:15
S10.3
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Short chain fatty acids in the regulation of energy homeostasis
Alastair Garfield
Wed 04 14:45
MTE7
Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Designer receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Annalisa Gastaldello
Tue 03 16:45
OC4.3
Oral Communications 4: Diabetes and cardiometabolic complications
5α-Tetrahydrocorticosterone exhibits topical anti-inflammatory action with limited adverse effects on angiogenesis
Laura Gathercole
Tue 03 17:30
OC3.6
Oral Communications 3: Steroids and adrenal
Female 5β-reductase knockout mice are protected from diet induced obesity, insulin resistance and glucose intolerance
Jyothis George
Mon 02 15:30
OC1.1
Oral Communications 1:Early Career Prize Session
A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901
Natalie German
Boston, USA
Mon 02 10:30
S3.1
Symposium 3: Fanning the flames of mitochondrial function
Novel regulation of fat metabolism in cancer
Boston, USA
Jacqueline Gilbert
Mon 02 16:45
CMW1.6
Clinical Management Workshop 1: How do I do it? (I)
How do I manage suspected non compliance for thyroxine replacement?
Anne-Paule Gimenez-Roqueplo
Paris, France
Mon 02 11:30
S2.3
Symposium 2: Zoning in on adrenal tumours
The new genetics of phaeochromocytoma
Paris, France
Thomas Giordano
Ann Arbor, USA
Tue 03 11:30
S6.3
Symposium 6: Clinical implications of thyroid genomics
TCGA genomic characterisation of papillary thyroid carcinoma
Ann Arbor, USA
Professor Neil Gittoes
Birmingham, United Kingdom
Mon 02 15:45
CMW1.2
Clinical Management Workshop 1: How do I do it? (I)
How do I treat osteoporosis after bisphosphonates?
Birmingham, United Kingdom
Caroline Gorvin
Birmingham, UK
Wed 04 12:45
OC6.4
Oral communications 6: Advances in reproduction and signalling
Calcium-sensing receptor internalisation is impaired in cells expressing FHH3-associated AP2σ mutations
Birmingham, UK
Gillian Gray
Wed 04 12:00
S12.1
Symposium 12: Corticosteroids - getting to the heart of the matter
Glucocorticoids and the control of cardiac function
Mrs Jo Grey
Southborough, UK
Tue 03 10:45
SK2.2
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
The battles of writing a lay summary
Southborough, UK
Professor Ashley Grossman
London, UK
Wed 04 14:45
MTE9
Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
Endocrine and non-endocrine aspects of hypothalamic syndromes

Unknown speaker

London, UK
Mark Gurnell
Cambridge, UK
Tue 03 12:15
MTE4
Meet the Expert 4: Investigation and management of TSHoma
Investigation and management of TSHoma

Unknown speaker

Cambridge, UK
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Thyrotropinomas (TSHomas) – do symptoms correlate with disease activity?

Unknown speaker

Cambridge, UK
Gordon Hager
Bethesda, USA
Mon 02 18:30
PL3
Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
An integrated view of nuclear receptor/chromatin interactions
Bethesda, USA
Geoffrey Hammond
Vancouver, Canada
Wed 04 16:15
PL9
Plenary Lecture 9: Society for Endocrinology International Medal Lecture
Controlling the freedom of steroids in health and disease
Vancouver, Canada
Neil Hanley
Wed 04 10:15
APW1.3
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Cell replacement and regeneration of beta cells as novel therapy for diabetes
Kate Hardy
Mon 02 15:30
S5.1
Symposium 5: Premature ovarian insufficiency
Determinants of ovarian follicle reserve: implications for the ageing ovary
Nick Harvey
Mon 02 10:30
S1.1
Symposium 1: Endocrinology meets the environment
Later life consequences of maternal vitamin D deficiency - MAVIDOS Study
Dr Jonathan Hazlehurst
Birmingham, United Kingdom
Tue 03 14:15
OC2.1
Oral Communications 2: Translational pathophysiology and therapeutics
Dual 5-alpha reductase inhibition promotes hepatic lipid accumulation in man as a result of changes to lipid metabolism in adipose tissue and the liver
Birmingham, United Kingdom
Eef Hogervorst
Mon 02 16:00
S5.2
Symposium 5: Premature ovarian insufficiency
Neurological and psychological effects of premature ovarian insufficiency
Anthony Hollenberg
Boston, USA
Tue 03 09:30
PL5
Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
New insights into thyroid hormone action
Boston, USA
Natalie Homer
Edinburgh, UK
Mon 02 12:35
FUT1.3
Futures 1: Branching out with endocrinology
The secret life of a core facilities manager
Edinburgh, UK
Riekelt Houtkooper
Amsterdam, The Netherlands
Mon 02 11:00
S3.2
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial protein homeostasis in the control of metabolism and aging
Amsterdam, The Netherlands
Dr Sasha Howard
London, UK
Mon 02 15:45
OC1.2
Oral Communications 1:Early Career Prize Session
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
London, UK
Sasha Howard
London, UK
Wed 04 12:30
OC6.3
Oral communications 6: Advances in reproduction and signalling
Mutations in HS6ST1 are causal in self-limited delayed puberty, as well as idiopathic hypogonadotropic hypogonadism
London, UK
Waraporn Imruetaicharoenchoke
Wed 04 12:45
OC5.4
Oral communications 5: Thyroid and parathyroid
A novel modulator of cellular invasion and metastasis in endocrine cancer
Adel Ismail
Wed 04 13:12
SE1.5
Senior Endocrinologists Session
Understanding the biochemistry underpinning hypoglycaemia of the Insulin Autoimmune Syndrome (IAS) is paramount for diagnosis and management
Dr Louise Izatt
London , UK
Tue 03 11:00
N1.2
Nurse Session 1: Multiple Endocrine Neoplasia
Genetics and MEN
London , UK
Chioma Izzi-Engbeaya
Tue 03 17:15
OC4.5
Oral Communications 4: Diabetes and cardiometabolic complications
Glucagon Increases Energy Expenditure Independently of Brown Adipose Tissue Activation in Humans
Frederic Jaisser
Paris, France
Wed 04 11:00
PL8
Plenary Lecture 8: Society for Endocrinology European Medal Lecture
Repositioning of the mineralocorticoid receptor antagonists: pathophysiological basis and therapeutic issues 
Paris, France
Jon Johnston
Mon 02 15:30
S4.1
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Sleep: what endocrinologists should know about the body clock
Alasdair Jubb
Wed 04 13:15
OC6.6
Oral communications 6: Advances in reproduction and signalling
Glucocorticoids induce rapid and persistent chromatin remodelling at a glucocorticoid receptor bound locus in macrophages
Professor  Partha Kar
Portsmouth, UK
Mon 02 12:15
FUT2.1
Futures 2: Overcoming the consultancy hurdle
Perspective of a next generation consultant
Portsmouth, UK
Niki Karavitaki
Birmingham, UK
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Challenges in acromegaly - resistance to somatostatin analogues
Birmingham, UK
Alice Kay
Mon 02 11:37
SK1.4
Skills 1: Working with the media
When hormones hit the headlines
Stephen Kershaw
Tue 03 16:30
OC3.2
Oral Communications 3: Steroids and adrenal
Glucocorticoids stabilise the microtubule network to inhibit cell migration
Alexei Kharitonenkov
Bloomington, USA
Tue 03 14:45
S7.2
Symposium 7: The rise and rise of the FGFs in endocrinology
FGF21: Starvation hormone to clinical drug?
Bloomington, USA
Parisut Kimkool
Mon 02 20:20
FUT3.3
Futures 3: Why endocrinology and diabetes?
An Endocrinology Club in your medical school - from concept to reality
Professor Márta Korbonits
London, UK
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Managing treatment resistance in Fimilial Isolated Pituitary Adenomas

Unknown speaker

London, UK
Olympia Koulouri
Wed 04 12:15
OC5.2
Oral communications 5: Thyroid and parathyroid
A novel, missense, mutation (P81R) in the thyrotropin-releasing hormone receptor gene in congenital central hypothyroidism
Graham Leese
Wed 04 13:15
OC5.6
Oral communications 5: Thyroid and parathyroid
Safety review of liothyronine use: a 20 year observational follow up study
Dr Kate Lines
Oxford, UK
Tue 03 15:30
OC2.6
Oral Communications 2: Translational pathophysiology and therapeutics
Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1 (MEN1)
Oxford, UK
Phil Lowry
Wed 04 12:00
SE1.1
Senior Endocrinologists Session
The new tachykinin, endokinin: its role in emesis, sialorrhea and smoking in pregnancy
Kenneth MacDonald
Mon 02 11:14
SK1.3
Skills 1: Working with the media
What journalists need from scientists
Tracy Mak
Tue 03 17:00
OC4.4
Oral Communications 4: Diabetes and cardiometabolic complications
Hyperinsulinaemia due to inhibition of 5α-reductases is ameliorated by liver-selective glucocorticoid receptor antagonism in diet-induced obesity
Alison McNeilly
Tue 03 16:15
OC4.1
Oral Communications 4: Diabetes and cardiometabolic complications
Acute intense exercise restores defective counter-regulation in Type 1 Diabetes through a process of dis-habituation
Eirini Meimaridou
Mon 02 16:00
OC1.3
Oral Communications 1:Early Career Prize Session
RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
Florian Merkle
Wed 04 09:15
APW1.1
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Modelling human diseases with stem cell derived hypothalamic neurones
Karen Miller
Boston, USA
Tue 03 16:15
S9.1
Symposium 9: The endocrinology of the thin
Endocrine dysfunction in anorexia nervosa
Boston, USA
Carla Moran
Dublin, Ireland
Tue 03 16:45
CMW3.2
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Endocrine sequelae of biological therapies
Dublin, Ireland
Annice Mukherjee
Manchester, UK
Wed 04 09:45
CMW4.3
Clinical Management Workshop 4: How do I do it? (II)
How far do I investigate chronic fatigue?
Manchester, UK
Dr Helen Murphy
Cambridge, UK
Tue 03 14:15
S8.1
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Revolutionising Type 1 diabetes metabolic control in pregnancy
Cambridge, UK
Robert Murray
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Interactive case studies
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Assessing disease burden in AI: data from the real world
Leeds Teaching Hospitals NHS Trust, Leeds, UK
John Newell-Price
Sheffield, UK
Mon 02 20:00
FUT3.1
Futures 3: Why endocrinology and diabetes?
What endocrinology did for me – from a consultant’s perspective
Sheffield, UK
Michael O'Reilly
Dublin, Ireland
Mon 02 16:15
OC1.4
Oral Communications 1:Early Career Prize Session
Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome
Dublin, Ireland
Sam O'Toole
Tue 03 14:30
OC2.2
Oral Communications 2: Translational pathophysiology and therapeutics
Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism
Society Office
Mon 02 10:52
SK1.2
Skills 1: Working with the media
Working with press officers to promote your research
Dr Bryn Owen
London, UK
Mon 02 17:30
ECP1.1
Early Career Prize Lectures
Basic Science - The Physiology and Pharmacology of the Fasting-Induced Hormone, FGF21
London, UK
Victoria Parker
Tue 03 11:30
SK2.5
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making social media work for promoting and recruiting science
Munro Peacock
Indianapolis, USA
Tue 03 15:15
S7.3
Symposium 7: The rise and rise of the FGFs in endocrinology
Targeting FGF23 in bone disease
Indianapolis, USA
Dr Nicola Peel
Sheffield, UK
Mon 02 15:30
CMW1.1
Clinical Management Workshop 1: How do I do it? (I)
How do I report and interpret a DXA scan?
Sheffield, UK
Robin Peeters
Rotterdam, The Netherlands
Tue 03 11:00
S6.2
Symposium 6: Clinical implications of thyroid genomics
Genetic underpinning of thyroid function in health and disease
Rotterdam, The Netherlands
Professor Petros Perros
United Kingdom
Mon 02 16:30
CMW1.5
Clinical Management Workshop 1: How do I do it? (I)
How do I prevent thyroid eye disease after radioiodine?
United Kingdom
Wed 04 14:45
MTE8
Meet the Expert 8: Updated thyroid cancer guidelines
Updated thyroid cancer guidelines
United Kingdom
Nelly Pitteloud
Lausanne, Switzerland
Tue 03 14:15
S7.1
Symposium 7: The rise and rise of the FGFs in endocrinology
FGFs and hypogonadism
Lausanne, Switzerland
Marysia Placzek
Sheffield, UK
Wed 04 09:45
APW1.2
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Regeneration in the hypothalamus
Sheffield, UK
Randall Platt
Boston, USA
Tue 03 12:15
MTE5
Meet the Expert 5: What every endocrine researcher should know about genome editing
What every endocrine researcher should know about genome editing
Boston, USA
Vikki Poole
Wed 04 13:00
OC6.5
Oral communications 6: Advances in reproduction and signalling
Pituitary tumor transforming gene binding factor (PBF): a novel modulator of iodide uptake and target for Src phosphorylation in breast cancer
John Pooley
Mon 02 16:30
OC1.5
Oral Communications 1:Early Career Prize Session
Interaction of the MR and GR in the Nucleus and at DNA
Julia Prague
Mon 02 20:10
FUT3.2
Futures 3: Why endocrinology and diabetes?
Let me tell you how it is – from a trainee’s perspective
Marcus Quinkler
Berlin, Germany
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Treatment and management of AI: insights from a German cohort
Berlin, Germany
Richard Quinton
London, UK
Mon 02 10:30
SK1.1
Skills 1: Working with the media
Why should we engage with the media?
London, UK
Dr Martin Read
Birmingham, UK
Wed 04 12:00
OC5.1
Oral communications 5: Thyroid and parathyroid
Functional consequences of germline mutations in a novel non-RET medullary thyroid cancer susceptibility gene
Birmingham, UK
Aled Rees
Cardiff University, United Kingdom
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Current thinking in the management of hyponatraemia and SIADH
Cardiff University, United Kingdom
Rebecca Reynolds
Edinburgh, United Kingdom
Tue 03 14:45
S8.2
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Pregnancy and obesity
Edinburgh, United Kingdom
Rachel Richardson
Tue 03 17:30
OC4.6
Oral Communications 4: Diabetes and cardiometabolic complications
Cardiac fibrosis and the balance between glucocorticoid and mineralocorticoid receptor signalling
Victoria Salem
London, UK
Tue 03 16:30
OC4.2
Oral Communications 4: Diabetes and cardiometabolic complications
Thermal imaging as a novel non-invasive method to measure human brown adipose tissue activity in humans
London, UK
Mario Salvi
Alessandria, Itay
Tue 03 16:15
CMW3.1
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
The thyroid and rituximab
Alessandria, Itay
Nadia Schoenmakers
Cambridge, United Kingdom
Wed 04 13:00
OC5.5
Oral communications 5: Thyroid and parathyroid
Investigating the genetic architecture of gland-in-situ congenital hypothyroidism by comprehensive screening of eight known causative genes
Cambridge, United Kingdom
Peter Selby
Wed 04 09:30
CMW4.2
Clinical Management Workshop 4: How do I do it? (II)
How do I manage refractory hypocalcaemia
Robert Semple
Edinburgh, UK
Mon 02 14:15
PL1
Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
Hyperactive PI-3-Kinase signalling without hormone excess: between cancer and endocrinology
Edinburgh, UK
Cedric Shackleton
Oakland, USA
Wed 04 12:36
SE1.3
Senior Endocrinologists Session
Steroid mass spectrometry: a 50 year history
Oakland, USA
Matthew Simmonds
Tue 03 10:30
SK2.1
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Engaging with the public: conveying the wonders of science
Karolina Skorupskaite
Wed 04 12:00
OC6.1
Oral communications 6: Advances in reproduction and signalling
Neurokinin B receptor antagonist limits kisspeptin-10 induced LH secretion in women
Rowena Speak
Tue 03 15:00
OC2.4
Oral Communications 2: Translational pathophysiology and therapeutics
Development of a long-acting growth hormone antagonist for the treatment of acromegaly
Francesca Spiga
Bristol, United Kingdom
Mon 02 16:00
S4.2
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Rhythms of adrenal glucocorticoid secretion
Bristol, United Kingdom
Helen Spoudeas
Wed 04 10:15
CMW4.5
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hormone replacement in teenagers/young adults with learning difficulties?
Professor Paul Stewart
Leeds, UK
Mon 02 12:25
FUT2.2
Futures 2: Overcoming the consultancy hurdle
Perspective of an established consultant
Leeds, UK
Angela Taylor
Tue 03 14:45
OC2.3
Oral Communications 2: Translational pathophysiology and therapeutics
Further advances in diagnosis of adrenal cancer: a high-throughput urinary steroid profiling method using liquid chromatography tandem mass spectrometry (LC-MS/MS)
Raj Thakker
Oxford, United Kingdom
Tue 03 09:00
PL4
Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
Calcium regulation: from rhinos to molecules
Oxford, United Kingdom
Tue 03 11:15
SK2.4
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making your impact statement pack a punch
Oxford, United Kingdom
Christina Thirlwell
Tue 03 17:15
CMW3.3
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Biological agents in pancreatic neuroendocrine tumours
Christopher Thompson
Dublin, Republic of Ireland
Wed 04 14:45
MTE10
Meet the Expert 10: Diagnosis and management of SIADH
Diagnosis and management of SIADH
Dublin, Republic of Ireland
Ana Tiganescu
Leeds, United Kingdom
Tue 03 16:45
OC3.3
Oral Communications 3: Steroids and adrenal
11β-HSD1-mediated decrease in COX-2 expression is abrogated by hypoxia in human dermal fibroblasts
Leeds, United Kingdom
Paul Tissier
Mon 02 16:30
S4.3
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Dynamics In Hypothalamic-Pituitary Function Over Multiple Time-scales
Jeremy Tomlinson
Oxford, UK
Mon 02 16:15
CMW1.4
Clinical Management Workshop 1: How do I do it? (I)
How do I manage adrenal suppression?
Oxford, UK
Andrew Toogood
Wed 04 10:30
CMW4.6
Clinical Management Workshop 4: How do I do it? (II)
How do I manage men who have used anabolic steroids?
Doug Turnball
Mon 02 11:30
S3.3
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial disease: problems and solutions
Helen Turner
Oxford, UK
Tue 03 15:15
N2.3
Nurse Session 2: Nurse-led clinics
Medicolegal aspects of endocrine nursing
Oxford, UK
Bijay Vaidya
Exeter
Tue 03 15:15
S8.3
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Autoimmune thyroid disease before and during pregnancy
Exeter
Mark Vanderpump
Mon 02 11:00
S1.2
Symposium 1: Endocrinology meets the environment
Iodine deficiency
Katharina Wang
Munich, Germany
Mon 02 16:45
OC1.6
Oral Communications 1:Early Career Prize Session
Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Munich, Germany
Nick Wareham
Wed 04 15:45
AYI1
A year in...Type 2 diabetes
A year in...Type 2 diabetes
Tony Weetman
Mon 02 19:20
D1.2
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
AGAINST
Wilmar Wiersinga
Amsterdam, The Netherlands
Mon 02 11:30
S1.3
Symposium 1: Endocrinology meets the environment
Environmental influences on autoimmunity
Amsterdam, The Netherlands
John Wilding
Liverpool, United Kingdom
Wed 04 09:15
S10.1
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Incretin hormones as regulators of appetite: from concept to clinical use
Liverpool, United Kingdom
Graham Williams
Mon 02 12:15
MTE2
Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
T4 vs T4/T3 – evidence vs expectations?
Karen Winer
Bethesda, USA
Tue 03 12:15
MTE6
Meet the Expert 6: Frontiers in the management of hypoparathyroidism
Frontiers in the management of hypoparathyroidism
Bethesda, USA
Kym Winter
Tue 03 11:30
N1.3
Nurse Session 1: Multiple Endocrine Neoplasia
Psychological support of the MEN patient
Morag Young
Clayton, Australia
Wed 04 12:30
S12.2
Symposium 12: Corticosteroids - getting to the heart of the matter
Selective targeting of the mineralocorticoid receptors (MR) and cardiovascular disease
Clayton, Australia
Faiez Zannad
Nancy, France
Wed 04 13:00
S12.3
Symposium 12: Corticosteroids - getting to the heart of the matter
MR antagonists - lessons from clinical trials
Nancy, France
Bone
P1
FHH3-associated AP2σ Mutations Impair MAPK Signalling Pathways
Angela Rogers, Caroline Gorvin, Michael Whyte, Rajesh Thakker
P2
Exploring the N-ethyl-N-nitrosourea (ENU) mutagenesis DNA archive for mutations in NFIX to derive mouse models for Marshall-Smith syndrome (MSS)
Kreepa Kooblall, Mark Stevenson, Sian Piret, Paul Potter, Roger Cox, Steve Brown, Raoul Hennekam, Rajesh Thakker
P3
Reduction in daily hydrocortisone dose in adrenal insufficiency improves significantly bone mineral density – results from a 2-years prospective trial
Julia Schulz, Kathrin Koetz, Manfred Ventz, Sven Diederich, Marcus Quinkler
P4
Mutations in G-protein Subunit α<sub>q</sub> (GNAQ) are not a Cause of Familial Hypocalciuric Hypercalcaemia (FHH)
Manish Modi, Treena Cranston, Angela Rogers, Sarah Howles, Caroline Gorvin, Rajesh Thakker
P5
Soy protein with isoflavones reduce bone turnover markers in women during their early menopause - A randomised double blind parallel study
Thozhukat Sathyapalan, Mo Aye, Eric S Kilpatrick, Alan S Rigby, William D Fraser, Natalie J Thatcher, Stephen L Atkin
P6
Increased circulating sclerostin levels in type 2 diabetic rats are not associated with changes in bone sclerostin production
Marie Pereira, Stephanie Gohin, Nina Lund, Anne Hvid, Peter Smitham, Michael Oddy, Ines Reichert, Chantal Chenu
P7
Differential effects of Parathyroid Hormone on key regulators of osteoblast mineralisation
Dean Houston, Katherine Myers, Vicky MacRae, Jose Luis Millan, Katherine Staines, Colin Farquharson
P8
Type 2 diabetes, bone mineral density and disc height
Rachel Agius, Stephen Fava
P9
The decreased plasma levels of sclerostin but not Dickkopf-1 are associated with increased risk of osteoporotic fracture and lower bone mineral density in Korean postmenopausal women
Yejee Lim, Jung-Min Koh, Beom-Jun Kim, Moo-Il Kang, Seung Hun Lee, Ki Hyun Baek, Yumie Rhee, Yong-Ki Min, Deog-Yoon Kim, Chong Hwa Kim
P10
A mutation in the Calcium Sensing Receptor (previously known to cause Neonatal Severe Hyperparathyroidism in the homozygote state) causing Familial Benign Hypocalciuric Hypercalcaemia in the heterozygote.
John Hinnie, Andrew Gallagher, Angela Collie
P11
The Effect of Oestradiol Circadian Rhythm on the Bone Mineral Density of Adult Males
Sajini Wijetilleka, Muhammad Khan, Aung Mon, Frank Joseph, William Fraser, Jiten Vora
P12
Familial Hypocalciuric Hypercalcaemia due to AP2S1 mutation in a patient with failed Parathyroidectomies - a case report
Eswari Chinnasamy, Paul Hurley, Katie Snape, Gul Bano
P13
Pre-operative localization of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT): Can a single modality of imaging be adequate?
Hafsa Imran, Paul Wilson, Rebecca Sinha, George Varughese, Ullal Nayak, Lakshminarayanan Varadhan
P14
A rare presentation of primary hyperparathyroidism.
Vidhya R Jahagirdar, Neil J Gittoes
P15
Lessons learnt after failed parathyroidectomy
Antonia Ugur, Rajiv Dave, Daniel Ashmore, Olivia Pereira, Deedar Ali
P16
Melorrheostosis: A rare cause of bone pain and limb deformity
Vinit Kirankumar Shah, Neil Gittoes
P17
Denosumab improves bone density in a female patient with severe anorexia nervosa
Andrew Jamieson, Anthony Pelosi, Georgina Weatherdon
P18
Improved Glycaemia following Parathyroidectomy for Primary Hyperparathyroidism
Rajni Mahto, Umar Raja, Deborah Markham
Clinical biochemistry
P19
A comparison of plasma copeptin and AVP responses during saline infusion studies.
Christopher Boot, Louise Hughes, Stephen Turner, Stephen Ball, Dermot Neely
P20
Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study
Paul Grant, Clare Jamookeeah, Penny Dhanjal, Gethin Griffith
P21
Genetic hypocalcaemia: a case of 22q deletion syndrome
Heather Watson, Alexander McGeoch, Waiel A Bashari, Mohammad I Butt, Samson O Oyibo, Satyanarayana V Sagi
P22
Effect of cortisol assay bias on the overnight dexamethasone suppression test: implications for the investigation of Cushing's syndrome
Rachel Brixey-McCann, Sarah Tennant, John Geen, Annie Armston, Julian H Barth, Brian Keevil, Aled Rees, Carol Evans
P23
Using SDHB immunostaining in characterising Pheochromocytoma and Paraganglioma
Anand Velusamy, Louise Izatt, Moonim Mufaddal, Barbara McGowan, Jonathan Hubbard, Rupert Obholzer, Paul Carroll
P24
Serum cortisol: What is your laboratory measuring?
James Hawley, Laura Owen, Phillip Monaghan, Annie Armston, Carrie Chadwick, Brian Keevil
P25
Vasopressin-2 receptor antagonists: potent but potentially dangerous drugs for the treatment of severe hyponatraemia secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Vikki Tilliridou, Waiel A Bashari, Samson O Oyibo
P26
Lactic Dehydrogenase, a biochemical marker to predict foetal outcome in pregnancies complicated by Intrauterine Growth Restriction  
AMRIT GUPTA, SHYAM PYARI JAISWAR, JYOTI ARORA
P27
Turn off the taps.
Sophie Jones, Mariam Alexander, Christopher Hilton, Sanjeev Mehta
P28
Where are the endocrinologists?
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P29
The Epidemiology of Hyper-prolactinaemia
Enrique Soto-Pedre, Paul Newey, John Bevan, Graham Leese
P30
Audit of management of patients with hypomagnesaemia in district general hospital
K. Tofeec, L. Pichaipillai, T. Bani, A. JOSTEL, Y. Demssie
P31
Single-centre audit of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
Christopher Boot, Barry Toole, Sarah Johnson, Stephen Ball, Dermot Neely
P32
An unusual presentation of osmotic demyelination syndrome
Vinit Kirankumar Shah, Jayadave Shakher
P33
Management of inpatient hypokalaemia: a District General Hospital (DGH) experience
Lucia Chen, Siva Sivappriyan
P34
Alkaline Phosphatase may predict tumour volume in patients with parathyroid adenoma
Hamid Mani, Franceska Lorford, Thrasos Macriyiannis, Miles Levy
P35
Biochemical Evaluation of Adrenal Incidentalomas Referred to Endocrine Surgery in a Large Teaching Hospital
Andrew Davison, Charlotte Hill, Nicki Russell, Alison Waghorn, Susannah Shore
P36
Inhibiting more than the proton pump
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P37
Asymptomatic hypokalaemia in an identical twin
Bnar Talabani, Preethi Nalla, Mohammad Adlan, Lakdasa Premawardhana
P38
Severe hyponatraemia in an inpatient setting - a role for the Endocrinologist?
Eveleigh Nicholson, Jana Bujanova, Iain Cranston
P39
Are we doing to many Short Synecthan Test
mohammad rahman, kofi Obuobie, onyebuchi Okosieme, Nadia El Farhan, Khaliq hamdan
P40
A case of B Cell Lymphoma of brain presenting as Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Suresha Muniyappa, Zulfiquar Zaida, Abdul Abdul
P41
Audit of the diagnosis and management of primary hyperparathyroidism        
Pei Chia Eng, Langstaff Lorna, Kaplan Felicity, Mochloulis George, Winocour Peter
P42
Novel treatment of refractory hypercalcaemia -A serendipitous discovery
Isuri Kurera, Jenny Bosworth, Frances Coyle, Jennifer Tringham, Mehjabeen Beebeejaun, Emma Bingham
Clinical practice/governance and case reports
P43
What is the prevalence of severe post-operative hypocalcaemia in patients who have undergone parathyroid surgery or a total thyroidectomy at the RVI, Newcastle? Does vitamin D play a role?
Anna Pawlak, Richard Quinton, Peter Truran, Thomas Lennard, Richard Bliss, Andrew Heed
P44
Urgent requirement for better patient selection for Short Synacthen Tests: results from a clinical audit.
Bernard Freudenthal, Daniel Beder, Arla Ogilvie
P45
Using Skype follow-up consultations for patients with thyroid disease
Catherine Gouveia, Shanti Vijayaraghavan, Susan Gelding
P46
Review in a specialist Turner clinic improves management
Caroline Packer, Christopher Jones, Paul Clift, Andrew Toogood
P47
A rare incidental cause of Cushing’s syndrome
Khaled Tofeec, Angela Paisley
P48
Partial response to sunitinib therapy in a metastatic dopamine-secreting paraganglioma.
Melanie Nana, Aled Rees
P49
Outcome of patients with Adrenal Incidentalomas: an analysis of  145 patients from a single centre
Emily Austin, Asad Rahim, Lisa Shepherd, Andrew Bates
P50
Early post-operative aldosterone concentration can be used to assess outcome from adrenalectomy in aldosterone producing adenoma
Irfan Baig, Barbara McGowan, Jake Powrie, Jonathan Hubbard, Paul Carroll
P51
Saccular Internal Carotid Artery Aneurysm Masquerading as Pituitary Macroadenoma
Louise Goldsmith, Stella Williams, Nabile Mohsin, Upendram Srinivas-Shankar
P52
Impact of a multidisciplinary diabetic foot clinic on patient outcomes
Lowri Phillips, Louise Osborne
P53
Out-of-hours cover for diabetes and endocrinology: a single UK tertiary centre experience
Sam O'Toole, Nigel Glynn, Cathy Gouveia, Raquel Sanchez Windt, Craig Stiles, Rasheeta Sivapackianathan, Scott Akker, Maralyn Druce, Mona Waterhouse, William Drake
P54
TB or not TB: that is the question
Catriona Farrell, Colin Perry
P55
A case of Polyglandular Autoimmune Disease associated with Common Variable Immunodeficiency
Ishrat Khan, Mirena Noyvirt, Aicha Bouraoui, Penny Owen, Helen Lane
P56
Phaeochromocytoma in pregnancy: good luck and judgement lead to a successful outcome
Mie Mie Tisdale, Neil Burgess, Alastair McKelvey, Debbie O'Hare, Francesca Swords
P57
Audit on Continuous Subcutaneous Insulin Infusion (CSII- Insulin Pump) Therapy:
Giulia Argentesi, Seifeledin Yahia, Anastasios Gazis
P58
Vitamin D deficiency in haemodialysis patients; treatment with colecalciferol.
Sharon Huish, Simon Fletcher, Janet Dunn, Martin Hewison, Rosemary Bland
P59
DIPNECH: under-recognised and a diagnostic challenge
Veneranda Lorelei Salazar, Ronan O'Driscoll, Annice Mukherjee
P60
Sodium-Glucose Co-Transporter 2 Inhibitor associated Normoglycemic Ketoacidosis
Shane Bobart, Benjamin Gleason, Jonathan Schroeder, Nydia Martinez, Keith Norris, Sandra Williams
P61
A novel management of Gitelman's syndrome
Suchitra Raj, Ahkallya Kuganolipava, Abiola Fatimilehin, James Clark, Benjamin Field, Sunil Zachariah
P62
Nothing to "sea" here: turning a blind eye to hyponatraemia
Chloe Broughton, Shaza Ahmed, Beas Bhattacharya
P63
A case to remember
mohammad Rahman, Kofi Obuobie, Tom Hickin, Khaliq Hamdan
P64
Resistant Hypocalcaemia Secondary to Denosumab: Two Case Reports.
Caroline Clay, Jan Hoong Ho, Maia Severn, Kalpana Kaushal, Simon Howell
P65
Multiple endocrine paraneoplastic syndromes in a patient with lung malignancy.
Alex Lewis, Isha Malik, Kelly Cheer, Cuong Dang
P66
National Audit of Transition in Endocrinology: Joint between Society for Endocrinology and the British Society of Paediatric Endocrinology & Diabetes
Helena Gleeson, Avril Mason, Colin Perry, Guftar Sheikh, Lorraine Albon, Antonia Brooke, Sailesh Sankar, Rohana Wright, Paul Dimitri
P67
IgG4 related hypophysitis: A novel candidate to the hypophysitis spectrum
Shemin S Vyas, Simon Page, Seifeldin Yahia, Peter Lanyon
P68
Management of Thyroid Disease in Pregnancy: Experience from an Antenatal Thyroid Clinic
Micha Thomas, Zaki Hassan-Smith, Andrew Bates, Asad Rahim
P69
Endometrial Hyperplasia in Transmen - to scan or not to scan?
Leighton Seal, Iffy Middleton, James Barrett
P70
Steroid responsive hypoglycaemia in a patient with spindle cell sarcoma
Emily Tafadzwa Mudenha, Andrew Okpe, Devaka Fernando
P71
Does the usual time of rising influence the stimulated cortisol response?
Anh Tran, Steve Hyer, Rashim Salota, Nikhil Johri, Andrew Rodin
P72
A woman with thyroid metastases twenty one years after renal carcinoma excision, with biphasic thyroid dysfunction on Sunitinib
Preethi Nalla, Bnar Talabani, Mohamed Adlan, Lakdasa Premawardhana
P73
Immobilisation hypercalcaemia in two intensive care patients
Jodie Sabin, Sharman Harris, Pierre Peyrasse, Ian Johnson, Ginette Jones, Anthony Wilton
P74
Audit  on Hyponatraemia in a West Kent Hospital experience
Nardia Poole, Bijal Patel, Siva Sivappiyan
P75
Large Benign Nerve Sheath Tumour in the Adrenal Gland - An Incidental Finding
Mehjabeen Beebeejaun, Eswari Chinnasamy, Gul Bano
P76
Aromatase inhibitor: A Potential therapy for Obesity Related Hypogonadotropic Hypogonadism and Gynaecomastia
Khin Swe Myint, Neetha Jose, Javier Gmoez, Rupa Ahluwalia, Maya Venu
P77
Pheochromocytoma- experience from a single centre in South India
Dukhabandhu Naik, Riddhi Das Gupta, Asha HS, Thomas V paul, Nitin Kapoor, Mahesh D M, Anish Jacob Cherian, Deepak T Abraham, Nylla Shanthly, Reji OOmen, Anuradha Chandramohan, Banumathi Ramakrishna, Rekha Pai, M J Paul, Simon Rajaratnam, Nihal Thomas
P78
Pituicytoma, Not a ‘Meningioma': Late Recurrence in a Rare Pituitary Tumour
Mahender Yadagiri, Simon Shaw, Natarajan Saravanappa, John Ayuk, Biju Jose
P79
Somatotroph Adenoma Localized with Composite 11C-Methionine-PET/MR Imaging: A Cost Effective Solution.
Leelavathy Kandaswamy, Leoni Lekkakou, Olympia Koulouri, Mark Gurnell, Harit Buch, Ananth Viswanath
P80
Vitamin-D Resistant Idiopathic Hypoparathyroidism
Rushi Shah, Avinash Jain, Varun Buch, Rahul Chaudhary, Harit Buch
P81
Glycogenic Hepatopathy- A tale infrequently told in the Diabetes world
Naveed Khalily, Nida Butt, Anthony Dixon
P82
Should all Short Synacthen Tests be agreed by an Endocrine team?
Peter Jarvis, Georgina Page, Helen Holt, Tristan Richardson, Helen Partridge
P83
Artifactual hypoglycemia - Lesson from a patient with unreliable finger-prick glucose due to absent finger tips
An Shing Ang, Daphne Lee, Varadarajan Baskar
P84
Decreased conscious level and a renal mass
Jolyon Dales, Jenny Prouten, Thrasos Macriyiannis, Marie-France Kong
P85
An Index Case of MEN-1 identified with imaging of the right thigh.
Anne Sillars, S.J. Gallacher
P86
4 years of tolvaptan: experience from two large teaching hospitals.
Joseph Follows, Ahmed Iqbal, Amit Allahabadia
P87
A single centre experience of adrenal vein sampling in a district general hospital serving a remote and rural population.
Evgenia Foteinopoulou, Alistair Todd, Anne Pollock, Marie Van Drimmelen, Roderick Harvey, Sandra MacRury, David MacFarlane
P88
Haemofiltration as a treatment option in refractory life-threatening diabetic ketoacidosis
Adnan Agha, Sarfraz Nawaz, Mazhar Saleem, Sharon Jones, Adeeba Ahmed
P89
Adrenal Insufficiency caused by bilateral primary adrenal lymphoma
Sharon Mackin, David Carty, Russell Drummond
P90
Congenital adrenal hyperplasia - are we really lost in transition?
Colin Perry, Malika Alimussina, Jennifer Locke, Hannah Pearlman, Marie Freel, Guftar Shaikh, Faisal Ahmed
P91
Audit of Plenadren use in selected patients.
Deirdre Maguire
P92
Hypovitaminosis D as a cause of Severe Hypocalcaemia in a Nigerian Female: A case report.
Oluwarotimi Olopade, Oluwakemi Yusuf, Abiona Odeyemi, olawumi Kolawole, Olayinka Owolabi
P93
Evaluation of use of combination dapagliflozin and GLP-1 agonist treatment in type 2 diabetes.
Jennifer Hayden, Feicong Huang, Lyndsey McConnell, Christopher Sainsbury, Gregory Jones
P94
Do guidelines improve the diagnosis and investigation of hyponatraemia?
Chloe Broughton, Emily Lucas, Beas Bhattacharya
P95
Diaphoresis: an unusual initial presenting complaint of Cushing’s Syndrome
Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran
P96
An Unusual Case of "Adrenal" Cushing's.
Leoni Lekkakou, Aamir Naeem, Peter Strouhal, Andrew Garnham, Ananth Viswanath, Harit Buch
P97
Accuracy of sample timing with Short Synacthen Tests at Royal Bournemouth Hospital
Peter Jarvis, Georgina Page, Helen Holt, Tristan Richardson, Helen Partridge
P98
Hyponatremia - An audit of the initial investigation & management
Imran Ghaffar, Paul Downie, Bushra Ahmad, Natasha Thorogood, Paul Thomas, Karin Bradley
P99
A case of haemorrhagic adrenalitis secondary to streptococcus oralis
Safwaan Adam, Shaishav Dhage, Elizabeth Keeler, Naveed Younis
P100
Xerostomia: An unseen consequence of statin use
Shemin Vyas, Alia El-Kadiki, Seifeldin Yahia
P101
A complex case of MEN-1
Dukhabandhu Naik, Mahesh DM, Asha HS, Deepak T Abraham, Nylla Shanthly, Anuradha Chandramohan, Deepak Burad, Banumathi Ramakrishna, M J Paul, Nitin Kapoor, Thomas Paul, Ari G Chacko, Nihal Thomas
P102
Hyperalphalipoproteinemia in an Epileptic patient – Cardiovascular Protection from Carbamaezipine Use?
Gurmit Gill, Biju Jose
P103
Splenunculi Masquerading as Neuroendocrine Tumours.
Emma Walkinshaw, Eleanor Lorenz, Tony Blakeborough, Alia Munir
P104
UK Primary Hyperparathyroidism Clinical Practice Audit
Paul Grant
P105
Pregnancy and Lactation Associated Osteoporosis (PAO) - Two Case Reports
Chung Thong Lim, Ritwik Banerjee
P106
Pseudohypoparathyroidism - A case of delayed diagnosis
Vikram Aarella, Manjusha Rath
P107
Opiate induced multiple pituitary hormone deficits
Jodie Sabin, Ginette Jones, Catrin Barwick, Anthony Wilton
P108
Separate, sequential, endocrine and glycaemic effects of ipilimumab and pembrolizumab in metastatic melanoma
Julia Anstey, Andrew Solomon, Paul Nathan, Heather Shaw
P109
Resistant hyperparathyroidism and hepatitis : Is there a link?
Suchitra Raj, Kavitha Lakshmipathy, James Clark, Benjamin Field, Matthew Cowan, Sunil Zachariah
P110
Hypogonadism in Noonan Syndrome
Andrea Brown, Louise Goldsmith, Claudia Gunga, Fareha Bawa, Upendram Srinivas-Shankar
P111
Hungry bones: a case of severe complications post parathyroidectomy
Anne DeBray, Camille Smyth, Tejaswi Makam, Amar Puttanna, Diana Raskauskiene
P112
Carbamazepine and Cushing's: a cautionary tale of assay interference mimicking disease
Mie Mie Tisdale, Francesca Swords
P113
Foreign bariatric procedures: Help or hindrance for the NHS?
Rhodri King, Mary O'Kane, Simon Dexter
P114
Variation in levels of Macroprolactin in the investigation of secondary hypogonadism
Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Jaimini Cegla, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran
P115
Audit of adult growth hormone replacement therapy in Nottingham
Ian Seetho, Carolyn Chee, Peter Mansell, Simon Page
P116
Erectile Dysfunction, Diabetes Mellitus, Sun-Tan - The Hypogonadism Story with a Difference
Mahender Yadagiri, Laks Varadhan, Changez Jadun, Biju Jose
P117
Cardiac manifestations of a Phaeochromocytoma
Christine J May, Neil Gittoes, Andrew Toogood, John Ayuk
P118
Management of patients with Adrenal Insufficiency attending Galway University Hospital compared with current Best Practice
Sarah Cormican, Ruth Casey, Paula O'Shea, Marcia Bell
P119
An audit in to the investigation of spontaneous hypoglycaemia: experience at a tertiary centre.
Mahesh Katreddy, Laks Varadhan, George Varughese, Mahamood Edavalath, Ananth Nayak
P120
Cyclophosphamide induced seminiferous tubule damage causing raised FSH and LH, and high testosterone levels
Luke McElhinney, Umar Raja
P121
A case of morning headache: Doege-Potter syndrome
Saifuddin Kassim, Anita Pillai, Ruth MacInerney, Isabelle Vanheeswijk, Jhittay Harsimar, Emma Robinson
P122
The Effects of Maggot Debridement Therapy (MDT) on Length of Hospital Inpatient Stay Muhammad Liyawdeen, Chung Thong Lim, Ritwik Banerjee Luton and Dunstable University Hospital, Luton, United Kingdom
Muhammad Liyawdeen, Chung Lim, Ritwik Banerjee
P123
A case of adrenal haemorrhage in severe sepsis
Maria Rita Talla, Alison Mackenzie
P124
A case of Graves’ disease occurring following cessation of the Oral Combined Contraceptive pill
Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran
P125
Benign or malignant adreno-cortical tumour; the relevance of size and androgen secretory capacity
Catherine Cunningham, Michelle Siu, Jenna Deakin, Vineet Prakash, Ahmed Yousseif
P126
Three Cases Highlighting the Varied Clinical Presentations of Adrenal Haemorrhages
Darshi Sivakumaran, Eswari Chinnasamy, Aye Naing, Mohammad Ashraghi, Gul Bano
P127
Asymtomatic Paget's Disease of the Bone in a 62-year-old Nigerian Man: Three Years Post Alendronate Therapy.
Clement Aransiola, Arinola Ipadeola
P128
Does thyroid armour cause autoimmune thyroid disease?
Vilashini Arul Devah, Moulinath Banerjee, Ambar Basu
Cytokines and growth factors
P129
Expression of Cytokines in Placenta from Pregnancies Complicated by Intrauterine Growth Restriction with Abnormal Umbilical Artery Doppler Indices
Amy Kelly, Meg Hill, Kathryn Reed, Sean Limesand
P130
Interleukin-27:  A predictive marker for  diabetic retinopathy progression
Maha houssen, Amr El-Kannishy, Dalia Sabry, Mona Abo Bakr EL-Hussiny, Rasha hassan el Mahdy, mohamed El-sayed Shaker
Growth and development
P140
Hormonal control of β-cell proliferation in fetal ovine pancreatic islets in vitro
Shelley E Harris, Amy Kelly, Melissa A Davis, Miranda Anderson, Alison J Forhead, Sean W Limesand
P141
Inter-correlations between placental genes regulating fetal glucocorticoid exposure and IGF2 in maternal severe obesity: a mechanism for higher birthweight?
Theresia Mina, Simon Riley, Jane Norman, Rebecca Reynolds
P142
Human fetal adrenal gland development and effects of maternal smoking
Zoe C. Johnston, Panagiotis Filis, Michelle Bellingham, Peter J. O'Shaughnessy, Paul A. Fowler
P143
VITAMIN D PROMOTES MYOGENIC DIFFERENTIATION AND INDUCES AN ANTIFIBROTIC PHENOTYPE IN PRIMARY CULTURES OF SKELETAL MUSCLE DERIVED SATELLITE CELLS AND FIBROBLASTS
Amanda Daoud, Irene Kim, Keith Norris, Monica Ferrini, Jorge Artaza
P144
Hypothyroidism, altered leptin and c-reactive protein synthesis characterized pregnancy exposed to genistein
Funmileyi Awobajo
Neoplasia, cancer and late effects
P145
Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma - impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis
Vasileios Chortis, Angela Taylor, Craig Doig, Eirini Meimaridou, Lou Metherell, Wiebke Arlt, Paul Foster
P146
The somatostatin analogue pasireotide decreased proliferation and increased apoptosis in pancreatic and pituitary neuroendocrine tumors (NETs) in a Multiple Endocrine Neoplasia type 1 (MEN1) mouse model.
Mark Stevenson, Gerard Walls, Ben Soukup, Kate Lines, Ashley Grossman, Herbert Schmid, Rajesh Thakker
P147
Steroid Sulphatase and G-protein Coupled Oestrogen Receptor in Human Colorectal Cancer: Correlation with Late-Stage Disease and Potential Therapeutic Targets.
Habibur Rahman, Lorna Gilligan, Anne-Marie Hewitt, Dion Morton, Paul Foster
P148
PTTG is phosphorylated at residue T60 and regulates p53 stability, in conjunction with PBF, in head and neck cancer.
Bhavika Modasia, Martin L Read, Vicki E Smith, Andy S Turnell, Peter C Rae, Rachel J Watkins, Waraporn Imruetaicharoenchoke, Vikki L Poole, Hisham Mehanna, Chris J McCabe
P149
Distinct p53 Response Profiles in Transgenic Mouse Models of Thyroid-specific PBF and PTTG Expression
Martin Read, Jim Fong, Waraporn Imruetaicharoenchoke, Bhavika Modasia, Greg Lewy, Gavin Ryan, Neil Sharma, Vicki Smith, John Watkinson, Kristien Boelaert, Andrew Turnell, Christopher McCabe
P150
Follow up of differentiated thyroid cancer survivors during pregnancy: A retrospective analysis
Rhodri King, Medha Rathod, Emma Ward
P151
Pituitary-related outcomes of cranial radiotherapy (cXRT) in adults with gliomas.
Nikolaos Kyriakakis, Julie Lynch, Steve M. Orme, Georgina Gerrard, Paul Hatfield, Carmel Loughrey, Susan C. Short, Robert D. Murray
P152
Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides
Ben Challis, Nicolai Albrechtsen, Vishakha Bansiya, Keith Burling, Peter Barker, Bolette Hartmann, Fiona Gribble, Stephen O'Rahilly, Jens Holst, Helen Simpson
P153
Novel targeted treatment combinations for malignant neuroendocrine tumour Olfactory Neuroblastoma
Karen Young, Ghassan Alusi, Marta Korbonits
P154
Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor
Dominic Cavlan, Helen Storr, Dan Berney, Chris Evagora, Peter King
P155
Primary cilia: a new player in phaeochromocytoma pathogenesis?
Sam O'Toole, Umasuthan Srirangalingam, William Drake, Paul Chapple
P156
Adverse metabolic profile in long-term survivors of adult and childhood-onset brain tumours:the role of growth hormone deficiency
Julie Lynch, Nikolaos Kyriakakis, Satish S. Kumar, Ramzi Ajjan, Georgina Gerrard, Carmel Loughrey, Adam Glaser, Robert D. Murray
P157
Ultrasound-guided percutaneous ethanol ablation for selected patients with papillary thyroid microcarcinoma: a novel, effective and well tolerated alternative to neck surgery or observation.
Ian Hay
P158
Clot structure analysis in survivors of acute lymphoblastic leukaemia: the role of growth hormone deficiency
Nikolaos Kyriakakis, Satish S. Kumar, Julie Lynch, Natalie Oxley, Fladia Phoenix, Ramzi Ajjan, Robert D. Murray
P159
Use of Sunitinib in Refractory Hypercalcaemia in Pancreatic Neuroendocrine Tumours.
Ladan Akbarian-Tefaghi, Jonathan Wadsley, John Newell-Price, Alia Munir
P160
Chromogranin B: a possible prognostic biomarker for neuroendocrine tumours?
Nipuni E Wanniachchi Wanigasekara, Paul Bech, Kevin Murphy
P161
Imaging and evaluating side effects of antiandrogen therapy
Serena Tommasini-Ghelfi, D. Alwyn Dart Dart, Charlotte Bevan
P162
Outcome of insulinomas diagnosed in a tertiary endocrine center
Raluca Trifanescu, Ionela Baciu, Monica Gheorghiu, Anda Dumitrascu, Catalina Poiana
P163
Metastatic paraganglioma with isolated 3-methoxytyramine rise in a patient with SDHC mutation
AKRAM ALKREKSHI, SACHIT ABHAYARATNA, SARAH PITKIN, ANNE DAWNAY, STEPHANIE E BALDEWEG
P164
Recurrent Phaeochromocytomas In Type2C Variant of Von Hippel-Lindau Syndrome 
Mehjabeen Beebeejaun, Eswari Chinnasamy, Gul Bano
P165
Lutetium ablation therapy as treatment for recurrent metastatic bladder paraganglioma
Sachith Abhayaratna, Taofeek Ojewuyi, Mark Gaze, P Kar, Stephanie E Baldeweg
P166
Somatostatin responsive ACTH and precursor excess in a midgut mesentery NET.
GK Dimitriadis, A Nasoodi, S Khan, W Shatwell, L Chambers, C Tomkins, C Darby, K Gopalakrishnan, HS Randeva, N Murthy, MO Weickert
P167
Primary Adrenal Lymphoma
Uzma Faruqi, Pawel Kaczmarek, Gleb Ivanov, Benjamin Field
P168
Metastatic small bowel Neuroendocrine tumour with bilateral carcinoid heart disease
Vidhya R Jahagirdar, Ali D Kamal, Rick Steeds, Stacey Smith, John Ayuk
P169
Familial Insulinoma in the absence of MEN
Danielle Jeffreys, Georgina Page, Helen Partridge, Tristan Richardson
P170
A young girl with bilateral adrenal tumours.
Sakina Koubeh, Pushpa Jinadev, Moayed Alhelfi, Julian Davis
P171
Acromegaly in association with a bronchial carcinoid tumour
Andrzej Rys, Jamie Smith
P172
Challenges in the diagnosis and management of a case of glucagonoma first presenting as a localised genital rash.
Frances Hunt, Farheen Raza, Agbor Ndip, Paula Chattington
P173
A management dilemma - emergency treatment of primary hyperparathyroidism in suspected but unconfirmed Multiple Endocrine Neoplasia type 1
Ramneet Khurana, Ashu Gandhi, Basil Issa
P174
PROMOTER METHYLATION SIGNATURES OF BRCA2 AND TP53 GENES IN THE SERUM OF SOME BREAST CANCER PATIENTS ATTENDING RADIOTHERAPY CLINIC IN LAGOS, NIGERIA
TITILOLA SAMUEL, BABATUNDE JAMES, AHMED ADARA-ALI, YETUNDE FAYODA, MYM HABEEB
P175
Confusion in a Patient with Carcinoid Syndrome
Vikram Aarella, Hannah Dix, Stuart Lee
Nursing practice
P176
Utilisation of Nurse Led Clinics in Endocrinology Practice
Lisa Shepherd, Anne Marland, Rachel Austin, Helen Turner
P177
How is the Society for Endocrinology Competency Framework for Adult Endocrine Nursing used in Practice?
Veronica Kieffer, Kate Davies, Christine Gibson, Morag Middleton, Jean Munday, Shashana Shalet, Lisa Shepherd, Phillip Yeoh
P178
Pre-pituitary Surgery Patient Satisfaction Audit 2015
Vivien Thornton-Jones, Helen Turner, Simon Cudlip, Ashley Grossman
P179
Development of IT based nurse led endocrine tracking system
Sue Cox, Kate Lissett
P180
A care service model for cost effective and structured individualised treatment choice for growth hormone replacement therapy
Sofia Llahana, Awal Mumuni, Marta Osz, Mawgen Baber, Stephanie Baldeweg, George Gannon, Gerard Conway
P181
Recurring Abscesses at Injection Sities on the Home Injection Programme
Morag Middleton
Obesity, diabetes, metabolism and cardiovascular
P182
Testing causality in the association of plasma cortisol with risk of coronary heart disease: a Mendelian randomisation study
Andrew Crawford, Nicholas Timpson, George Davey Smith, Brian Walker
P183
Gender-related differences in circulating microparticles characteristics: implications for cardiovascular risk?
Justyna Witczak, Aled Rees, Philip James
P184
Longer duration of sitting down in pregnancy is associated with gestational diabetes, greater weight gain and depressive symptoms
Nithya Sukumar, Jacqueline Farmer, Hema Venkataraman, Ponnusamy Saravanan
P185
Transcriptome Profiles of Human Pancreatic Islets Following Transient Ischemia Identify Inflammatory and Cell Death Responses. 
Amy Kelly, Kate Smith, Fiona McCarthy, Breonna Smith, Vasudeo Badarinarayana, Leah Steyn, Peter Strop, Sean Limesand, Klearchos Papas
P186
Studies of Nuf mice with an activating calcium-sensing receptor (CaSR) mutation demonstrate the CaSR to regulate pancreatic beta-cell mass and glucose homeostasis
Valerie N Babinsky, Fadil M Hannan, M Andrew Nesbit, Alison Hough, Michelle Stewart, Elizabeth Joynson, Tertius A Hough, Liz Bentley, Abhishek Aggarwal, Enikö Kallay, Sara Wells, Roger D Cox, Duncan Richards, Rajesh V Thakker
P187
ROLE OF ORAL CHOLECALCIFEROL AS ADJUVANT THERAPY IN TYPE 1 DIABETES MELLITUS: RANDOMIZED CONTROLLED TRIAL
Shreya Sharma, Niranjan Biswal, Medha R, Sadish Kumar Kamalanathan, Adhisivam B
P188
PREVALENCE AND DETERMINANTS OF METABOLIC SYNDROME AMONG HIV INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN KANO, NORTHWESTERN NIGERIA
FAKHRADDEEN MUHAMMAD, RAHILA MUKHTAR, ENIKUOMEHIN ADENIKE, FAUZIYYAH MUHAMMAD, IBRAHIM GEZAWA
P189
The effect of L-arginine on anorectic gut hormone release in humans
Anjali Amin, Christina Neophytou, Kevin Murphy
P190
Generation of a long acting GCSF for treatment of neutropenia and stem cell harvest
Abdulrahman Alshehri
P191
Hypercortisolaemia increases femoral adipose tissue blood flow but not net fatty acid release in vivo.
Konstantinos Manolopoulos, Iwona Bujalska, Steve Luzio, Wiebke Arlt, Jeremy Tomlinson
P192
CENTRAL IL-6 SIGNALLING AND THE DEVELOPMENT OF IMPAIRED INSULIN SECRETION IN TYPE2 DIABETES
Adonis Yiannakas, Alison D. McNeilly, Jennifer Gallagher, Kathryn Wright, Rory J. McCrimmmon
P193
Women with idiopathic intracranial hypertension (IIH) have a distinct andro-metabolic signature compared to polycystic ovary syndrome (PCOS) and simple obesity.
Michael O'Reilly, Punith Kempegowda, Hannah Botfield, Fizzah Ali, Angela Taylor, Beverley Hughes, Jeremy Tomlinson, Wiebke Arlt, Alex Sinclair
P194
Differences between Men and Women in Markers of Dietary Fatty Acid Oxidation
Catriona McNeil, Camilla Pramfalk, Michael Pavlides, Fredrik Karpe, Leanne Hodson
P195
Establishing Human Liver Cell Models to Investigate the Effects of Exogenous Metabolic Substrates on Fatty Acid Partitioning
Charlotte Green, Catriona McNeil, Karl Morten, Leanne Hodson
P196
Evidence for 11β-HSD1 regulation of brain energy metabolism following systemic inflammation
Manu Verma, Tiina Kipari, Jonathan Seckl, Megan Holmes, Karen Chapman
P197
Impact of number of transplanted human islet equivalents on successful return to normoglycaemia in an NSG diabetic mouse model.
Andrew Bond, June Noble, John Casey, John Campbell, Shareen Forbes
P198
Vascular dysfunction in horses with insulin resistance
Ruth Morgan, John Keen, Brian Walker, Patrick Hadoke
P199
Evidence for improved mitochondrial efficiency in adipose tissue of T2DM women after malabsorptive but not restrictive bariatric surgery
Lucia Martinez de la Escalera, Laura Jackisch, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Milan Piya, Sudhesh Kumar, Gyanendra Tripathi, Philip McTernan
P200
AMPK activators modulate pro-inflammatory responses in human adipocytes
Anna White, Sarah Mancini, Aurelie Nguyen Dinh Cat, Augusto Montezano, Ian Salt, Rhian Touyz
P201
eNAMPT-monomer plays a critical role in pathophysiology of experimental diabetes and represents a novel target for treatment of type 2 diabetes
Julius Kieswich, Marta Silvestre, Steven Harwood, Muhammad Yaqoob, Paul Caton
P202
Predictors of glycaemic response and impact on weight and BP of dapagliflozin therapy in type 2 diabetes
Feicong Huang, Lyndsey McConnell, Christopher Sainsbury, Gregory Jones
P203
Pre-operative assessment for Sleep apnoea in patients referred for bariatric surgery: the usefulness of various clinical screening tools
Chrysiis Martinou, Ullal Nayak, George Varughese, Ajit Thomas, Martin Allen, Lakshminarayanan Varadhan
P204
Effect of Vitamin D supplementation on cardiovascular risk factors and exercise performance in healthy subjects; a randomised placebo controlled pilot study
Nimrah Munir, Raquel Revuelta Iniesta, Emad A S AL-DUJAILI
P205
EVALUATION OF ADIPOCYTOKINES AND TRADITIONAL CARDIOMETABOLIC RISK FACTORS IN YOUNG MALE CANCER SURVIVORS: AN AGE-MATCHED CONTROL STUDY
Diana Greenfield, Alice Blewitt, Robert Coleman, Jennifer Walsh, John Snowden, Richard Ross, Thang Han
P206
Low Vitamin B12 in pregnancy is associated with maternal obesity and gestational diabetes
Nithya Sukumar, Sean Wilson, Hema Venkataraman, Ponnusamy Saravanan
P207
Adrenaline Mediated Metabolic and Functional Quiescence Protects Insulin Producing Cells From Hypoxia
Amy Kelly, Rachel Smith, Samantha DiBase, Hailey Davenport, Sean Limesand
P208
Bile acids stimulate GLP-1 release predominantly by accessing basolateral GPBAR1 (TGR5)
Cheryl A Brighton, Juraj Rievaj, Rune E Kuhre, Leslie L Glass, Jens J Holst, Fiona M Gribble, Frank Reimann
P209
Vitamin B12 deficiency alters adipogenesis and associated microRNA's in human adipocytes
Antonysunil Adaikalakoteswari, Manu Vatish, Philip McTernan, Harpal Randeva, Gyanendra Tripathi, Ponnusamy Saravanan
P210
Proteomic detection of extracellular matrix proteins in insulin-resistant skeletal muscle
Li Kang, De Lin, Claire Sneddon
P211
Longitudinal changes in adipose tissue gene expression profile are asociated with deteriorating glucose tolerance
Conor Woods, Rachel Crowley, Laura Gathercole, Beverly Hughes, Joanna Gray, Theresa McCarthy, Nicola Crabtree, Paul Stewart, Jeremy Tomlinson
P212
Distinguishing different subtypes of aldosterone-producing adenoma by histological, immunohistochemical & radiological features; a basis for individualised treatment strategies in primary aldosteronism?
Andrew S Powlson, Ada Teo, Lalarukh Haris, Carmela Maniero, Alison Marker, Elena Azizan, Mark Gurnell, Morris J Brown
P213
Adrenal insufficiency following bariatric surgery
Chinnadorai Rajeswaran, Sarah Oglesby, Syed Zulfiqar Raza Zaidi, Suresha Muniyappa
P214
Discovery and localisation of the expression of calcitonin-type and CRH-type neuropeptide precursors in an echinoderm
Weigang Cai, Michaela Egertova, Yusef Badi, Dean Semmens, Maurice Elphick
P215
The Role of Vitamin B12 deficiency in Molecular Mechanism of Metformin
May Oo Khin, Adaikala Antonysunil, Warunee Kumsaiyai, Philip Voyias, Philip Mcternan, Simon Gates, Gyanandra Tripathi, Ponnusamy Saravanan
P216
Enhanced orbitofrontal cortex activation following sympathetic neural stimulation in young women with polycystic ovary syndrome: an fMRI study
Andrew Lansdown, Esther Warnert, Richard Wise, Aled Rees
P217
Enhanced insulin secretion and insulin action in young lambs with intrauterine growth restriction
Leticia Camacho, Sean Limesand
P218
Glucocorticoid excess increases hypothalamic AgRP and results in obesity and hyperinsulinaemia in mice
Jonathan Wray, Erika Harno, Alison Davies, Charlotte Sefton, Thanuja Gali Ramamoorthy, Tiffany-Jayne Allen, Anthony P Coll, Anne White
P219
Non-selective Beta-Adrenergic Agonist Infusion Acutely Stimulates the Temperature of Brown Adipose Tissue in Adult Males
Hannah Scotney, Michael Symonds, James Law, Helen Budge, Don Sharkey, Konstantinos Manolopoulos
P220
Endogenous ARX knockdown enhances beta-cell lineage specification and maturation during ex vivo transdifferentiation of human exocrine pancreatic tissue
Maria Joao Lima, Hilary M Docherty, Kenneth R Muir, Shareen Forbes, John Casey, Kevin Docherty
P221
Altered Adipocytes in an Ovine Model of Polycystic Ovary Syndrome (PCOS)
Katarzyna Siemienowicz, Flavien Couckan, Avi Lerner, Steve Franks, Mick Rae, Colin Duncan
P222
Transcriptional Profiles Explain Insulin Hypersecretion Following Chronic Adrenergic Stimulation in Fetal Sheep Islets
Amy Kelly, Xiaochuan Chen, Christopher Bidwell, Fiona McCarthy, Sean Limesand
P223
Measuring the contribution of de novo lipogenesis to fatty liver disease: a mouse and translational human study using high resolution mass spectrometry
Francis Sanders, Matthew Harvey, Zsuzsanna Ament, Jessie Tingley, Michele Vacca, Julian Griffin
P224
The hypoglycaemic and antioxidant properties of oleanolic acid ameliorate blood pressure and kidney function of experimental animals
Andile Khathi, Bonisiwe Mbatha, Cephas T Musabayane
P225
Dietary Cocoa (Theobroma cacao) and Turmeric (Curcuma longa) Consumption: A Comparison of Metabolic Effect in High-Fat Fed Rats
Olufeyi Adegoke, Olufemi Morakinyo, Daniel Adekunbi, Wurola Ajibola
P226
Glucose tolerance, insulin sensitivity and adiponectin level in niacin-treated obese rats
Olufemi Morakinyo, Titilola Samuel, Daniel Adekunbi, Olufeyi Adegoke
P227
Circadian rhythm of Ambulatory Blood Pressure in rotating night shift nursing professionals and its relation with  6- Sulfatoxy Melatonin as neuroendocrine chronomolecule.
B Anjum, Narsingh Verma, Sandeep Tiwari, Ranjana Singh, Abbas Mahdi
P228
<em>Characterising fat distribution and response to weight loss in Idiopathic Intracranial Hypertension</em>
Fizzah Ali, Michael O'Reilly, Hannah Botfield, Keira Markey, Jeremy Tomlinson, Wiebke Arlt, Alexandra Sinclair
P229
Anti-inflammatory effects of metformin and their relationship to the therapeutic action of the drug
Amy Cameron, Calum Forteath, Craig Beall, Graham Rena
P230
Maternal overnutrition programs hypothalamic neuropeptides and metabolic syndrome in offspring
Thanuja Gali Ramamoorthy, Tiffany-Jayne Allen, Alison Davies, Erika Harno, Charlotte Sefton, Jonathan Wray, Christopher Murgatroyd, Anne White
P231
“Thin-fat”  phenotype in early fetal life in GDM pregnancies – Novel evidence from an Indian Cohort
Hema Venkataraman, Uma Ram, A Anuradhai, S Suresh, P Saravanan
P232
Functional significance of renal gene expression changes in a mouse model of ACTH-dependent Cushing's Syndrome
Marie-Louise Monaghan, Nichole Sime, Bryan Conway, Matthew Bailey, Christopher Kenyon
P233
Brown adipose tissue plays a role in regulating fetal growth by undergoing a gestational-dependent phenotypic change
Saraid McIlvride, Shadi Abu-Hayyeh, Georgia Papacelovoulou, Eugene Jansen, Jennifer Steel, Xanthi Maragkoudaki, Catherine Williamson
P234
Seasonal variation of HbA1c
Jordan Burgess, Paul Broughton, Graham Leese
P235
RELATIONSHIP BETWEEN HIGH-SENSISTIVITY C-REACTIVE PROTEIN AND ANTHROPOMETRIC INDICES OF OBESITY
David Soyoye, Babatope Kolawole, Rosemary Ikem, Adenike Enikuomehin
P236
2beta-hydroxybetulinic acid 3beta-caprylate: an active principle from euryale ferox salisb. seeds with antidiabetic, antioxidant, pancreas & hepatoprotective potential in streptozotocin induced diabetic rats
Danish Ahmed, Manju Sharma, Vikas Kumar, Harish Kumar Bajaj, Amita Verma
P237
Clinical Profile and Outcome of Patients with Hyperglycaemic Emergencies Presenting at a Rural Hospital in Southern Nigera
Orebowale Olugbemide, Patrick Adunbiola, Idowu Bankole, Kennedy Akhuemokhan
P238
DIABETIC NEUROPATHY: AN EVALUATION USING THE NTSS-6 QUESTIONAIRE AND BIOTHESIOMETRY IN TYPE 2 DM PATIENTS.
Lawal-Bello AT, Owolabi FA, Yusuff OT, Amjo OO, Raiyemo OA, kolawole BA, Ikem RT
P239
Hypothalamic glucocorticoid levels increase in an in vivo model of glucocorticoid-induced obesity and hyperinsulinaemia
Charlotte Sefton, Erika Harno, Alison Davies, Helen Small, Tiffany-Jayne Allen, Jonathan Wray, Thanuja Gali Ramamoorthy, Anthony P Coll, Anne White
P240
Effects of androgen on the adipokinome and metabolic genes in white and brown adipose tissue
Avi Lerner, Drashti Kewada, Anthony Okolo, Kate Hardy, Stephan Franks
P241
From the bronze age to the iron age
Sheila Grecian, Safwaan Adam, Akheel Syed
P242
Characterisation of the astrocytic response to acute and recurrent hypoglycaemia
Julia Vlachaki Walker, Mike Ashford, Rory McCrimmon, Craig Beall
P243
Markers of adipose tissue hypoxia are elevated in subcutaneous adipose tissue of morbidly obese patients with hypoventilation syndrome and obstructive sleep apnoea syndrome but not in the moderately obese
Marijana TodorčevićTodorčević, Luke Austen, Ari Manuel, Zoi Michailidou, John Stradling, Fredrik Karpe
P244
PREVALENCE OF DIABETES MELLITUS AMONG HIV PATIENTS IN KANO, NORTHWESTERN NIGERIA.
FAKHRADDEEN MUHAMMAD, ANDREW ULOKO, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD
P245
Obstructive sleep apnoea (OSA) and bariatric surgery: The need for more universal screening and post-operative follow up
Chrysiis Martinou, Ullal Nayak, Mahesh Katreddy, George Varughese, Lakshminarayanan Varadhan
P246
The effect of soy protein with and without isoflavones in men with type 2 diabetes mellitus and subclinical hypogonadism - A randomised double blind parallel study
Thozhukat Sathyapalan, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin
P247
Is polycythaemia a marker of an increased cardiovascular risk in transmen?
Aye Naing, Lily Lei, Katie Jones, James Barrett, Leighton Seal
P248
COST OF ILLNESS AMONG PATIENTS WITH DIABETIC FOOT ULCER IN SECONADRY AND TERTIARY HEALTH FACILITIES IN KANO, NORTHWESTERN NIGERIA
FAKHRADDEEN MUHAMMAD, LATEEFAH PEDRO, HASSAN SULEIMAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD, ANDREW ULOKO
P249
Impact of DAFNE and subsequent CSII therapy on Glycaemic Control in Type-1 Diabetes Mellitus
Saba Yunus, Hannah Forde, Sonya Browne, Helen Twamley, Eimear Fanning, Diarmuid Smith
P250
Lifelong exposure to sewage sludge chemicals causes proteome-wide and sex-specific disturbances in the liver
Panagiotis Filis, Emily Eaton-Turner, Michelle Bellingham, Maria Amezaga, Beatrice Mandon-Pepin, Neil Evans, Richard Sharpe, Corinne Cotinot, Stewart Rhind, Peter O'Shaughnessy, Paul Fowler
P260
GLP-1 agonist based therapy has modest effect on weight and glycaemic control among UAE patients with diabetes: analysis of data on 3725 patients 
Raya A Almazrouei, Fatima M Alkaabi, Nader Lessan, Maha T Barakat
P261
EXTRACTS OF HYMENOCARDIA ACIDA AMELIORATE INSULIN RESISTANCE IN SKELETAL MUSCLE CELLS.
II Ezeigbo, S Gibbons, ME Cleasby
P262
A Study of Metabolic Syndrome among HAART Naïve HIV Patients in Kano, North Western Nigeria
FAKHRADDEEN MUHAMMAD, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD, IBRAHIM GEZAWA
P263
Anthropometric Indices: Optimal cut-off for abdominal obesity in adult Nigerians
Ejiro Umuerri, Christiana Ayandele, Godson Eze, Chinedu Anizor
P264
INFLUENCE OF GENDER ON THE DISTRIBUTION OF TYPE 2 DIABETIC COMPLICATIONS AT THE OBAFEMI AWOLOWO TEACHING HOSPITAL, ILE-IFE, NIGERIA
Adenike Enikuomehin, Babatope Kolawole, Rosemary Ikem, Bukunmi Soyoye
P265
A study of the influence of West African ethnicity and gender on beta cell function and insulin sensitivity in essential hypertensives treated with hydrochlorothiazide and hydrochlorothiazide-Lisinopril combination
Micheal Olamoyegun, Babatope Kolawole, Adesuyi Ajayi
P266
COMPARISON OF SURROGATE MEASURES OF PERCENTAGE BODY FAT WITH BIOELECTRIC IMPEDANCE  IN NIGERIANS
ALALADE BOLADAE, IWUALA SANDRA, ODENIYI IFE, FASANMADE OLUFEMI, OHWOVORIOLE AUGUSTINE
P267
Evidence of Fetal Growth Restriction in South-Asian (SA) foetuses of GDM mothers ?
Hema Venkatarman, Sam Craik, Nithya Sukumar, Ponnusamy Saravanan
P268
Prediabetes incidence and risk of developing cardiovascular disease in women with polycystic ovary syndrome
Zelija Velija Asimi, Sabina Semiz, Tanja Dujic
P269
Improving glycaemic control in T1DM: The FIFE Diabetes Structured Education Programme
Luke Boyle, Fiona Jamieson, Denise Burns, Katie Duncan, Jill Malcolm, Leslie White, John Chalmers, Louise Osborne, Catherine Patterson
P270
Intra-Individual correlation between Flow Mediated Dilation (FMD) and Reactive Hyperaemia Peripheral Arterial Tonometry (RH-PAT) in PCOS
Ehtesham Ehtesham, Zeeshan Javed, Eric S Kilpatrick, Stephen L Atkin, Thozhukat Sathyapalan
P271
Evaluation of Hypoglycemia unawareness in individuals with Type 1 Diabetes Mellitus using  Continuous glucose monitoring(CGM)  in a tertiary care center.
Dukhabandhu Naik, Shilpa R M, Mahesh D M, Asha H S, Nitin Kapoor, Thomas Paul, Padmanabhan V, Mercy Inbakumari, Flory Christina, Jansi Rani, Divya Natarajan, Jeyaseelan L, Nihal Thomas
P272
Postnatal screening in patients with gestational diabetes
Nishal Nimish Patel, Yamini Malhotra, Satyanarayana Sagi, Muhammad Imran Butt
P273
Prevalence of Vitamin D deficiency and its association with Diabetes Mellitus in a South-Asian population.
Kavinga Gunawardane, Noel Somasundaram, Neil Thalagala, Pubudu Chulasiri, Sudath Fernando
P274
What the Mouth has to say about Diabetes in a Nigerian Tertiary Hospital
Ogunmuyiwa Stella, Adesina Olubiyi, Alalade Boladale, Otukoya Adedeji, Adewusi Titilope, Olukunle Oluwale, Bello Adejoke
P275
ANTHROPOMETRIC INDEXES CORRELLATE OF BODY FAT PERCENTAGE AMONG NIGERIANS
GBADEBO AJANI, MICHAEL OLAMOYEGUN
P276
Lipid Profile In Apparently Healthy Nigerian Adults
Mansur Ramalan, Andrew Uloko, Muhammad Fakhradeen, Ibrahim Gezawa
P277
Overweight and Obesity in a rural Nigerian Adult Population
Mansur Ramalan, Bage Aishatu, Muhammad Fakhrudeen
P278
Comparison of glycaemic control in patients with Type-1 Diabetes Mellitus on CSII therapy with different basal rates.
Saba Yunus Yunus, Hannah Forde, Sonya Browne, Anne Moore, Eimear Fanning, Diarmuid Smith
P279
Effects of gypenoside on pancreatic beta cell function and insulin secretion
Chinmai Patibandla, Steven Patterson, Xinhua Shu
P280
GPR142 plays a critical role in Tryptophan-induced insulin and incretin secretion in mice
Hua Lin, Alexander Efanov, Xiankang Fang, Lisa Beavers, Xuesong Wang, Isabel Gonzalez, Tianwei Ma
P281
Inborn errors of metabolism and the endocrinologist
Waiel A Bashari, Samson O Oyibo
P282
An Unusual Case of Fish Odour Syndrome- Tabloid paper helped in diagnosis?
Ambar Basu, Moulinath Banerjee
P283
EGFR using CKD-EPI, MDRD and Cockcroft- Gault and glycaemic control among type 2 diabetics in an out- patient clinic in Nigeria
amanda onwah, omotola ayandele, eunice chike- ezue, anthony kweki
P284
CORRELATES OF DYSGLYCAEMIA AND IMPLICATIONS FOR DIABETES CARE IN CALABAR, NIGERIA.
Ofem Enang, Akinyele Akinlade, Olufemi Fasanmade, Augustine Ohwovoriole
P285
PREVALENCE AND RISK FACTORS FOR OBESITY AMONG HIV PATIENTS IN KANO, NORTH WESTERN NIGERIA
FAKHRADDEEN MUHAMMAD, ANDREW ULOKO, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD
P286
RELATIONSHIP BETWEEN INDICES OF CENTRAL OBESITY AND FASTING PLASMA GLUCOSE IN SOUTH-WESTERN NIGERIA
Taiwo Raimi, Adesina Odewabi, Olatunde Odusan, Olufemi Fasanmade
P287
How well do front line healthcare professionals understand type 2 diabetes?
Xavier Boland, Rhys Martin, Suzannah Yarwood, Duncan Browne
P288
ACCURACY AND RELIABILITY OF GLUCOSE METERS USED AT DIABETES CLINIC OF OAUTHC, ILE IFE, OSUN STATE, NIGERIA.
Funmilayo Owolabi, Oluwatomi Yusuff, Amina Lawal-Bello, Oluwabukola Ala, Oluwadamilola Amjo, Adenike Raiyemo, Tewogbade Adedeji, Babatope Kolawole, Rosemary Ikem
P289
BEHAVIOURAL RISK FACTORS FOR DIABETES MELLITUS: A STUDY OF SECONDARY SCHOOL STAFF IN A COMMUNITY IN SOUTH WEST NIGERIA
Olubukola Ojo, Olayinka Ilesanmi, Bridget Omotoso, Olalekan Ojo, Oladimeji Junaid
P290
Influence of deuterium depleted water on indicators of prooxidant-antioxidant and detoxifying systems in experimental diabetes
Stepan Dzhimak, Alexander Basov, Lilia Fedulova, Elena Kotenkova
P291
RENAL FUNCTION IN TYPE 2 DIABETES PATIENTS AT PRESENTATION IN A TERTIARY HOSPITAL IN NIGERIA- A PRELIMINARY REPORT
Olalekan Ojo, Olubukola Ojo
P292
Blood Glucose Monitoring in Diabetic Inpatients - Hyperglycaemia
Anita Phung, Nathan Brown, Christina Micanovic, Isaac Aloysius
P293
CASE REPORT OF A TYPE 2 DM PATIENT WITH VITAMIN B12 DEFICIENCY ANEMIA
Akinyele Akinlade, Michael Olamoyegun, Ofem Enang
P294
RELATIONSHIP BETWEEN ANTHROPOMETRIC INDICES AND INSULIN RESISTANCE IN NIGERIANS WITH TYPE 2 DIABETES MELLITUS
CHIKEZIE ONWUKWE, NKIRU CHIKEZIE
P295
ASSESSMENT OF THE RELATIONSHIP BETWEEN OBESITY INDICES AND LIPID PARAMETERS AMONG NIGERIANS WITH HYPERTENSION
Michael Olamoyegun, Ajani David, Akinyele Akinlade, Babajide Gbadegesin, Clement Aransiola, Rotimi Olopade, Olujide Ojo, Ofem Enang, Stella Adetokunbo
P296
HYPERURICAEMIA AND PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH DIABETES MELLITUS
Anthonia Ogbera, Victor Osagie
P297
Similia similibus curantur: using DPP-IV inhibitor to treat reactive hypoglycaemia.
Marisa Clemente, Moulinath B
P298
CLINICAL PROFILE OF PERSONS WITH DIABETES MELLITUS ATTENDING  AN ENDOCRINOLOGY CLINIC IN  RURAL NIGERIA
PATRICK ADUNBIOLA, ORE OLUGBEMIDE, IDOWU BANKOLE, KENNEDY AKHUEMOKHAN
Pituitary
P299
A role for 11C-methionine PET/CT-MRI in the management of de novo and residual acromegaly
Olympia Koulouri, Andrew Hoole, Andrea Steuwe, Daniel Gillett, Andrew Powlson, Scott Akker, Simon Aylwin, Antonia Brooke, Harit Buch, Will Drake, Miles Levy, Ayesha Siddiqi, Helen Simpson, Krishna Chatterjee, Neil Burnet, Nagui Antoun, Heok Cheow, Richard Mannion, John Pickard, Mark Gurnell
P300
The effect of AIP on AHR transcriptional activity – implications for AIP mutations pathogenicity
Matheus de Oliveira Andrade, Dan Sebastian Soare, Serban Radian, Márta Korbonits
P301
Investigation of the invasive phenotype of AIP-mutated pituitary adenomas
Craig Stiles, Sayka Barry, Emanuela Gadaleta, Claude Chelala, Carol C Shoulders, Marta Korbonits
P302
Menin regulates the expression of miR-15a, which is downregulated and inversely correlates with cyclin D1 expression in mouse Men1-associated pituitary tumours.
Kate E Lines, Paul J Newey, Chris J Yates, Gerard V Walls, Rajesh V Thakker
P303
An Association Between Visual Morphometric Changes and Psychiatric Outcomes in Patients With Acromegaly
Syed Imran, Michael Vallis, Jitske Tiemesma, Ferhan Siddiqi, Churn-Ern Yip, Barna Tugwell, Thomas Ransom, Lisa Tramble, Ebad Abidi, David Clarke, Stephanie Kaiser
P304
The founder R304* AIP mutation is prevalent in Irish acromegaly and gigantism patients as well as in the general population of Ireland
Serban Radian, Yoan Diekmann, Plamena Gabrovska, Brendan Holland, Lisa Bradley, Helen Wallace, Karen Stals, Anna-Marie Bussell, Karen McGurren, Martin Cuesta, Anthony W. Ryan, Maria Herincs, Laura Cristina Hernández-Ramírez, Aidan Holland, Jade Samuels, Elena Daniela Aflorei, Sayka Barry, Judit Dénes, Ida Pernicova, Craig E. Stiles
P305
In vitro effect of Imatinib on somatotropinoma cell line
Prakamya Gupta, Ashutosh Rai, Naresh Sachdeva, Bishan Das Radotra, Anil Bhansali, Kanchan Kumar Mukherjee, Debashish Hota, Márta Korbonits, Pinaki Dutta
P306
Unique clinical picture in patients with X-linked acrogigantism (X-LAG)
Donato Iacovazzo, Sian Jose, Benjamin Bunce, Richard Caswell, Laura Cristina Hernández-Ramírez, Francisca Caimari, Francesco Ferraù, Sonal Kapur, Plamena Gabrovska, Mary N Dang, Celia Rodd, Mary Lee Vance, Claudia Ramírez, Moises Mercado, Anthony P Goldstone, Michael Buchfelder, Christine Burren, Pinaki Dutta, Catherine Choong, Timothy Cheetham
P307
Silencing of Aryl Hydrocarbon Receptor Protein (AIP) up-regulates the small Rho GTPase, CDC42
Nadira B. Mothojakan, Craig E. Stiles, Sayka Barry, Carol C. Shoulders, Márta Korbonits
P308
Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels
Peter Trainer, John Newell-Price, John Ayuk, Simon Aylwin, Aled Rees, Will Drake, Philippe Chanson, Thierry Brue, Susan Webb, Carmen Fajardo, Javier Aller, Ann McCormack, David Torpy, Lynne Atley, George Tachas
P309
Developing a pituitary Distress Thermometer (PDT) - a means to improve patient quality of life
Sue Jackson, Alyson Norman, Anna Crown
P310
Mortality of patients with non-functioning pituitary macroadenoma is significantly elevated: systematic analysis of 546 cases in a tertiary referral centre in the UK
Georgia Ntali, Cristina Capatina, Violet Fazal-Sanderson, James V Byrne, Simon Cudlip, John AH Wass, Ashley B Grossman, Niki Karavitaki
P311
The burden of AIP mutations in pituitary adenoma patients from the UK
F. Caimari, M.N Dang, P. Gabrovska, L.C Hernández-Ramírez, K. Stals, A.M. Bussell, T. Cranston, N. Karavitaki, A.V. Kumar, S. Hunter, T. Kearney, P.J. Trainer, I. Izatt, J. Bevan, R. Quinton, J. Grieve, S.E. Baldeweg, A.B. Grossman, P. Morrison, M. Korbonits
P312
ACTH and gonadotrophin deficiency predict mortality in patients treated for non-functioning pituitary adenomas (NFPAs) in the UK and Republic of Ireland: long-term follow-up of 519 patients across two tertiary referral centres
Michael O'Reilly, Raoul Reulen, Saket Gupta, Rosemary Dineen, C Thompson, Harriet Pearce, Gabriella Bugg, Andrew Toogood, Neil Gittoes, Christopher Thompson, John Ayuk
P313
A prospective observational study of the causation and management of SIADH in a tertiary referral hospital.
Saba Yunus, Martin Questa, David Slattery, Saket Gupta, William Tormey, CJ Thompson
P314
Biochemical assessment of disease activity in acromegaly; a comparison of single GH, GH day series mean, OGTT nadir and IGF-1 in 51 patients
Kirupakaran Arun, Andrew S Powlson, Afzal N Chaudhry, David J Halsall, Mark Gurnell
P315
Expression of MGMT in a large series of pituitary adenomas: lactotroph  and corticotroph adenomas are more likely to be MGMT-negative than somatotroph and gonadotroph adenomas
Danielle A Dixon, Paraskevi Xekouki, Paola Salaris, Omar Mustafa, Julia Prague, Nadeem Abbas, Benjamin Whitelaw, Istvan Bodi, Simon JB Aylwin
P316
Does basal post-operative early morning cortisol measurement predict HPA axis integrity as assessed by an insulin tolerance test in patients who have undergone pituitary surgery?
Syed Mustafa Ali Ahmad, Debbie Papadopoulou, Emma Hatfield, Nigel Mendoza, Ramesh Nair, Karim Meeran, Niamh M Martin
P317
Patient experiences of living with acromegaly in the UK.
Antonia Brooke, Jacqui Lyttle, Lynne Goss, Lou Pobereskin, Peninsula Endocrinology Network
P318
An Association between Self-Drawing, Morphometric Changes and Psychological Outcomes in Patients with Acromegaly versus Non-functioning Pituitary Adenoma
Stephanie Kaiser, Jitske Tiemensema, Michael Vallis, Ferhan Siddiqi, Churn-Ern Yip, Barna Tugwell, Thomas Ransom, Lisa Tramble, Ebad Abidi, David Clarke, Syed Ali Imran
P319
The Accuracy of Bilateral Inferior Petrosal Sinus Cannulation and Usefulness of Prolactin Adjustment in One Scottish Centre
Kerri Devine, Karen Smith, Iain Robertson, Colin Perry, Marie Freel
P320
Neuronatin emerges in the rat pituitary stem/progenitor cells and terminates its role in the terminally differentiating cells
Naoko Kanno, Masahi Higuchi, Saishu Yoshida, Hideji Yako, Mo Chen, Hiroki Ueharu, Naoto Nishimura, Hiroto Nishihara, Takako Kato, Yukio Kato
P321
Current clinical management of acromegaly in the UK; a survey of endocrinologists
Joanne Edwards, Vathani Siva, Laura Baldock, John Ayuk
P322
Traditional Cardiac Risk Factors in a Cohort of Hypopituitary Patients: A Preliminary Look at the Utility of QRISK2 Score
Rasheeta Sivapackianathan, Jayani Suriyakumaran, Scott Akker, William Drake, Mona Waterhouse, Maralyn Druce
P323
Long term follow up of patients with craniopharyngioma.
Nigel Glynn, Raquel Sanchez Windt, Mona Waterhouse, Scott Akker, William Drake, Maralyn Druce
P324
Metabolic  state  in  ACTH insufficient & ACTH sufficient patients with hypopituitarism not treated for growth hormone deficiency (GHD): a comparative study
Dragana Miljic, Sandra Pekic, Mirjana Doknic, Marko Stojanovic, Milan Petakov, Vera Popovic
P325
Using modified clamp study to replicate insulin stress test
Horng Kai Tan, Gina Twine, Daniel Flanagan
P326
Impaired quality of life in patients with acromegaly despite long-term disease control: results from a longitudinal study
Nikolaos Kyriakakis, Julie Lynch, John O'Dwyer, Stephen G. Gilbey, Robert D. Murray
P327
Pituitary Incidentaloma: Features and outcomes - Recent experience at a tertiary centre
Gurmit Gill, Biju Jose
P328
DEVELOPMENT OF A PATIENT-REPORTED OUTCOME MEASURE (PROM) FOR PITUITARY SURGERY
Ali Nikzad Suren, Anna Crown, Sue Jackson
P329
Management of Pituitary Apoplexy - The Greater Manchester Experience
Sumithra Giritharan, Kanna Gnanalingham, Tina Karabatsou, Tara Kearney
P330
Feedback and Gonadotropin releasing hormone (GnRH) pulse frequency decoding: a mathematical model for GnRH signalling in gonadotrophs
Amitesh Pratap, Than Pham, Kathryn Garner, Krasi Tsaneva-Atanasova, Craig McArdle
P331
Keep Calm and Give Cabergoline: A giant prolactinoma presenting with seizures
Su Ann Tee, Paul Peter, Giridhar Tarigopula, Praveen Partha, Shafie Kamaruddin
P332
Loperamide-induced hypopituitarism
Catherine Napier, Simon HS Pearce
P333
An unusual case of pituitary pathology and the utility of whole body 18F-FDG PET-CT imaging in identifying extraneural biopsy targets
Jenna Deakin, Michelle Siu, Harriet Cunningham, Nikhil Patel, Thomas Osborne, Vineet Prakash, Ahmed Yousseif
P334
Clinically Non-Functioning Pituitary Macroadenomas:  Presenting Features and Outcomes - Recent Experience at a Tertiary Centre
Mahender Yadagiri, Arun Vijay, Mark Pritchard, Ananth Nayak, Simon Shaw, Natarajan Saravanappa, John Ayuk, Biju Jose
P335
Pituitary Service Review in a District General Hospital - A Case for Nationally Agreed Guidelines?
Eveleigh Nicholson, Jana Bujanova, Nadia Zarif, Partha Kar
P336
A case of pituitary functional recovery in a patient with Langerhan's Cell Histiocytosis following chemotherapy with chlorodeoxyadenosine and Mercaptopurine.
ANDREW GHABBOUR, ROSELLE HERRING, DAVID RUSSELLL-JONES
P337
Unusual features in a case of hypophysitis following ipilimumab therapy 
Ali Rathore, Charlotte Siegler, Hafiz Algurafi, James Ahlquist
P338
EVOLUTION IN ACROMEGALIC PATIENTS WITH DISCORDANT GH - IGF1 LEVELS DURING MEDICAL TREATMENT
Monica Livia Gheorghiu, Iulia Vargatu, Raluca Alexandra Trifanescu, Anda Dumitrascu, Andra Caragheorgheopol
P339
Frontal Bone Recurrent Ectopic Craniopharyngioma after transfrontal resection: case report
Ana Maria Hilma, Ana-Maria Codreanu, Sergiu Stoica, Corin Badiu, Camelia Procopiuc
P340
An unusual case of acromegaly
Mia Sheridan, Emma Turtle, Liesbeth Van Look
P341
How common is Ipilimumab induced Hypophysitis leading to cortisol deficiency?
Sid McNulty, Fareha Bawa, Dhanya Kalathil
P342
TSH secreting Pituitary Adenoma with negative TSH Staining
Amber Khan, Khai Leow, Jan Hoong Ho, Kalpana Kaushal, Simon Howell
P343
An Unusual  Cause of Headache in Pregnancy
T Htay, J Bedford, M Harvie, P Dassan, S R Mehta
P344
The  Aggressive Clinical Course Of Silent Corticotroph Pituitary Adenomas -  A case series
Mehjabeen Beebeejaun, Eswari Chinnasamy, Philip Rich, Leslie Bridges, Gul Bano
P345
Intrasellar Meningioma
Faisal Ozair, Eswari Chinnasamy, Gul Bano
P346
Silent corticotroph adenoma presenting with severe visual loss
Laura Rich, Julia Thomas, Joan Grieve
Reproduction
P347
Analysis of the human fetal gonadal proteome at 13-14 weeks of gestation.
Rebecca Matthews, Panagiotis Filis, Peter O'Shaughnessy, Paul Fowler
P348
Development of a single-injection non-surgical sterilant via modification of Measles Virus pseudotyped particles.
Cornelia Roesl, Nathan Jeffery, Sarah Smith, Laura Milne, Pamela Brown, Lee Smith
P349
Decoding gonadotrophin receptor signalling via spatial regulation of the luteinizing hormone receptor
Silvia Sposini, Frederic Jean-Alphonse, Aylin Hanyaloglu
P350
IGF-I action in trophoblast involves endocytic and post-endocytic pathways
Magda Karolczak-Bayatti, James Horn, Patrick Case, Lynda Harris, John Aplin, Melissa Westwood
P351
Intracrine Androgens Enhance Decidualisation and Modulate Expression of Human Endometrial Receptivity genes.
Douglas Gibson, Ioannis Simitsidellis, Hilary Critchley, Philippa Saunders
P352
Intravenous and subcutaneous infusions of kisspeptin-54 stimulate gonadotrophin release similarly in healthy women
Shakunthala Narayanaswamy, Channa Jayasena, Noel Ng, Risheka Ratnasabapathy, Deborah Papadopoulou, Julia Prague, Ali Abbara, Alexander Comninos, Stephen Bloom, Waljit Dhillo
P353
Assessment of Reproductive Parameters and Oxidative Stress Following Treatment With Alcohol and/or Cannabinol in Male Wistar Rats
Christopher Akintayo, Moyo Ayodele, Shimile Karga
P354
Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
Thozhukat Sathyapalan, Rhiannon David, Nigel J Gooderham, Stephen L Atkin
P355
Vitamin D regulates extravillous trophoblast migration by inhibiting sphingosine-1-phosphate (S1P) signalling via S1P receptor-2
Edward Johnstone, Khiria Al-Saghir, Cherlyn Tan, Daman Adlam, Melissa Westwood
P356
Visceral fat drives 5alpha-reductase activity independent of body mass index in women with polycystic ovarian syndrome
Punith Kempegowda, Michael W. O'Reilly, Nicola J. Crabtree, Angela E. Taylor, Beverly A. Hughes, Jeremy W. Tomlinson, Wiebke Arlt
P357
Impact of male cholestasis on the sperm epigenome and consequences for the health of the offspring
Vanessa Pataia, Georgia Papacleovoulou, Lucilla Poston, Catherine Williamson
P358
Isoform-specific knockdown of PKC isoforms reveals PKCβ2 is required for Epidermal Growth Factor stimulated expression of the prostaglandin synthase COX2 in human myometrium.
Claire Hudson, Andres Lopez Bernal
P359
Information Transfer in Gonadotropin-Releasing Hormone (GnRH) Signalling: ERK-mediated feedback loops control hormone sensing.
Kathryn Garner, Rebecca Perrett, Margaritis Voliotis, Thanh Pham, Krasimira Tsaneva-Atanasova, Craig McArdle
P360
Whole Exome Sequencing in Congenital Hypogonadotropic Hypogonadism
Louise Izatt, Paul Carroll, Suzanne Lillis, Lina Brodd, Kristina Stone, Kevin Ryan, JooWook Ahn, Michael Simpson, Michael Yau
P361
Implantation and Pregnancy Outcome of Rats Fed With Low and High Salt Diet
Iranloye Bolanle, Oludare Gabriel
P362
Vitamin D metabolic profiling across pregnancy 
Radhika Susarla, Carl Jenkinson, Jennifer Tamblyn, Brian Keevil, Shiao-Yng Chan, Mark Kilby, Martin Hewison
P363
Vitamin D and Fetomaternal Immunity: Effects on Uterine Natural Killer Cells
Jennifer Tamblyn, Louisa Jeffery, Radhika Susarla, Paul Moss, Martin Hewison, Mark Kilby
P364
Use of an animal model to identify the origin and validity of the testicular dysgenesis syndrome hypothesis in humans
Sander van den Driesche, Karen Kilcoyne, Ida Wagner, Ashley Boyle, Chris McKinnell, Sheila Macpherson, Rod Mitchell, Richard Sharpe
P365
Investigation into the Effects of Glucocorticoids in a Mouse Model of Induced Menstruation
Alison A Murray, Gregory M Armstrong, Reena Murgai, Alexandra E Gray-Renfrew, Rebecca EA Vere, Karen E Chapman, Hilary OD Critchley
P366
Structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome: SUCCESS-RCT improved physical activity and illness perception
Hamidreza Mani, Kamlesh Khunti, Miles Levy, Danielle Bodicoat, Laura Gray, Janette Barnett, Heather Daly, Trevor Howlett, Melanie Davies
P367
Characterization of a GnRH-type signaling system in an echinoderm
Shi Tian, Meet Zandawala, Michaela Egertová, Isabel Beets, Susan E. Slade, James H. Scrivens, Maurice R. Elphick
P368
Low-dose gonadotrophin therapy for induction of ovulation: comparison of results in women with PCOS or hypothalamic amenorrhoea
Suzie Lovelock, Kate Hardy, Davinia White, Stephen Franks
P369
Characterisation of bile acid pathways in steroidogenic tissues
Sheba Jarvis, Raffaela. M Gadaleta, Elizabeth. J Want, Nicola Gray, Shadi Abu-Hayyeh, Lord Robert Winston, Catherine Williamson, Charlotte. L Bevan
P370
Food, drink and medical plants and their molecules can affect female hormones and reproductive functions
Alexander V. Sirotkin, Attila Kadasi, Aneta Stochmalova, Richard Alexa, Andrej Balazi, Abdel Halim Harrath
P371
Regulation of Cyp17a1 expression in mouse ovarian theca cells in vivo and in vitro
Hanako Kakuta, Tomomi Sato
P372
Maternal Insulin-Like Growth Factor-1 and Transforming Growth Factor Beta-1 levels during Pregnancy in Rats Fed with Low and High Salt
Gabriel Oludare, Bolanle Iranloye
P373
Identification of novel transcription factors that may regulate transcription of the equine chorionic gonadotrophin beta subunit
Jordan Read, Victoria Cabrera-Sharp, Samantha Mirczuk, Robert Fowkes, Amanda de Mestre
P374
A Rare Form Genetic Abnormality in Turner Syndrome
Mariana-Cristina Costache-Outas, Camelia Procopiuc, Oana Popa, Madalina-Aura Vintila, Cosmina-Raluca Costache, Danai Stambouli
P375
Long-term monitoring of hypogonadal men receiving intramuscular testosterone replacement: a retrospective audit
Andrzej Rys, Jonathan Candan, Sue Cox, Jamie Smith
P376
PREVALENCE AND CORRELATES OF PREMATURE EJACULATION AMONG NIGERIANS IN A TERTIARY HEALTH CENTRE: A PRELIMINARY CROSS-SECTIONAL STUDY
Michael Olamoyegun, Akinyele Akinlade, David Ajani, Clement Aransiola, Ofem Enang, Babajide Gbadegesin, Rotimi Olopade, Olujide Ojo
P377
EFFECTS OF ORAL, INJECTABLE, AND IMPLANT HORMONAL CONTRACEPTION ON SERUM LEVELS OF IRON, FERRITIN, COPPER, CERULOPLASMIN AND VITAMIN E
TITILOLA SAMUEL, OLUFEMI MORAKINYO, ADEPEJU BALOGUN, JO OLAMIJULO, OLUBUNMI MAGBAGBEOLA
P378
Importance of social support and implications of gender reassignment in congenital adrenal hyperplasia due to 3-beta hydroxysteroid deficiency
Leelavathy Kandaswamy, Rajeev Raghavan, Vijay Nandini Cherukuri, Harit Buch
P379
Testicular regression syndrome and severe psychiatric disorder - a  rare association preventing the optimal management of the endocrine condition
Cristina Capatina, Adela Ghinea, Diana Deciu, Catalina Poiana
P380
Self medication in transpeople is not associated with deterioration in cardiovascular risk factors but is associated with reduced vitamin D levels and antidepressant use.
Leighton Seal, Fahmin Khaleque, James Barrett
P381
A pragmatic review of patient satisfaction and testosterone replacement therapy
Adam Smith, Sarah Dickinson, Michael Arber
P382
Spontaneous resolution of hypothalamic amenorrhea post diagnostic GnRH test.
GK Dimitriadis, MO Weickert, TM Barber, HS Randeva
Steroids
P383
Adrenocortical function in glucocorticoid receptor deficient mice
Ghazaleh Mohammadi-Zaniani, Rachel Richardson, Steve Morley, Karen Chapman, Chris Kenyon
P384
TNFα regulates Steroid Sulphatase Activity in Healthy and Malignant tissue.
Lorna Gilligan, Mai Nguyen, Anne-Marie Hewitt, Kirsty Burnell, Habibur Rahman, Rowan Hardy, Paul Foster
P385
Genome-wide binding analysis of glucocorticoid receptors in the rat hippocampus in response to corticosterone and stress.
Benjamin P. Flynn, John R. Pooley, Yvonne M. Kershaw, Songjoon Baek, Lars Grontved, Michael J. Guertin, Gordon L. Hager, Stafford L. Lightman, Becky L. Conway-Campbell
P386
Impact of 5α-Dihydrotestosterone (DHT) on Glandular Epithelial Proliferation in the Mouse Uterus
Ioannis Simitsidellis, Fiona L. Cousins, Douglas A. Gibson, Lee B. Smith, Philippa T. K. Saunders
P387
Plasma Corticosteroid-Binding Globulin: Biomarker of inflammation onset and severity in a rat arthritis model
Lesley Hill, Tamara Bodner, Joanne Weinberg, Geoffrey Hammond
P388
A novel animal model to explore the whole-organism response to 21-hydroxylase deficiency
Andreas Zaucker, Tulay Guran, Nazia Thakur, Angela Taylor, Aliesha Griffin, Nils Krone
P389
Regulation of Glucocorticoid Receptor Action by ARID subunits of SWI/SNF
Felicity Ellen Russell, Becky L. Conway-Campbell, Matthew Birnie, Simon Biddie, Stafford Lightman
P390
Alpha-MSH secretion from a gastro-intestinal stromal tumour leading to ACTH-independent Cushing’s syndrome.
Dominic Cavlan, William Drake, Phil Lowry, Andrew Bicknell, Christopher Evagora, Peter King
P391
Involvement of the TORC isoforms in adrenal responsiveness to basal and stress-induced HPA activity
Lorna Smith, Zidong Zhao, George Hazell, Greti Aguilera, Stafford Lightman, Francesca Spiga
P392
Exploring metabolomic changes due to cortisol deficiency in early development using the ferredoxin (fdx1b) null-allele zebrafish
Meltem Weger, Aliesha Griffin, Benjamin Goerling, Angela E. Taylor, Burkhard Luy, Ferenc Mueller, Nils Krone
P393
The effects of chronic administration of the synthetic glucocorticoid dexamethasone on memory and learning in the rat
Emma Earl, Yvonne Kershaw, Stafford Lightman, Becky Conway-Campbell
P394
Synthetic glucocorticoid treatment induces prolonged activation of glucocorticoid receptors in discrete brain regions and impairs memory and learning processes in the rat.
Matthew Birnie, Rebecca Demski-Allen, Ben Flynn, Yvonne Kershaw, Gareth Barker, Clea Warburton, Stafford Lightman, Becky Conway-Campbell
P395
Vitamin D2 vs vitamin D3: effects of total and free 25D on immune cells in vivo
Ivan Hernandez, Rene Chun, Dean Larner, Carl Jemkinson, Louisa Jeffery, John S Adams, Martin Hewison
P396
Model systems to define the role of AKR1D1 in metabolic liver disease
Nikolaos Nikolaou, Laura Gathercole, James Dunford, Wenhwa Lee, Reina Lim, Jane McKeating, Udo Oppermann, Leanne Hodson, Jeremy Tomlinson
P397
Molecular and immunohistochemical analysis of aldosterone producing adenomas
Rea Ganatra, Lewis Saunders, Candy Sze, Ashley Parker, Philip Hall, Dominic Cavlan, Peter King
P398
Discrimination of adrenocortical carcinoma from other adrenal lesions: use of a new 13 steroid serum panel based on LC-MS/MS
David Taylor, Lea Ghataore, Royce Vincent, Roy Sherwood, Ben Whitelaw, Dorota Dworakowska, Klaus-Martin Schulte, Salvadore Diaz-Cano, Dylan Lewis, Simon Aylwin, Norman Taylor
P399
Glucocorticoid-induced lipolysis across human ageing and the relationship to fat mass and androgens
Zaki Hassan-Smith, Angela Taylor, Beverly Hughes, Theresa Brady, Pamela Jones, Stuart Morgan, Gareth Lavery, Jeremy Tomlinson, Paul Stewart
P400
Rapid Equilibriation of Cortisol Between the Free and Total Plasma Pools
Anna Anderson, Carolynn Cairns, Roland Stimson, Ruth Andrew, Nor Mohd-Shukri, Rebecca Reynolds, Brian Walker
P401
Do Androgens Lead to Increased Erythropoiesis in Women with Congenital Adrenal Hyperplasia (CAH)?
Nayananjani Karunasena, Meredith Elman, Ashwini Mallappa, Deborah P. Merke, Richard Ross, Eleni Daniel
P402
Bioinformatic analysis of microRNAs associated with aldosterone secretion.
Nur Izah Ab Razak, Scott M. MacKenzie, Louise A. Diver, Martin M. McBride, Eleanor Davies
P403
Immunogenicity in AAD patients treated with depot tetracosactide
Joanna L Davis, Catherine Napier, Anna L Mitchell, Earn H Gan, Simon HS Pearce
P404
Unveiling the complexity of the Undifferentiated Zone in the human adrenal cortex.
Irene Hadjidemetriou, Gerard Ruiz-Babot, Celso Gomez-Sanchez, Peter King, Leonardo Guasti
P405
Cytosolic innate immune receptor RIG-I amplifies glucocorticoid action within lung epithelial cells
Shuji Sai
P406
Quantitative analysis of an adrenal steroid profile, canrenone and mifepristone in plasma by triple quadrupole mass spectrometry
Catriona Kyle, Gregorio Naredo, Ruth Andrew, Brian Walker, Natalie Homer
P407
Conventional versus modified release hydrocortisone in mitotane treated patients with adrenocortical cancer
Marianne Weigel, Stefanie Hahner, Daniela Beier, Kathrin Zopf, Marcus Quinkler
P408
Effects of diet and gender on postprandial salivary glucocorticoid levels and bile acid excretion in healthy volunteers
Graham Anderson, Christopher Kenyon, Emad A S AL-DUJAILI
P409
Shocking? A systematic review of adrenal insufficiency in adults on oral steroids
Louise Hunter, Rebecca M Joseph, David W Ray, William G Dixon
P410
Hormone replacement therapy with prednisolone in adrenal insufficiency (AI) patients - data from the European Adrenal Insufficiency Registry (EuAIR)
Marcus Quinkler, Bertil Ekman, Claudio Marelli, Sharif Uddin, Pierre Zelissen, Robert Murray
P411
The effect of adrenalectomy on cardiovascular morbidity in adrenal tumor patients with Subclinical Cushing's Syndrome: Systematic review and meta-analysis
Irina Bancos, Fares Alahdab, Rachel Crowley, Vasileios Chortis, Dana Erickson, Neena Natt, Massimo Terzolo, Wiebke Arlt, Mohammad Murad
P412
DHEA reduces the palmitate-induced apoptosis in L6 myotubes
Vitor Felitti, Gabriela Spiazzi, Caio Teixeira, Carla Carvalho
P413
Profiling of multiple vitamin D metabolites in a healthy human cohort by high-throughput LC-MS/MS analysis
Carl Jenkinson, Angela Taylor, Radhika Susarla, Jennifer Tamblyn, Zaki Hassan-Smith, Brian Keevil, Martin Hewison
P414
Support from clinical audit data for liberal minimum 9am cortisol cut-off to avoid Short Synacthen Tests.
Bernard Freudenthal, Daniel Beder, Arla Ogilvie
P415
Lineage conversion of human cells to an adrenocortical phenotype: a new technology to study the adrenal gland.
Gerard Ruiz Babot, Irene Hadjidemetriou, Sharon Jane Ajodha, David Taylor, Norman Taylor, Leonardo Guasti
P416
Steroid-dependent patients with multiple co-morbidities are more vulnerable to adrenal crisis
Katherine White, John Wass
P417
Comorbidities are the norm for steroid-dependent patients and predispose to adrenal crisis
Katherine White, John Wass
P418
Lack of awareness contributes to delayed diagnosis and inappropriate management in men with low testosterone: findings from a UK study of men diagnosed with hypogonadism
David Edwards, Laurence Olding
P419
Heterogeneity in the clinical management of adrenal insufficiency - data from EU-AIR
Robert Murray, Bertil Ekman, Sharif Uddin, Claudio Marelli, Marcus Quinkler, Pierre Zelissen
P420
PHAEOCHROMOCYTOMA RELATED REVERSIBLE TAKOTSUBO CARDIOMYOPATHY                                     
ZEENAT BANU, PATRICK CHONG
P421
Iatrogenic Cushing's syndrome secondary to Combined Oral Contraceptive Pill in a patient with Congenital Adrenal hyperplasia
Satish Artham, Yaasir Mamoojee, Simon Ashwell
P422
Bilateral adrenal haemorrhage in a patient with anti-phospholipid syndrome
Taofeek Ojewuyi, Akram Alkrekshi, Teng Teng Chung
P423
Transient Adrenal Insufficiency following Acute Bilateral Adrenal Haemorrhage
Jan Hoong Ho, Khai Leow, Amber Khan, Simon Howell, Kalpana Kaushal
P424
X-linked Adrenoleukodystrophy- How to improve identification in the Addison's populatation
Louis Tapper, Sarah Hogg, Graham Wood, Karen Harrison, Alasdair Parker
P425
Primary testicular lymphoma with bilateral adrenal masses and adrenal insufficiency
Satish Artham, Yaasir Mamoojee, Sath Nag
P426
Adrenal Insufficiency from bilateral adrenal haemorrhage in a postoperative patient on warfarin
Emily Tafadzwa Mudenha, Manjusha Rathi
P427
Cushing's syndrome secondary to bilateral functioning adrenocortical adenoma
zeenat banu, Saiful kassim
P428
Complications of CAH in pregnancy
Natasha Archer, Chandrima Roy, Miles Levy
P429
Liquorice induced hypermineralocorticoidism – A Case report from Midyorkshire Hospitals NHS trust
Vani Shankaran, Mark Freeman
P430
Autoimmune Polyendocrine Syndrome Type 4
Shang Shaho
P431
A severe case of Ectopic ACTH presenting with Cushing's Syndrome with Hypokalemia, Hypomagnesemia, Hypophosphatemia, Hyponatremia and Hypocalcemia.
Sheharyar Qureshi, Anna Gray, Nisha Adjmal, Junaid Farooq, Noushad Padinjakara
Thyroid
P432
PERIPHERAL BLOOD MICRORNA MARKERS IN PATIENTS WITH PAPILLARY THYROID CANCER
Petros Perros, Ujjal Mallick, Simon Pearce
P433
Effect of hypothyroidism on pancreatic β-cell mass and circulating insulin concentration in the ovine fetus
Shelley E Harris, Miles J De Blasio, FB Peter Wooding, Abigail L Fowden, David Meredith, Alison J Forhead
P434
Thyroid hormones and mitochondrial development in skeletal muscle of fetal sheep near term
K.L. Davies, A.J. Forhead, M.J. De Blasio, A.J. Murray, A.L. Fowden
P435
The natural history of subclinical hyperthyroidism due to Graves' disease.
Sviatlana Zhyzhneuskaya, Caroline Addison, Jola Weaver, Vasileios Tsatlidis, Salman Razvi
P436
Epitopes, Specificity, Functional Effects and Immunoglobulin G Subclasses of Anti-Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1
Mahmoud Habibullah, Nicolas Kluger, Annamari Ranki, Kai Krohn, Anthony Weetman, Helen Kemp
P437
Reliability of Thyroid Ultrasounds in assessment of thyroid nodules
Salini Sumangala, Gurmit Gill, Paul Wilson, Zafar Hashim, Muthukumarasamy Balasubramaniam, Lakshminarayanan Varadhan
P438
Subclinical and overt hypothyroidism in pregnancy: what happens next?
David Carty, Flora Doogan, Sarah-Jane Duffus, Elaine Butler, Paul Welsh, Christian Delles
P439
Soy protein with isoflavones impairs thyroid function
Thozhukat Sathyapalan, Mo Aye, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin
P440
Increased rehospitalisation rate and cardiovascular morbidity in inpatients with hyperthyroidism - a matched case-control study
Barbara Torlinska, James Hodson, Jayne Franklyn, Jamie Coleman, Kristien Boelaert
P441
Small fibre dysfunction in Hypothyroidism - a prospective study using methods of small fibre function and structure
Sanjeev Sharma, Gerry Rayman
P442
A cross-sectional survey to determine iodine status of school girls living in Northern Ireland.
Paul McMullan, Lesley Hamill, Jayne Woodside, Katie Dolan, Karen Mullan
P443
Thyroid abnormalities during anti-PD1 cancer immunotherapy
Cathrine Mace, Stefan Diem, Martin Gore, James Larkin, Daniel Morganstein
P444
The effect of isoflavone-free soy protein supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized double blind crossover study.
Thozhukat Sathyapalan, Zeeshan Javed, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin
P445
A cross sectional survey of dietary iodine intake in pregnant women living in Northern Ireland.
Paul McMullan, Jayne Woodside, Lesley Hamil, Karen Mullan
P446
Is One Benign Thyroid FNA Cytology Sufficient To Out rule Malignancy? : A University Teaching Hospital Experience.
Mohamed Ahmed, Michael Jeffers, John Feeney, Pardeep Govender, Mark Sherlock, James Gibney
P447
The value of second fine needle aspiration cytology tests when investigating benign thyroid nodules (Thy2/Thy2c)
Alan Muhyaldeen, Angelos Kyriacou, Jonathan Schofield, Anisa Ali, Sunethra Ghattamaneni, Sakinah Thiryayi, Rana Durgesh, Narine Nadira, Steve Lee, Akheel Syed, Neil Parrott, Handrean Soran
P448
Managemenet of amiodarone induced thyrotoxicosis within the United Kingdom: is it time for a consensus guideline? A single centre retrospective review.
Mie Mie Tisdale, Francesca Swords, Rupa Ahluwalia
P449
Serum thyroid stimulating hormone concentration after withdrawal of  thionamides as a predictor of Graves’ disease outcome
Preethi Nalla, Mohamed Adlan, Lakdasa D Premawardhana
P450
Maternal thyroid function in pregnancy and risk of Breech presentation.
Bridget Knight, Beverly Shields, Rachel Sturley, Bijay Vaidya
P451
Ultrasound Guided Thyroid FNA with Cytopathology In-attendance Significantly Improved Accuracy in a University Teaching Hospital.
Mohamed Ahmed, Michael Jeffers, John Feeney, Pardeep Govender, Mark Sherlock, James Gibney
P452
Diagnostic and therapeutic challenges in medullary thyroid carcinoma
Ruxandra Dobrescu, Ionela Baciu, Dumitru Ioachim, Corin Badiu
P453
Less is more: superior efficacy and tolerability of 400 MBq radioactive iodine for management of thyrotoxicosis
Joannis Vamvakopoulos, Laura Guest, Alexandra Paul, Emily Austin, Lisa Shepherd, Andrew Bates
P454
Incidental thyroid malignancy in Grave's thyrotoxicosis.
Nazia Rashid, Tom Kurzawinski, Teng-Teng Chung
P455
Management of thyroid cancer: a 5-year retrospective audit
Lavanta Farouk, Nisha Kaimal
P456
Thyroid Eye Disease Audit – The Wolverhampton experience
Feaz Babwah, Ananth Viswanath, Soupramanien Sandramouli
P457
R438H Missense Mutation Related Generalized Resistance to Thyroid Hormone (GRTH): A Case Series Report in Three Generations
Jawad Bashir, Tamar Saeed, Khaliq Hamdan, Hadeel Bashir, Irfan Khan
P458
Imaging in subclinical hyperthyroidism
Anne DeBray, Amar Puttanna
P459
Qualitative analysis of ultrasound reports assessing radiological descriptors of thyroid nodules - a retrospective pilot audit
Satish Artham, Yaasir Mamoojee, Sue Jones, Vikram Lal, Sath Nag
P460
An audit of Hyperthyroidism in Pregnancy
Eswari Chinnasamy, Faisal Ozair, Sidrah Khan, Emmanuel Ofori-Asare, Carolyn Romer, Ingrid Watt-Coote, Arshia Panahloo
P461
Thyroxine administration: a challenging case
P. Loumpardia, S. Wordsworth, G. Curtis, C.M. Bellamy, N. Waterfield, S.P.Y. Wong
P462
Thyroid deficiency refractory to treatment: Is this a case for DOT?
Emily Tafadzwa Mudenha, Devaka Fernando
P463
Recurring thyroid eye disease: a diagnostic dilemma.
Pauline McAleer, Emma Turtle, Jan Kerr, Karen Adamson
P464
Timing of food intake and L-thyroxine replacement - a cost saving simple change of phrasing in the British National Formula (BNF)
Rajendran Bellan Kannan
P465
The value of thyroxine absorption test followed by weekly thyroxine administration in determining the cause of persistent hypothyroidism despite high dose levothyroxine treatment: A case report
Khaliq Hamdan, Mohammad Rahman, Priya Mohan-Babu, Kofi Obuobie
P466
Resistance to thyroid hormone in a family of Bangladeshi extraction
Muhammad Asam
P467
More Than Meets the Eye: A case of longstanding hypothyroidism due to Hashimoto's thyroiditis presenting with unilateral thyroid eye disease (TED)
Su Ann Tee, Paul Peter, Praveen Partha, Shafie Kamaruddin, Giridhar Tarigopula
P468
TSH Receptor antibodies Testing In Hypothyroid Pregnant Women
Nabeel Saeed, Shakir Ahmed, Firas Haddadin
P469
Thyroid dysfunction secondary to antiviral therapy: a simple management protocol
Saher Tariq, Waiel A Bashari, Katherine Barry, Mary Ninkovic, Samson O Oyibo
P470
Propylthiouracil induced ANCA associated vasculitis (AAV).
Laxmi Manohar Rao Balmuri, Komal Imtiaz
P471
Odd TFTs: when it doesn’t fit, it probably isn’t right!
Khyatisha Seejore, Thet Koko, Andrew Pettit
P472
Primary radioactive iodine ablation for TSH secretingadenoma - an uncommon treatment for a rare disease.
Farheen Raza, Haider Khan, Paula Chattington
P473
An unusual cause of hypercalcemia
Sushuma Kalidindi, Mussarat Riaz, Alexandra Lubina-Solomon
P474
Buying time: a unique case of delayed thyroidectomy post thyroid storm
Gautam Sen, Marc Atkin
P475
A disputable but effective therapy in neutropenia associated with Graves' disease.
Isuri Kurera, Mehjabeen Beebeejaun, Emma Bingham
P476
Late stage Hashimato’s or Riedel’s? A case report illustrating this diagnostic conundrum.
Charlene Tang, Sanjaya Dissanayake, Varadarajan Baskar
P477
Investigating pyrexia whilst awaiting thyroidectomy for Thy3, Hurthle cell nodule.
P. Loumpardia, T. Dacruz, H. Zeitoun, S.P.Y. Wong
P478
The roller-coaster ride of thyroid function before, during and after pregnancy
Sian Wynne, Stella Mwenechanya, Moulinath Banerjee
P479
Metastatic differentiated thyroid cancer with undetectable serum thyroglobulin: diagnostic, management and follow-up challenges
Pedro Marques, Teresa Ferreira, Lucília Salgado, Rafael Cabrera, Valeriano Leite
P480
Thionamides resistant Graves' Disease - It's not always poor compliance.
Sajjad Ahmad, Ijaz Farooq, Stephen Stanaway
P481
Recurrent Hashimoto's Encephalopathy: A case report of reversible coma and status epilepticus
Adnan Agha, Htwe Htun, Adeeba Ahmed
P482
Hyperthyroidism in a elderly patient intolerant to carbimazole
Sushuma Kalidindi, Stephanie Bailey, Shakeel Mohammed, Alexandra Lubina-Solomon
P483
Audit - Radioiodine therapy in benign thyroid disease
Jill Nicholson, Finn Catling, Myuri Moorthy, Anukul Garg, Nethaji Chidambaram
P484
Severe Myxoedema complicated by peri-orbital oedema, gum oedema, SIADH and ECG changes
Aye Aye Min, Deirdre Maguire
P485
Inadequate TSH - resistance to thyroid hormones: 2 case reports
Adriana Gogoi, Simona Jercalau, Corin Badiu
P486
Management of Hypothyroidism in Pregnancy with Armour Thyroid
Tolulope Shonibare, Alia Munir
P487
A case of thyroid hormone resistance with unusually elevated free thyroxine
Louise Curtis, Georgina Page, Helen Partridge, Helen Holt, Tristan Richardson
P488
Hypercalcaemia - Look beyond the usual.
Mohammad M Rahman, Thomas R Hickin
P489
If it feels like Myxoedema Coma, then it probably is!
Heechan Kang, Waiel A Bashari, Samson O Oyibo
P490
Preoperative parathyroid imaging: a retrospective audit
Natalie Winfield
Featured Posters
FP1
Inhibition of NFAT signalling in vivo improves microvascular endothelial function in a mouse model of chronic diabetes
Alison McNeilly, Eliana Garcia-Vaz, Jennifer Gallagher, Rory McCrimmon, Maria Gomez, Faisel Khan
FP2
Corticosterone in human saliva is highly abundant and lacks a diurnal rhythm
Catriona Kyle, Rita Upreti, Anna Anderson, Shaoyun Chen, Natalie Homer, Ruth Andrew, Roland Stimson, Brian Walker
FP3
Maternal genotype is an important determinant of the outcome of antenatal glucocorticoid treatment in GR<sup>+/+</sup> and GR<sup>+/-</sup> fetal mice
Emma Batchen, Rachel Richardson, Adrian Thomson, Carmel Moran, Gillian Gray, Karen Chapman
FP4
GLP-1 reduces cerebrospinal fluid secretion and intracranial pressure: A novel treatment for idiopathic intracranial hypertension?
Hannah Botfield, Maria Uldall, James Mitchell, Ana Maria Gonzalez, Rigmor Jensen, Alexandra Sinclair
FP5
<sup>Generation of GnRH neurons from human Embryonic Stem Cells (hESCs) and induced Pluripotent Stem Cells (iPSCs) of healthy individuals and patients with Kallmann's Syndrome</sup>
Ariel Poliandri, Duncan Miller, Leo Dunkel
FP6
The role of 11beta-Hydroxysteroid dehydrogenase type 2 in the central regulation of blood pressure and salt appetite
Julie McNairn, Matthew Bailey, Carmel Moran, Lorraine Work, Megan Holmes
FP7
Regulation of adipogenesis by wnt10b signalling in cultured human adipocytes taken from an obese patient with a WNT10B-C256Y mutation.
Sahar Azharian, Philip D.Voyias, Alice Murphy, Lucia Martinez de la Escalera Clapp, Antonysunil Adaikalakoteswari,, Ponnusamy Saravanan, Milan K.Piya, Philip G.McTernan, Gyanendra Tripathi
FP8
Reduced circulating levels of kisspeptin, human chorionic gonadotropin, placental-like growth factor, soluble fms-like tyrosine kinase-1 and soluble endoglin but not prokineticin-1 are associated with miscarriage risk
Ali Abbara, Channa Jayasena, Alexander Comninos, Shakunthala Narayanaswamy, Juan Gonzalez Maffe, Chioma Izzi-Engbeaya, Jaimie Oldham, Zubair Sarang, Zainab Malik, Richard Harvey, Mandish Dhanjal, Catherine Williamson, Stephen Bloom, Waljit Dhillo
FP9
How well can we measure oestradiol?
Laura Owen, Phillip Monaghan, Brian Keevil
FP10
A dedicated Turners clinic improves adherence to UK recommended best practice and is well liked by patients.
Jean Munday, Anjana Siva, Huw Thomas, Lisa Cross, Michelle Evans, Kim Page, Eleni Karathanasi, Lorraine Albon
FP11
Potential molecular mechanism of AIP-mediated cellular invasion
Sayka Barry, Eivind Carlsen, Jumana A Saleh, Emanuela Gadaleta, Claude Chelala, Márta Korbonits
FP12
Characterising the functional significance of the first reported mutations in the pituitary tumor-transforming gene binding factor (PBF)
Waraporn Imruetaicharoenchoke, Rachel Watkins, Bhavika Modasia, Vikki Poole, Alice Fletcher, Rebecca Thompson, Kristien Boelaert, Vicki Smith, Martin Read, Christopher McCabe
Abstract Code Title Authors Affiliations Category
P1 FHH3-associated AP2σ Mutations Impair MAPK Signalling Pathways Angela Rogers, Caroline Gorvin, Michael Whyte, Rajesh Thakker Bone
P2 Exploring the N-ethyl-N-nitrosourea (ENU) mutagenesis DNA archive for mutations in NFIX to derive mouse models for Marshall-Smith syndrome (MSS) Kreepa Kooblall, Mark Stevenson, Sian Piret, Paul Potter, Roger Cox, Steve Brown, Raoul Hennekam, Rajesh Thakker Bone
P3 Reduction in daily hydrocortisone dose in adrenal insufficiency improves significantly bone mineral density – results from a 2-years prospective trial Julia Schulz, Kathrin Koetz, Manfred Ventz, Sven Diederich, Marcus Quinkler Bone
P4 Mutations in G-protein Subunit α<sub>q</sub> (GNAQ) are not a Cause of Familial Hypocalciuric Hypercalcaemia (FHH) Manish Modi, Treena Cranston, Angela Rogers, Sarah Howles, Caroline Gorvin, Rajesh Thakker Bone
P5 Soy protein with isoflavones reduce bone turnover markers in women during their early menopause - A randomised double blind parallel study Thozhukat Sathyapalan, Mo Aye, Eric S Kilpatrick, Alan S Rigby, William D Fraser, Natalie J Thatcher, Stephen L Atkin Bone
P6 Increased circulating sclerostin levels in type 2 diabetic rats are not associated with changes in bone sclerostin production Marie Pereira, Stephanie Gohin, Nina Lund, Anne Hvid, Peter Smitham, Michael Oddy, Ines Reichert, Chantal Chenu Bone
P7 Differential effects of Parathyroid Hormone on key regulators of osteoblast mineralisation Dean Houston, Katherine Myers, Vicky MacRae, Jose Luis Millan, Katherine Staines, Colin Farquharson Bone
P8 Type 2 diabetes, bone mineral density and disc height Rachel Agius, Stephen Fava Bone
P9 The decreased plasma levels of sclerostin but not Dickkopf-1 are associated with increased risk of osteoporotic fracture and lower bone mineral density in Korean postmenopausal women Yejee Lim, Jung-Min Koh, Beom-Jun Kim, Moo-Il Kang, Seung Hun Lee, Ki Hyun Baek, Yumie Rhee, Yong-Ki Min, Deog-Yoon Kim, Chong Hwa Kim Bone
P10 A mutation in the Calcium Sensing Receptor (previously known to cause Neonatal Severe Hyperparathyroidism in the homozygote state) causing Familial Benign Hypocalciuric Hypercalcaemia in the heterozygote. John Hinnie, Andrew Gallagher, Angela Collie Bone
P11 The Effect of Oestradiol Circadian Rhythm on the Bone Mineral Density of Adult Males Sajini Wijetilleka, Muhammad Khan, Aung Mon, Frank Joseph, William Fraser, Jiten Vora Bone
P12 Familial Hypocalciuric Hypercalcaemia due to AP2S1 mutation in a patient with failed Parathyroidectomies - a case report Eswari Chinnasamy, Paul Hurley, Katie Snape, Gul Bano Bone
P13 Pre-operative localization of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT): Can a single modality of imaging be adequate? Hafsa Imran, Paul Wilson, Rebecca Sinha, George Varughese, Ullal Nayak, Lakshminarayanan Varadhan Bone
P14 A rare presentation of primary hyperparathyroidism. Vidhya R Jahagirdar, Neil J Gittoes Bone
P15 Lessons learnt after failed parathyroidectomy Antonia Ugur, Rajiv Dave, Daniel Ashmore, Olivia Pereira, Deedar Ali Bone
P16 Melorrheostosis: A rare cause of bone pain and limb deformity Vinit Kirankumar Shah, Neil Gittoes Bone
P17 Denosumab improves bone density in a female patient with severe anorexia nervosa Andrew Jamieson, Anthony Pelosi, Georgina Weatherdon Bone
P18 Improved Glycaemia following Parathyroidectomy for Primary Hyperparathyroidism Rajni Mahto, Umar Raja, Deborah Markham Bone
P19 A comparison of plasma copeptin and AVP responses during saline infusion studies. Christopher Boot, Louise Hughes, Stephen Turner, Stephen Ball, Dermot Neely Clinical biochemistry
P20 Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study Paul Grant, Clare Jamookeeah, Penny Dhanjal, Gethin Griffith Clinical biochemistry
P21 Genetic hypocalcaemia: a case of 22q deletion syndrome Heather Watson, Alexander McGeoch, Waiel A Bashari, Mohammad I Butt, Samson O Oyibo, Satyanarayana V Sagi Clinical biochemistry
P22 Effect of cortisol assay bias on the overnight dexamethasone suppression test: implications for the investigation of Cushing's syndrome Rachel Brixey-McCann, Sarah Tennant, John Geen, Annie Armston, Julian H Barth, Brian Keevil, Aled Rees, Carol Evans Clinical biochemistry
P23 Using SDHB immunostaining in characterising Pheochromocytoma and Paraganglioma Anand Velusamy, Louise Izatt, Moonim Mufaddal, Barbara McGowan, Jonathan Hubbard, Rupert Obholzer, Paul Carroll Clinical biochemistry
P24 Serum cortisol: What is your laboratory measuring? James Hawley, Laura Owen, Phillip Monaghan, Annie Armston, Carrie Chadwick, Brian Keevil Clinical biochemistry
P25 Vasopressin-2 receptor antagonists: potent but potentially dangerous drugs for the treatment of severe hyponatraemia secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Vikki Tilliridou, Waiel A Bashari, Samson O Oyibo Clinical biochemistry
P26 Lactic Dehydrogenase, a biochemical marker to predict foetal outcome in pregnancies complicated by Intrauterine Growth Restriction   AMRIT GUPTA, SHYAM PYARI JAISWAR, JYOTI ARORA Clinical biochemistry
P27 Turn off the taps. Sophie Jones, Mariam Alexander, Christopher Hilton, Sanjeev Mehta Clinical biochemistry
P28 Where are the endocrinologists? Chloe Broughton, Shaza Ahmed, Beas Bhattacharya Clinical biochemistry
P29 The Epidemiology of Hyper-prolactinaemia Enrique Soto-Pedre, Paul Newey, John Bevan, Graham Leese Clinical biochemistry
P30 Audit of management of patients with hypomagnesaemia in district general hospital K. Tofeec, L. Pichaipillai, T. Bani, A. JOSTEL, Y. Demssie Clinical biochemistry
P31 Single-centre audit of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma. Christopher Boot, Barry Toole, Sarah Johnson, Stephen Ball, Dermot Neely Clinical biochemistry
P32 An unusual presentation of osmotic demyelination syndrome Vinit Kirankumar Shah, Jayadave Shakher Clinical biochemistry
P33 Management of inpatient hypokalaemia: a District General Hospital (DGH) experience Lucia Chen, Siva Sivappriyan Clinical biochemistry
P34 Alkaline Phosphatase may predict tumour volume in patients with parathyroid adenoma Hamid Mani, Franceska Lorford, Thrasos Macriyiannis, Miles Levy Clinical biochemistry
P35 Biochemical Evaluation of Adrenal Incidentalomas Referred to Endocrine Surgery in a Large Teaching Hospital Andrew Davison, Charlotte Hill, Nicki Russell, Alison Waghorn, Susannah Shore Clinical biochemistry
P36 Inhibiting more than the proton pump Chloe Broughton, Shaza Ahmed, Beas Bhattacharya Clinical biochemistry
P37 Asymptomatic hypokalaemia in an identical twin Bnar Talabani, Preethi Nalla, Mohammad Adlan, Lakdasa Premawardhana Clinical biochemistry
P38 Severe hyponatraemia in an inpatient setting - a role for the Endocrinologist? Eveleigh Nicholson, Jana Bujanova, Iain Cranston Clinical biochemistry
P39 Are we doing to many Short Synecthan Test mohammad rahman, kofi Obuobie, onyebuchi Okosieme, Nadia El Farhan, Khaliq hamdan Clinical biochemistry
P40 A case of B Cell Lymphoma of brain presenting as Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Suresha Muniyappa, Zulfiquar Zaida, Abdul Abdul Clinical biochemistry
P41 Audit of the diagnosis and management of primary hyperparathyroidism         Pei Chia Eng, Langstaff Lorna, Kaplan Felicity, Mochloulis George, Winocour Peter Clinical biochemistry
P42 Novel treatment of refractory hypercalcaemia -A serendipitous discovery Isuri Kurera, Jenny Bosworth, Frances Coyle, Jennifer Tringham, Mehjabeen Beebeejaun, Emma Bingham Clinical biochemistry
P43 What is the prevalence of severe post-operative hypocalcaemia in patients who have undergone parathyroid surgery or a total thyroidectomy at the RVI, Newcastle? Does vitamin D play a role? Anna Pawlak, Richard Quinton, Peter Truran, Thomas Lennard, Richard Bliss, Andrew Heed Clinical practice/governance and case reports
P44 Urgent requirement for better patient selection for Short Synacthen Tests: results from a clinical audit. Bernard Freudenthal, Daniel Beder, Arla Ogilvie Clinical practice/governance and case reports
P45 Using Skype follow-up consultations for patients with thyroid disease Catherine Gouveia, Shanti Vijayaraghavan, Susan Gelding Clinical practice/governance and case reports
P46 Review in a specialist Turner clinic improves management Caroline Packer, Christopher Jones, Paul Clift, Andrew Toogood Clinical practice/governance and case reports
P47 A rare incidental cause of Cushing’s syndrome Khaled Tofeec, Angela Paisley Clinical practice/governance and case reports
P48 Partial response to sunitinib therapy in a metastatic dopamine-secreting paraganglioma. Melanie Nana, Aled Rees Clinical practice/governance and case reports
P49 Outcome of patients with Adrenal Incidentalomas: an analysis of  145 patients from a single centre Emily Austin, Asad Rahim, Lisa Shepherd, Andrew Bates Clinical practice/governance and case reports
P50 Early post-operative aldosterone concentration can be used to assess outcome from adrenalectomy in aldosterone producing adenoma Irfan Baig, Barbara McGowan, Jake Powrie, Jonathan Hubbard, Paul Carroll Clinical practice/governance and case reports
P51 Saccular Internal Carotid Artery Aneurysm Masquerading as Pituitary Macroadenoma Louise Goldsmith, Stella Williams, Nabile Mohsin, Upendram Srinivas-Shankar Clinical practice/governance and case reports
P52 Impact of a multidisciplinary diabetic foot clinic on patient outcomes Lowri Phillips, Louise Osborne Clinical practice/governance and case reports
P53 Out-of-hours cover for diabetes and endocrinology: a single UK tertiary centre experience Sam O'Toole, Nigel Glynn, Cathy Gouveia, Raquel Sanchez Windt, Craig Stiles, Rasheeta Sivapackianathan, Scott Akker, Maralyn Druce, Mona Waterhouse, William Drake Clinical practice/governance and case reports
P54 TB or not TB: that is the question Catriona Farrell, Colin Perry Clinical practice/governance and case reports
P55 A case of Polyglandular Autoimmune Disease associated with Common Variable Immunodeficiency Ishrat Khan, Mirena Noyvirt, Aicha Bouraoui, Penny Owen, Helen Lane Clinical practice/governance and case reports
P56 Phaeochromocytoma in pregnancy: good luck and judgement lead to a successful outcome Mie Mie Tisdale, Neil Burgess, Alastair McKelvey, Debbie O'Hare, Francesca Swords Clinical practice/governance and case reports
P57 Audit on Continuous Subcutaneous Insulin Infusion (CSII- Insulin Pump) Therapy: Giulia Argentesi, Seifeledin Yahia, Anastasios Gazis Clinical practice/governance and case reports
P58 Vitamin D deficiency in haemodialysis patients; treatment with colecalciferol. Sharon Huish, Simon Fletcher, Janet Dunn, Martin Hewison, Rosemary Bland Clinical practice/governance and case reports
P59 DIPNECH: under-recognised and a diagnostic challenge Veneranda Lorelei Salazar, Ronan O'Driscoll, Annice Mukherjee Clinical practice/governance and case reports
P60 Sodium-Glucose Co-Transporter 2 Inhibitor associated Normoglycemic Ketoacidosis Shane Bobart, Benjamin Gleason, Jonathan Schroeder, Nydia Martinez, Keith Norris, Sandra Williams Clinical practice/governance and case reports
P61 A novel management of Gitelman's syndrome Suchitra Raj, Ahkallya Kuganolipava, Abiola Fatimilehin, James Clark, Benjamin Field, Sunil Zachariah Clinical practice/governance and case reports
P62 Nothing to "sea" here: turning a blind eye to hyponatraemia Chloe Broughton, Shaza Ahmed, Beas Bhattacharya Clinical practice/governance and case reports
P63 A case to remember mohammad Rahman, Kofi Obuobie, Tom Hickin, Khaliq Hamdan Clinical practice/governance and case reports
P64 Resistant Hypocalcaemia Secondary to Denosumab: Two Case Reports. Caroline Clay, Jan Hoong Ho, Maia Severn, Kalpana Kaushal, Simon Howell Clinical practice/governance and case reports
P65 Multiple endocrine paraneoplastic syndromes in a patient with lung malignancy. Alex Lewis, Isha Malik, Kelly Cheer, Cuong Dang Clinical practice/governance and case reports
P66 National Audit of Transition in Endocrinology: Joint between Society for Endocrinology and the British Society of Paediatric Endocrinology & Diabetes Helena Gleeson, Avril Mason, Colin Perry, Guftar Sheikh, Lorraine Albon, Antonia Brooke, Sailesh Sankar, Rohana Wright, Paul Dimitri Clinical practice/governance and case reports
P67 IgG4 related hypophysitis: A novel candidate to the hypophysitis spectrum Shemin S Vyas, Simon Page, Seifeldin Yahia, Peter Lanyon Clinical practice/governance and case reports
P68 Management of Thyroid Disease in Pregnancy: Experience from an Antenatal Thyroid Clinic Micha Thomas, Zaki Hassan-Smith, Andrew Bates, Asad Rahim Clinical practice/governance and case reports
P69 Endometrial Hyperplasia in Transmen - to scan or not to scan? Leighton Seal, Iffy Middleton, James Barrett Clinical practice/governance and case reports
P70 Steroid responsive hypoglycaemia in a patient with spindle cell sarcoma Emily Tafadzwa Mudenha, Andrew Okpe, Devaka Fernando Clinical practice/governance and case reports
P71 Does the usual time of rising influence the stimulated cortisol response? Anh Tran, Steve Hyer, Rashim Salota, Nikhil Johri, Andrew Rodin Clinical practice/governance and case reports
P72 A woman with thyroid metastases twenty one years after renal carcinoma excision, with biphasic thyroid dysfunction on Sunitinib Preethi Nalla, Bnar Talabani, Mohamed Adlan, Lakdasa Premawardhana Clinical practice/governance and case reports
P73 Immobilisation hypercalcaemia in two intensive care patients Jodie Sabin, Sharman Harris, Pierre Peyrasse, Ian Johnson, Ginette Jones, Anthony Wilton Clinical practice/governance and case reports
P74 Audit  on Hyponatraemia in a West Kent Hospital experience Nardia Poole, Bijal Patel, Siva Sivappiyan Clinical practice/governance and case reports
P75 Large Benign Nerve Sheath Tumour in the Adrenal Gland - An Incidental Finding Mehjabeen Beebeejaun, Eswari Chinnasamy, Gul Bano Clinical practice/governance and case reports
P76 Aromatase inhibitor: A Potential therapy for Obesity Related Hypogonadotropic Hypogonadism and Gynaecomastia Khin Swe Myint, Neetha Jose, Javier Gmoez, Rupa Ahluwalia, Maya Venu Clinical practice/governance and case reports
P77 Pheochromocytoma- experience from a single centre in South India Dukhabandhu Naik, Riddhi Das Gupta, Asha HS, Thomas V paul, Nitin Kapoor, Mahesh D M, Anish Jacob Cherian, Deepak T Abraham, Nylla Shanthly, Reji OOmen, Anuradha Chandramohan, Banumathi Ramakrishna, Rekha Pai, M J Paul, Simon Rajaratnam, Nihal Thomas Clinical practice/governance and case reports
P78 Pituicytoma, Not a ‘Meningioma': Late Recurrence in a Rare Pituitary Tumour Mahender Yadagiri, Simon Shaw, Natarajan Saravanappa, John Ayuk, Biju Jose Clinical practice/governance and case reports
P79 Somatotroph Adenoma Localized with Composite 11C-Methionine-PET/MR Imaging: A Cost Effective Solution. Leelavathy Kandaswamy, Leoni Lekkakou, Olympia Koulouri, Mark Gurnell, Harit Buch, Ananth Viswanath Clinical practice/governance and case reports
P80 Vitamin-D Resistant Idiopathic Hypoparathyroidism Rushi Shah, Avinash Jain, Varun Buch, Rahul Chaudhary, Harit Buch Clinical practice/governance and case reports
P81 Glycogenic Hepatopathy- A tale infrequently told in the Diabetes world Naveed Khalily, Nida Butt, Anthony Dixon Clinical practice/governance and case reports
P82 Should all Short Synacthen Tests be agreed by an Endocrine team? Peter Jarvis, Georgina Page, Helen Holt, Tristan Richardson, Helen Partridge Clinical practice/governance and case reports
P83 Artifactual hypoglycemia - Lesson from a patient with unreliable finger-prick glucose due to absent finger tips An Shing Ang, Daphne Lee, Varadarajan Baskar Clinical practice/governance and case reports
P84 Decreased conscious level and a renal mass Jolyon Dales, Jenny Prouten, Thrasos Macriyiannis, Marie-France Kong Clinical practice/governance and case reports
P85 An Index Case of MEN-1 identified with imaging of the right thigh. Anne Sillars, S.J. Gallacher Clinical practice/governance and case reports
P86 4 years of tolvaptan: experience from two large teaching hospitals. Joseph Follows, Ahmed Iqbal, Amit Allahabadia Clinical practice/governance and case reports
P87 A single centre experience of adrenal vein sampling in a district general hospital serving a remote and rural population. Evgenia Foteinopoulou, Alistair Todd, Anne Pollock, Marie Van Drimmelen, Roderick Harvey, Sandra MacRury, David MacFarlane Clinical practice/governance and case reports
P88 Haemofiltration as a treatment option in refractory life-threatening diabetic ketoacidosis Adnan Agha, Sarfraz Nawaz, Mazhar Saleem, Sharon Jones, Adeeba Ahmed Clinical practice/governance and case reports
P89 Adrenal Insufficiency caused by bilateral primary adrenal lymphoma Sharon Mackin, David Carty, Russell Drummond Clinical practice/governance and case reports
P90 Congenital adrenal hyperplasia - are we really lost in transition? Colin Perry, Malika Alimussina, Jennifer Locke, Hannah Pearlman, Marie Freel, Guftar Shaikh, Faisal Ahmed Clinical practice/governance and case reports
P91 Audit of Plenadren use in selected patients. Deirdre Maguire Clinical practice/governance and case reports
P92 Hypovitaminosis D as a cause of Severe Hypocalcaemia in a Nigerian Female: A case report. Oluwarotimi Olopade, Oluwakemi Yusuf, Abiona Odeyemi, olawumi Kolawole, Olayinka Owolabi Clinical practice/governance and case reports
P93 Evaluation of use of combination dapagliflozin and GLP-1 agonist treatment in type 2 diabetes. Jennifer Hayden, Feicong Huang, Lyndsey McConnell, Christopher Sainsbury, Gregory Jones Clinical practice/governance and case reports
P94 Do guidelines improve the diagnosis and investigation of hyponatraemia? Chloe Broughton, Emily Lucas, Beas Bhattacharya Clinical practice/governance and case reports
P95 Diaphoresis: an unusual initial presenting complaint of Cushing’s Syndrome Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran Clinical practice/governance and case reports
P96 An Unusual Case of "Adrenal" Cushing's. Leoni Lekkakou, Aamir Naeem, Peter Strouhal, Andrew Garnham, Ananth Viswanath, Harit Buch Clinical practice/governance and case reports
P97 Accuracy of sample timing with Short Synacthen Tests at Royal Bournemouth Hospital Peter Jarvis, Georgina Page, Helen Holt, Tristan Richardson, Helen Partridge Clinical practice/governance and case reports
P98 Hyponatremia - An audit of the initial investigation & management Imran Ghaffar, Paul Downie, Bushra Ahmad, Natasha Thorogood, Paul Thomas, Karin Bradley Clinical practice/governance and case reports
P99 A case of haemorrhagic adrenalitis secondary to streptococcus oralis Safwaan Adam, Shaishav Dhage, Elizabeth Keeler, Naveed Younis Clinical practice/governance and case reports
P100 Xerostomia: An unseen consequence of statin use Shemin Vyas, Alia El-Kadiki, Seifeldin Yahia Clinical practice/governance and case reports
P101 A complex case of MEN-1 Dukhabandhu Naik, Mahesh DM, Asha HS, Deepak T Abraham, Nylla Shanthly, Anuradha Chandramohan, Deepak Burad, Banumathi Ramakrishna, M J Paul, Nitin Kapoor, Thomas Paul, Ari G Chacko, Nihal Thomas Clinical practice/governance and case reports
P102 Hyperalphalipoproteinemia in an Epileptic patient – Cardiovascular Protection from Carbamaezipine Use? Gurmit Gill, Biju Jose Clinical practice/governance and case reports
P103 Splenunculi Masquerading as Neuroendocrine Tumours. Emma Walkinshaw, Eleanor Lorenz, Tony Blakeborough, Alia Munir Clinical practice/governance and case reports
P104 UK Primary Hyperparathyroidism Clinical Practice Audit Paul Grant Clinical practice/governance and case reports
P105 Pregnancy and Lactation Associated Osteoporosis (PAO) - Two Case Reports Chung Thong Lim, Ritwik Banerjee Clinical practice/governance and case reports
P106 Pseudohypoparathyroidism - A case of delayed diagnosis Vikram Aarella, Manjusha Rath Clinical practice/governance and case reports
P107 Opiate induced multiple pituitary hormone deficits Jodie Sabin, Ginette Jones, Catrin Barwick, Anthony Wilton Clinical practice/governance and case reports
P108 Separate, sequential, endocrine and glycaemic effects of ipilimumab and pembrolizumab in metastatic melanoma Julia Anstey, Andrew Solomon, Paul Nathan, Heather Shaw Clinical practice/governance and case reports
P109 Resistant hyperparathyroidism and hepatitis : Is there a link? Suchitra Raj, Kavitha Lakshmipathy, James Clark, Benjamin Field, Matthew Cowan, Sunil Zachariah Clinical practice/governance and case reports
P110 Hypogonadism in Noonan Syndrome Andrea Brown, Louise Goldsmith, Claudia Gunga, Fareha Bawa, Upendram Srinivas-Shankar Clinical practice/governance and case reports
P111 Hungry bones: a case of severe complications post parathyroidectomy Anne DeBray, Camille Smyth, Tejaswi Makam, Amar Puttanna, Diana Raskauskiene Clinical practice/governance and case reports
P112 Carbamazepine and Cushing's: a cautionary tale of assay interference mimicking disease Mie Mie Tisdale, Francesca Swords Clinical practice/governance and case reports
P113 Foreign bariatric procedures: Help or hindrance for the NHS? Rhodri King, Mary O'Kane, Simon Dexter Clinical practice/governance and case reports
P114 Variation in levels of Macroprolactin in the investigation of secondary hypogonadism Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Jaimini Cegla, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran Clinical practice/governance and case reports
P115 Audit of adult growth hormone replacement therapy in Nottingham Ian Seetho, Carolyn Chee, Peter Mansell, Simon Page Clinical practice/governance and case reports
P116 Erectile Dysfunction, Diabetes Mellitus, Sun-Tan - The Hypogonadism Story with a Difference Mahender Yadagiri, Laks Varadhan, Changez Jadun, Biju Jose Clinical practice/governance and case reports
P117 Cardiac manifestations of a Phaeochromocytoma Christine J May, Neil Gittoes, Andrew Toogood, John Ayuk Clinical practice/governance and case reports
P118 Management of patients with Adrenal Insufficiency attending Galway University Hospital compared with current Best Practice Sarah Cormican, Ruth Casey, Paula O'Shea, Marcia Bell Clinical practice/governance and case reports
P119 An audit in to the investigation of spontaneous hypoglycaemia: experience at a tertiary centre. Mahesh Katreddy, Laks Varadhan, George Varughese, Mahamood Edavalath, Ananth Nayak Clinical practice/governance and case reports
P120 Cyclophosphamide induced seminiferous tubule damage causing raised FSH and LH, and high testosterone levels Luke McElhinney, Umar Raja Clinical practice/governance and case reports
P121 A case of morning headache: Doege-Potter syndrome Saifuddin Kassim, Anita Pillai, Ruth MacInerney, Isabelle Vanheeswijk, Jhittay Harsimar, Emma Robinson Clinical practice/governance and case reports
P122 The Effects of Maggot Debridement Therapy (MDT) on Length of Hospital Inpatient Stay Muhammad Liyawdeen, Chung Thong Lim, Ritwik Banerjee Luton and Dunstable University Hospital, Luton, United Kingdom Muhammad Liyawdeen, Chung Lim, Ritwik Banerjee Clinical practice/governance and case reports
P123 A case of adrenal haemorrhage in severe sepsis Maria Rita Talla, Alison Mackenzie Clinical practice/governance and case reports
P124 A case of Graves’ disease occurring following cessation of the Oral Combined Contraceptive pill Sabreen Ali, Ali Abbara, Alexander Comninos, Rozana Ramli, Niamh Martin, Emma Hatfield, Amir Sam, Karim Meeran Clinical practice/governance and case reports
P125 Benign or malignant adreno-cortical tumour; the relevance of size and androgen secretory capacity Catherine Cunningham, Michelle Siu, Jenna Deakin, Vineet Prakash, Ahmed Yousseif Clinical practice/governance and case reports
P126 Three Cases Highlighting the Varied Clinical Presentations of Adrenal Haemorrhages Darshi Sivakumaran, Eswari Chinnasamy, Aye Naing, Mohammad Ashraghi, Gul Bano Clinical practice/governance and case reports
P127 Asymtomatic Paget's Disease of the Bone in a 62-year-old Nigerian Man: Three Years Post Alendronate Therapy. Clement Aransiola, Arinola Ipadeola Clinical practice/governance and case reports
P128 Does thyroid armour cause autoimmune thyroid disease? Vilashini Arul Devah, Moulinath Banerjee, Ambar Basu Clinical practice/governance and case reports
P129 Expression of Cytokines in Placenta from Pregnancies Complicated by Intrauterine Growth Restriction with Abnormal Umbilical Artery Doppler Indices Amy Kelly, Meg Hill, Kathryn Reed, Sean Limesand Cytokines and growth factors
P130 Interleukin-27:  A predictive marker for  diabetic retinopathy progression Maha houssen, Amr El-Kannishy, Dalia Sabry, Mona Abo Bakr EL-Hussiny, Rasha hassan el Mahdy, mohamed El-sayed Shaker Cytokines and growth factors
P140 Hormonal control of β-cell proliferation in fetal ovine pancreatic islets in vitro Shelley E Harris, Amy Kelly, Melissa A Davis, Miranda Anderson, Alison J Forhead, Sean W Limesand Growth and development
P141 Inter-correlations between placental genes regulating fetal glucocorticoid exposure and IGF2 in maternal severe obesity: a mechanism for higher birthweight? Theresia Mina, Simon Riley, Jane Norman, Rebecca Reynolds Growth and development
P142 Human fetal adrenal gland development and effects of maternal smoking Zoe C. Johnston, Panagiotis Filis, Michelle Bellingham, Peter J. O'Shaughnessy, Paul A. Fowler Growth and development
P143 VITAMIN D PROMOTES MYOGENIC DIFFERENTIATION AND INDUCES AN ANTIFIBROTIC PHENOTYPE IN PRIMARY CULTURES OF SKELETAL MUSCLE DERIVED SATELLITE CELLS AND FIBROBLASTS Amanda Daoud, Irene Kim, Keith Norris, Monica Ferrini, Jorge Artaza Growth and development
P144 Hypothyroidism, altered leptin and c-reactive protein synthesis characterized pregnancy exposed to genistein Funmileyi Awobajo Growth and development
P145 Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma - impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis Vasileios Chortis, Angela Taylor, Craig Doig, Eirini Meimaridou, Lou Metherell, Wiebke Arlt, Paul Foster Neoplasia, cancer and late effects
P146 The somatostatin analogue pasireotide decreased proliferation and increased apoptosis in pancreatic and pituitary neuroendocrine tumors (NETs) in a Multiple Endocrine Neoplasia type 1 (MEN1) mouse model. Mark Stevenson, Gerard Walls, Ben Soukup, Kate Lines, Ashley Grossman, Herbert Schmid, Rajesh Thakker Neoplasia, cancer and late effects
P147 Steroid Sulphatase and G-protein Coupled Oestrogen Receptor in Human Colorectal Cancer: Correlation with Late-Stage Disease and Potential Therapeutic Targets. Habibur Rahman, Lorna Gilligan, Anne-Marie Hewitt, Dion Morton, Paul Foster Neoplasia, cancer and late effects
P148 PTTG is phosphorylated at residue T60 and regulates p53 stability, in conjunction with PBF, in head and neck cancer. Bhavika Modasia, Martin L Read, Vicki E Smith, Andy S Turnell, Peter C Rae, Rachel J Watkins, Waraporn Imruetaicharoenchoke, Vikki L Poole, Hisham Mehanna, Chris J McCabe Neoplasia, cancer and late effects
P149 Distinct p53 Response Profiles in Transgenic Mouse Models of Thyroid-specific PBF and PTTG Expression Martin Read, Jim Fong, Waraporn Imruetaicharoenchoke, Bhavika Modasia, Greg Lewy, Gavin Ryan, Neil Sharma, Vicki Smith, John Watkinson, Kristien Boelaert, Andrew Turnell, Christopher McCabe Neoplasia, cancer and late effects
P150 Follow up of differentiated thyroid cancer survivors during pregnancy: A retrospective analysis Rhodri King, Medha Rathod, Emma Ward Neoplasia, cancer and late effects
P151 Pituitary-related outcomes of cranial radiotherapy (cXRT) in adults with gliomas. Nikolaos Kyriakakis, Julie Lynch, Steve M. Orme, Georgina Gerrard, Paul Hatfield, Carmel Loughrey, Susan C. Short, Robert D. Murray Neoplasia, cancer and late effects
P152 Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides Ben Challis, Nicolai Albrechtsen, Vishakha Bansiya, Keith Burling, Peter Barker, Bolette Hartmann, Fiona Gribble, Stephen O'Rahilly, Jens Holst, Helen Simpson Neoplasia, cancer and late effects
P153 Novel targeted treatment combinations for malignant neuroendocrine tumour Olfactory Neuroblastoma Karen Young, Ghassan Alusi, Marta Korbonits Neoplasia, cancer and late effects
P154 Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor Dominic Cavlan, Helen Storr, Dan Berney, Chris Evagora, Peter King Neoplasia, cancer and late effects
P155 Primary cilia: a new player in phaeochromocytoma pathogenesis? Sam O'Toole, Umasuthan Srirangalingam, William Drake, Paul Chapple Neoplasia, cancer and late effects
P156 Adverse metabolic profile in long-term survivors of adult and childhood-onset brain tumours:the role of growth hormone deficiency Julie Lynch, Nikolaos Kyriakakis, Satish S. Kumar, Ramzi Ajjan, Georgina Gerrard, Carmel Loughrey, Adam Glaser, Robert D. Murray Neoplasia, cancer and late effects
P157 Ultrasound-guided percutaneous ethanol ablation for selected patients with papillary thyroid microcarcinoma: a novel, effective and well tolerated alternative to neck surgery or observation. Ian Hay Neoplasia, cancer and late effects
P158 Clot structure analysis in survivors of acute lymphoblastic leukaemia: the role of growth hormone deficiency Nikolaos Kyriakakis, Satish S. Kumar, Julie Lynch, Natalie Oxley, Fladia Phoenix, Ramzi Ajjan, Robert D. Murray Neoplasia, cancer and late effects
P159 Use of Sunitinib in Refractory Hypercalcaemia in Pancreatic Neuroendocrine Tumours. Ladan Akbarian-Tefaghi, Jonathan Wadsley, John Newell-Price, Alia Munir Neoplasia, cancer and late effects
P160 Chromogranin B: a possible prognostic biomarker for neuroendocrine tumours? Nipuni E Wanniachchi Wanigasekara, Paul Bech, Kevin Murphy Neoplasia, cancer and late effects
P161 Imaging and evaluating side effects of antiandrogen therapy Serena Tommasini-Ghelfi, D. Alwyn Dart Dart, Charlotte Bevan Neoplasia, cancer and late effects
P162 Outcome of insulinomas diagnosed in a tertiary endocrine center Raluca Trifanescu, Ionela Baciu, Monica Gheorghiu, Anda Dumitrascu, Catalina Poiana Neoplasia, cancer and late effects
P163 Metastatic paraganglioma with isolated 3-methoxytyramine rise in a patient with SDHC mutation AKRAM ALKREKSHI, SACHIT ABHAYARATNA, SARAH PITKIN, ANNE DAWNAY, STEPHANIE E BALDEWEG Neoplasia, cancer and late effects
P164 Recurrent Phaeochromocytomas In Type2C Variant of Von Hippel-Lindau Syndrome  Mehjabeen Beebeejaun, Eswari Chinnasamy, Gul Bano Neoplasia, cancer and late effects
P165 Lutetium ablation therapy as treatment for recurrent metastatic bladder paraganglioma Sachith Abhayaratna, Taofeek Ojewuyi, Mark Gaze, P Kar, Stephanie E Baldeweg Neoplasia, cancer and late effects
P166 Somatostatin responsive ACTH and precursor excess in a midgut mesentery NET. GK Dimitriadis, A Nasoodi, S Khan, W Shatwell, L Chambers, C Tomkins, C Darby, K Gopalakrishnan, HS Randeva, N Murthy, MO Weickert Neoplasia, cancer and late effects
P167 Primary Adrenal Lymphoma Uzma Faruqi, Pawel Kaczmarek, Gleb Ivanov, Benjamin Field Neoplasia, cancer and late effects
P168 Metastatic small bowel Neuroendocrine tumour with bilateral carcinoid heart disease Vidhya R Jahagirdar, Ali D Kamal, Rick Steeds, Stacey Smith, John Ayuk Neoplasia, cancer and late effects
P169 Familial Insulinoma in the absence of MEN Danielle Jeffreys, Georgina Page, Helen Partridge, Tristan Richardson Neoplasia, cancer and late effects
P170 A young girl with bilateral adrenal tumours. Sakina Koubeh, Pushpa Jinadev, Moayed Alhelfi, Julian Davis Neoplasia, cancer and late effects
P171 Acromegaly in association with a bronchial carcinoid tumour Andrzej Rys, Jamie Smith Neoplasia, cancer and late effects
P172 Challenges in the diagnosis and management of a case of glucagonoma first presenting as a localised genital rash. Frances Hunt, Farheen Raza, Agbor Ndip, Paula Chattington Neoplasia, cancer and late effects
P173 A management dilemma - emergency treatment of primary hyperparathyroidism in suspected but unconfirmed Multiple Endocrine Neoplasia type 1 Ramneet Khurana, Ashu Gandhi, Basil Issa Neoplasia, cancer and late effects
P174 PROMOTER METHYLATION SIGNATURES OF BRCA2 AND TP53 GENES IN THE SERUM OF SOME BREAST CANCER PATIENTS ATTENDING RADIOTHERAPY CLINIC IN LAGOS, NIGERIA TITILOLA SAMUEL, BABATUNDE JAMES, AHMED ADARA-ALI, YETUNDE FAYODA, MYM HABEEB Neoplasia, cancer and late effects
P175 Confusion in a Patient with Carcinoid Syndrome Vikram Aarella, Hannah Dix, Stuart Lee Neoplasia, cancer and late effects
P176 Utilisation of Nurse Led Clinics in Endocrinology Practice Lisa Shepherd, Anne Marland, Rachel Austin, Helen Turner Nursing practice
P177 How is the Society for Endocrinology Competency Framework for Adult Endocrine Nursing used in Practice? Veronica Kieffer, Kate Davies, Christine Gibson, Morag Middleton, Jean Munday, Shashana Shalet, Lisa Shepherd, Phillip Yeoh Nursing practice
P178 Pre-pituitary Surgery Patient Satisfaction Audit 2015 Vivien Thornton-Jones, Helen Turner, Simon Cudlip, Ashley Grossman Nursing practice
P179 Development of IT based nurse led endocrine tracking system Sue Cox, Kate Lissett Nursing practice
P180 A care service model for cost effective and structured individualised treatment choice for growth hormone replacement therapy Sofia Llahana, Awal Mumuni, Marta Osz, Mawgen Baber, Stephanie Baldeweg, George Gannon, Gerard Conway Nursing practice
P181 Recurring Abscesses at Injection Sities on the Home Injection Programme Morag Middleton Nursing practice
P182 Testing causality in the association of plasma cortisol with risk of coronary heart disease: a Mendelian randomisation study Andrew Crawford, Nicholas Timpson, George Davey Smith, Brian Walker Obesity, diabetes, metabolism and cardiovascular
P183 Gender-related differences in circulating microparticles characteristics: implications for cardiovascular risk? Justyna Witczak, Aled Rees, Philip James Obesity, diabetes, metabolism and cardiovascular
P184 Longer duration of sitting down in pregnancy is associated with gestational diabetes, greater weight gain and depressive symptoms Nithya Sukumar, Jacqueline Farmer, Hema Venkataraman, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P185 Transcriptome Profiles of Human Pancreatic Islets Following Transient Ischemia Identify Inflammatory and Cell Death Responses.  Amy Kelly, Kate Smith, Fiona McCarthy, Breonna Smith, Vasudeo Badarinarayana, Leah Steyn, Peter Strop, Sean Limesand, Klearchos Papas Obesity, diabetes, metabolism and cardiovascular
P186 Studies of Nuf mice with an activating calcium-sensing receptor (CaSR) mutation demonstrate the CaSR to regulate pancreatic beta-cell mass and glucose homeostasis Valerie N Babinsky, Fadil M Hannan, M Andrew Nesbit, Alison Hough, Michelle Stewart, Elizabeth Joynson, Tertius A Hough, Liz Bentley, Abhishek Aggarwal, Enikö Kallay, Sara Wells, Roger D Cox, Duncan Richards, Rajesh V Thakker Obesity, diabetes, metabolism and cardiovascular
P187 ROLE OF ORAL CHOLECALCIFEROL AS ADJUVANT THERAPY IN TYPE 1 DIABETES MELLITUS: RANDOMIZED CONTROLLED TRIAL Shreya Sharma, Niranjan Biswal, Medha R, Sadish Kumar Kamalanathan, Adhisivam B Obesity, diabetes, metabolism and cardiovascular
P188 PREVALENCE AND DETERMINANTS OF METABOLIC SYNDROME AMONG HIV INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN KANO, NORTHWESTERN NIGERIA FAKHRADDEEN MUHAMMAD, RAHILA MUKHTAR, ENIKUOMEHIN ADENIKE, FAUZIYYAH MUHAMMAD, IBRAHIM GEZAWA Obesity, diabetes, metabolism and cardiovascular
P189 The effect of L-arginine on anorectic gut hormone release in humans Anjali Amin, Christina Neophytou, Kevin Murphy Obesity, diabetes, metabolism and cardiovascular
P190 Generation of a long acting GCSF for treatment of neutropenia and stem cell harvest Abdulrahman Alshehri Obesity, diabetes, metabolism and cardiovascular
P191 Hypercortisolaemia increases femoral adipose tissue blood flow but not net fatty acid release in vivo. Konstantinos Manolopoulos, Iwona Bujalska, Steve Luzio, Wiebke Arlt, Jeremy Tomlinson Obesity, diabetes, metabolism and cardiovascular
P192 CENTRAL IL-6 SIGNALLING AND THE DEVELOPMENT OF IMPAIRED INSULIN SECRETION IN TYPE2 DIABETES Adonis Yiannakas, Alison D. McNeilly, Jennifer Gallagher, Kathryn Wright, Rory J. McCrimmmon Obesity, diabetes, metabolism and cardiovascular
P193 Women with idiopathic intracranial hypertension (IIH) have a distinct andro-metabolic signature compared to polycystic ovary syndrome (PCOS) and simple obesity. Michael O'Reilly, Punith Kempegowda, Hannah Botfield, Fizzah Ali, Angela Taylor, Beverley Hughes, Jeremy Tomlinson, Wiebke Arlt, Alex Sinclair Obesity, diabetes, metabolism and cardiovascular
P194 Differences between Men and Women in Markers of Dietary Fatty Acid Oxidation Catriona McNeil, Camilla Pramfalk, Michael Pavlides, Fredrik Karpe, Leanne Hodson Obesity, diabetes, metabolism and cardiovascular
P195 Establishing Human Liver Cell Models to Investigate the Effects of Exogenous Metabolic Substrates on Fatty Acid Partitioning Charlotte Green, Catriona McNeil, Karl Morten, Leanne Hodson Obesity, diabetes, metabolism and cardiovascular
P196 Evidence for 11β-HSD1 regulation of brain energy metabolism following systemic inflammation Manu Verma, Tiina Kipari, Jonathan Seckl, Megan Holmes, Karen Chapman Obesity, diabetes, metabolism and cardiovascular
P197 Impact of number of transplanted human islet equivalents on successful return to normoglycaemia in an NSG diabetic mouse model. Andrew Bond, June Noble, John Casey, John Campbell, Shareen Forbes Obesity, diabetes, metabolism and cardiovascular
P198 Vascular dysfunction in horses with insulin resistance Ruth Morgan, John Keen, Brian Walker, Patrick Hadoke Obesity, diabetes, metabolism and cardiovascular
P199 Evidence for improved mitochondrial efficiency in adipose tissue of T2DM women after malabsorptive but not restrictive bariatric surgery Lucia Martinez de la Escalera, Laura Jackisch, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Milan Piya, Sudhesh Kumar, Gyanendra Tripathi, Philip McTernan Obesity, diabetes, metabolism and cardiovascular
P200 AMPK activators modulate pro-inflammatory responses in human adipocytes Anna White, Sarah Mancini, Aurelie Nguyen Dinh Cat, Augusto Montezano, Ian Salt, Rhian Touyz Obesity, diabetes, metabolism and cardiovascular
P201 eNAMPT-monomer plays a critical role in pathophysiology of experimental diabetes and represents a novel target for treatment of type 2 diabetes Julius Kieswich, Marta Silvestre, Steven Harwood, Muhammad Yaqoob, Paul Caton Obesity, diabetes, metabolism and cardiovascular
P202 Predictors of glycaemic response and impact on weight and BP of dapagliflozin therapy in type 2 diabetes Feicong Huang, Lyndsey McConnell, Christopher Sainsbury, Gregory Jones Obesity, diabetes, metabolism and cardiovascular
P203 Pre-operative assessment for Sleep apnoea in patients referred for bariatric surgery: the usefulness of various clinical screening tools Chrysiis Martinou, Ullal Nayak, George Varughese, Ajit Thomas, Martin Allen, Lakshminarayanan Varadhan Obesity, diabetes, metabolism and cardiovascular
P204 Effect of Vitamin D supplementation on cardiovascular risk factors and exercise performance in healthy subjects; a randomised placebo controlled pilot study Nimrah Munir, Raquel Revuelta Iniesta, Emad A S AL-DUJAILI Obesity, diabetes, metabolism and cardiovascular
P205 EVALUATION OF ADIPOCYTOKINES AND TRADITIONAL CARDIOMETABOLIC RISK FACTORS IN YOUNG MALE CANCER SURVIVORS: AN AGE-MATCHED CONTROL STUDY Diana Greenfield, Alice Blewitt, Robert Coleman, Jennifer Walsh, John Snowden, Richard Ross, Thang Han Obesity, diabetes, metabolism and cardiovascular
P206 Low Vitamin B12 in pregnancy is associated with maternal obesity and gestational diabetes Nithya Sukumar, Sean Wilson, Hema Venkataraman, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P207 Adrenaline Mediated Metabolic and Functional Quiescence Protects Insulin Producing Cells From Hypoxia Amy Kelly, Rachel Smith, Samantha DiBase, Hailey Davenport, Sean Limesand Obesity, diabetes, metabolism and cardiovascular
P208 Bile acids stimulate GLP-1 release predominantly by accessing basolateral GPBAR1 (TGR5) Cheryl A Brighton, Juraj Rievaj, Rune E Kuhre, Leslie L Glass, Jens J Holst, Fiona M Gribble, Frank Reimann Obesity, diabetes, metabolism and cardiovascular
P209 Vitamin B12 deficiency alters adipogenesis and associated microRNA's in human adipocytes Antonysunil Adaikalakoteswari, Manu Vatish, Philip McTernan, Harpal Randeva, Gyanendra Tripathi, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P210 Proteomic detection of extracellular matrix proteins in insulin-resistant skeletal muscle Li Kang, De Lin, Claire Sneddon Obesity, diabetes, metabolism and cardiovascular
P211 Longitudinal changes in adipose tissue gene expression profile are asociated with deteriorating glucose tolerance Conor Woods, Rachel Crowley, Laura Gathercole, Beverly Hughes, Joanna Gray, Theresa McCarthy, Nicola Crabtree, Paul Stewart, Jeremy Tomlinson Obesity, diabetes, metabolism and cardiovascular
P212 Distinguishing different subtypes of aldosterone-producing adenoma by histological, immunohistochemical & radiological features; a basis for individualised treatment strategies in primary aldosteronism? Andrew S Powlson, Ada Teo, Lalarukh Haris, Carmela Maniero, Alison Marker, Elena Azizan, Mark Gurnell, Morris J Brown Obesity, diabetes, metabolism and cardiovascular
P213 Adrenal insufficiency following bariatric surgery Chinnadorai Rajeswaran, Sarah Oglesby, Syed Zulfiqar Raza Zaidi, Suresha Muniyappa Obesity, diabetes, metabolism and cardiovascular
P214 Discovery and localisation of the expression of calcitonin-type and CRH-type neuropeptide precursors in an echinoderm Weigang Cai, Michaela Egertova, Yusef Badi, Dean Semmens, Maurice Elphick Obesity, diabetes, metabolism and cardiovascular
P215 The Role of Vitamin B12 deficiency in Molecular Mechanism of Metformin May Oo Khin, Adaikala Antonysunil, Warunee Kumsaiyai, Philip Voyias, Philip Mcternan, Simon Gates, Gyanandra Tripathi, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P216 Enhanced orbitofrontal cortex activation following sympathetic neural stimulation in young women with polycystic ovary syndrome: an fMRI study Andrew Lansdown, Esther Warnert, Richard Wise, Aled Rees Obesity, diabetes, metabolism and cardiovascular
P217 Enhanced insulin secretion and insulin action in young lambs with intrauterine growth restriction Leticia Camacho, Sean Limesand Obesity, diabetes, metabolism and cardiovascular
P218 Glucocorticoid excess increases hypothalamic AgRP and results in obesity and hyperinsulinaemia in mice Jonathan Wray, Erika Harno, Alison Davies, Charlotte Sefton, Thanuja Gali Ramamoorthy, Tiffany-Jayne Allen, Anthony P Coll, Anne White Obesity, diabetes, metabolism and cardiovascular
P219 Non-selective Beta-Adrenergic Agonist Infusion Acutely Stimulates the Temperature of Brown Adipose Tissue in Adult Males Hannah Scotney, Michael Symonds, James Law, Helen Budge, Don Sharkey, Konstantinos Manolopoulos Obesity, diabetes, metabolism and cardiovascular
P220 Endogenous ARX knockdown enhances beta-cell lineage specification and maturation during ex vivo transdifferentiation of human exocrine pancreatic tissue Maria Joao Lima, Hilary M Docherty, Kenneth R Muir, Shareen Forbes, John Casey, Kevin Docherty Obesity, diabetes, metabolism and cardiovascular
P221 Altered Adipocytes in an Ovine Model of Polycystic Ovary Syndrome (PCOS) Katarzyna Siemienowicz, Flavien Couckan, Avi Lerner, Steve Franks, Mick Rae, Colin Duncan Obesity, diabetes, metabolism and cardiovascular
P222 Transcriptional Profiles Explain Insulin Hypersecretion Following Chronic Adrenergic Stimulation in Fetal Sheep Islets Amy Kelly, Xiaochuan Chen, Christopher Bidwell, Fiona McCarthy, Sean Limesand Obesity, diabetes, metabolism and cardiovascular
P223 Measuring the contribution of de novo lipogenesis to fatty liver disease: a mouse and translational human study using high resolution mass spectrometry Francis Sanders, Matthew Harvey, Zsuzsanna Ament, Jessie Tingley, Michele Vacca, Julian Griffin Obesity, diabetes, metabolism and cardiovascular
P224 The hypoglycaemic and antioxidant properties of oleanolic acid ameliorate blood pressure and kidney function of experimental animals Andile Khathi, Bonisiwe Mbatha, Cephas T Musabayane Obesity, diabetes, metabolism and cardiovascular
P225 Dietary Cocoa (Theobroma cacao) and Turmeric (Curcuma longa) Consumption: A Comparison of Metabolic Effect in High-Fat Fed Rats Olufeyi Adegoke, Olufemi Morakinyo, Daniel Adekunbi, Wurola Ajibola Obesity, diabetes, metabolism and cardiovascular
P226 Glucose tolerance, insulin sensitivity and adiponectin level in niacin-treated obese rats Olufemi Morakinyo, Titilola Samuel, Daniel Adekunbi, Olufeyi Adegoke Obesity, diabetes, metabolism and cardiovascular
P227 Circadian rhythm of Ambulatory Blood Pressure in rotating night shift nursing professionals and its relation with  6- Sulfatoxy Melatonin as neuroendocrine chronomolecule. B Anjum, Narsingh Verma, Sandeep Tiwari, Ranjana Singh, Abbas Mahdi Obesity, diabetes, metabolism and cardiovascular
P228 <em>Characterising fat distribution and response to weight loss in Idiopathic Intracranial Hypertension</em> Fizzah Ali, Michael O'Reilly, Hannah Botfield, Keira Markey, Jeremy Tomlinson, Wiebke Arlt, Alexandra Sinclair Obesity, diabetes, metabolism and cardiovascular
P229 Anti-inflammatory effects of metformin and their relationship to the therapeutic action of the drug Amy Cameron, Calum Forteath, Craig Beall, Graham Rena Obesity, diabetes, metabolism and cardiovascular
P230 Maternal overnutrition programs hypothalamic neuropeptides and metabolic syndrome in offspring Thanuja Gali Ramamoorthy, Tiffany-Jayne Allen, Alison Davies, Erika Harno, Charlotte Sefton, Jonathan Wray, Christopher Murgatroyd, Anne White Obesity, diabetes, metabolism and cardiovascular
P231 “Thin-fat”  phenotype in early fetal life in GDM pregnancies – Novel evidence from an Indian Cohort Hema Venkataraman, Uma Ram, A Anuradhai, S Suresh, P Saravanan Obesity, diabetes, metabolism and cardiovascular
P232 Functional significance of renal gene expression changes in a mouse model of ACTH-dependent Cushing's Syndrome Marie-Louise Monaghan, Nichole Sime, Bryan Conway, Matthew Bailey, Christopher Kenyon Obesity, diabetes, metabolism and cardiovascular
P233 Brown adipose tissue plays a role in regulating fetal growth by undergoing a gestational-dependent phenotypic change Saraid McIlvride, Shadi Abu-Hayyeh, Georgia Papacelovoulou, Eugene Jansen, Jennifer Steel, Xanthi Maragkoudaki, Catherine Williamson Obesity, diabetes, metabolism and cardiovascular
P234 Seasonal variation of HbA1c Jordan Burgess, Paul Broughton, Graham Leese Obesity, diabetes, metabolism and cardiovascular
P235 RELATIONSHIP BETWEEN HIGH-SENSISTIVITY C-REACTIVE PROTEIN AND ANTHROPOMETRIC INDICES OF OBESITY David Soyoye, Babatope Kolawole, Rosemary Ikem, Adenike Enikuomehin Obesity, diabetes, metabolism and cardiovascular
P236 2beta-hydroxybetulinic acid 3beta-caprylate: an active principle from euryale ferox salisb. seeds with antidiabetic, antioxidant, pancreas & hepatoprotective potential in streptozotocin induced diabetic rats Danish Ahmed, Manju Sharma, Vikas Kumar, Harish Kumar Bajaj, Amita Verma Obesity, diabetes, metabolism and cardiovascular
P237 Clinical Profile and Outcome of Patients with Hyperglycaemic Emergencies Presenting at a Rural Hospital in Southern Nigera Orebowale Olugbemide, Patrick Adunbiola, Idowu Bankole, Kennedy Akhuemokhan Obesity, diabetes, metabolism and cardiovascular
P238 DIABETIC NEUROPATHY: AN EVALUATION USING THE NTSS-6 QUESTIONAIRE AND BIOTHESIOMETRY IN TYPE 2 DM PATIENTS. Lawal-Bello AT, Owolabi FA, Yusuff OT, Amjo OO, Raiyemo OA, kolawole BA, Ikem RT Obesity, diabetes, metabolism and cardiovascular
P239 Hypothalamic glucocorticoid levels increase in an in vivo model of glucocorticoid-induced obesity and hyperinsulinaemia Charlotte Sefton, Erika Harno, Alison Davies, Helen Small, Tiffany-Jayne Allen, Jonathan Wray, Thanuja Gali Ramamoorthy, Anthony P Coll, Anne White Obesity, diabetes, metabolism and cardiovascular
P240 Effects of androgen on the adipokinome and metabolic genes in white and brown adipose tissue Avi Lerner, Drashti Kewada, Anthony Okolo, Kate Hardy, Stephan Franks Obesity, diabetes, metabolism and cardiovascular
P241 From the bronze age to the iron age Sheila Grecian, Safwaan Adam, Akheel Syed Obesity, diabetes, metabolism and cardiovascular
P242 Characterisation of the astrocytic response to acute and recurrent hypoglycaemia Julia Vlachaki Walker, Mike Ashford, Rory McCrimmon, Craig Beall Obesity, diabetes, metabolism and cardiovascular
P243 Markers of adipose tissue hypoxia are elevated in subcutaneous adipose tissue of morbidly obese patients with hypoventilation syndrome and obstructive sleep apnoea syndrome but not in the moderately obese Marijana TodorčevićTodorčević, Luke Austen, Ari Manuel, Zoi Michailidou, John Stradling, Fredrik Karpe Obesity, diabetes, metabolism and cardiovascular
P244 PREVALENCE OF DIABETES MELLITUS AMONG HIV PATIENTS IN KANO, NORTHWESTERN NIGERIA. FAKHRADDEEN MUHAMMAD, ANDREW ULOKO, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD Obesity, diabetes, metabolism and cardiovascular
P245 Obstructive sleep apnoea (OSA) and bariatric surgery: The need for more universal screening and post-operative follow up Chrysiis Martinou, Ullal Nayak, Mahesh Katreddy, George Varughese, Lakshminarayanan Varadhan Obesity, diabetes, metabolism and cardiovascular
P246 The effect of soy protein with and without isoflavones in men with type 2 diabetes mellitus and subclinical hypogonadism - A randomised double blind parallel study Thozhukat Sathyapalan, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin Obesity, diabetes, metabolism and cardiovascular
P247 Is polycythaemia a marker of an increased cardiovascular risk in transmen? Aye Naing, Lily Lei, Katie Jones, James Barrett, Leighton Seal Obesity, diabetes, metabolism and cardiovascular
P248 COST OF ILLNESS AMONG PATIENTS WITH DIABETIC FOOT ULCER IN SECONADRY AND TERTIARY HEALTH FACILITIES IN KANO, NORTHWESTERN NIGERIA FAKHRADDEEN MUHAMMAD, LATEEFAH PEDRO, HASSAN SULEIMAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD, ANDREW ULOKO Obesity, diabetes, metabolism and cardiovascular
P249 Impact of DAFNE and subsequent CSII therapy on Glycaemic Control in Type-1 Diabetes Mellitus Saba Yunus, Hannah Forde, Sonya Browne, Helen Twamley, Eimear Fanning, Diarmuid Smith Obesity, diabetes, metabolism and cardiovascular
P250 Lifelong exposure to sewage sludge chemicals causes proteome-wide and sex-specific disturbances in the liver Panagiotis Filis, Emily Eaton-Turner, Michelle Bellingham, Maria Amezaga, Beatrice Mandon-Pepin, Neil Evans, Richard Sharpe, Corinne Cotinot, Stewart Rhind, Peter O'Shaughnessy, Paul Fowler Obesity, diabetes, metabolism and cardiovascular
P260 GLP-1 agonist based therapy has modest effect on weight and glycaemic control among UAE patients with diabetes: analysis of data on 3725 patients  Raya A Almazrouei, Fatima M Alkaabi, Nader Lessan, Maha T Barakat Obesity, diabetes, metabolism and cardiovascular
P261 EXTRACTS OF HYMENOCARDIA ACIDA AMELIORATE INSULIN RESISTANCE IN SKELETAL MUSCLE CELLS. II Ezeigbo, S Gibbons, ME Cleasby Obesity, diabetes, metabolism and cardiovascular
P262 A Study of Metabolic Syndrome among HAART Naïve HIV Patients in Kano, North Western Nigeria FAKHRADDEEN MUHAMMAD, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD, IBRAHIM GEZAWA Obesity, diabetes, metabolism and cardiovascular
P263 Anthropometric Indices: Optimal cut-off for abdominal obesity in adult Nigerians Ejiro Umuerri, Christiana Ayandele, Godson Eze, Chinedu Anizor Obesity, diabetes, metabolism and cardiovascular
P264 INFLUENCE OF GENDER ON THE DISTRIBUTION OF TYPE 2 DIABETIC COMPLICATIONS AT THE OBAFEMI AWOLOWO TEACHING HOSPITAL, ILE-IFE, NIGERIA Adenike Enikuomehin, Babatope Kolawole, Rosemary Ikem, Bukunmi Soyoye Obesity, diabetes, metabolism and cardiovascular
P265 A study of the influence of West African ethnicity and gender on beta cell function and insulin sensitivity in essential hypertensives treated with hydrochlorothiazide and hydrochlorothiazide-Lisinopril combination Micheal Olamoyegun, Babatope Kolawole, Adesuyi Ajayi Obesity, diabetes, metabolism and cardiovascular
P266 COMPARISON OF SURROGATE MEASURES OF PERCENTAGE BODY FAT WITH BIOELECTRIC IMPEDANCE  IN NIGERIANS ALALADE BOLADAE, IWUALA SANDRA, ODENIYI IFE, FASANMADE OLUFEMI, OHWOVORIOLE AUGUSTINE Obesity, diabetes, metabolism and cardiovascular
P267 Evidence of Fetal Growth Restriction in South-Asian (SA) foetuses of GDM mothers ? Hema Venkatarman, Sam Craik, Nithya Sukumar, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P268 Prediabetes incidence and risk of developing cardiovascular disease in women with polycystic ovary syndrome Zelija Velija Asimi, Sabina Semiz, Tanja Dujic Obesity, diabetes, metabolism and cardiovascular
P269 Improving glycaemic control in T1DM: The FIFE Diabetes Structured Education Programme Luke Boyle, Fiona Jamieson, Denise Burns, Katie Duncan, Jill Malcolm, Leslie White, John Chalmers, Louise Osborne, Catherine Patterson Obesity, diabetes, metabolism and cardiovascular
P270 Intra-Individual correlation between Flow Mediated Dilation (FMD) and Reactive Hyperaemia Peripheral Arterial Tonometry (RH-PAT) in PCOS Ehtesham Ehtesham, Zeeshan Javed, Eric S Kilpatrick, Stephen L Atkin, Thozhukat Sathyapalan Obesity, diabetes, metabolism and cardiovascular
P271 Evaluation of Hypoglycemia unawareness in individuals with Type 1 Diabetes Mellitus using  Continuous glucose monitoring(CGM)  in a tertiary care center. Dukhabandhu Naik, Shilpa R M, Mahesh D M, Asha H S, Nitin Kapoor, Thomas Paul, Padmanabhan V, Mercy Inbakumari, Flory Christina, Jansi Rani, Divya Natarajan, Jeyaseelan L, Nihal Thomas Obesity, diabetes, metabolism and cardiovascular
P272 Postnatal screening in patients with gestational diabetes Nishal Nimish Patel, Yamini Malhotra, Satyanarayana Sagi, Muhammad Imran Butt Obesity, diabetes, metabolism and cardiovascular
P273 Prevalence of Vitamin D deficiency and its association with Diabetes Mellitus in a South-Asian population. Kavinga Gunawardane, Noel Somasundaram, Neil Thalagala, Pubudu Chulasiri, Sudath Fernando Obesity, diabetes, metabolism and cardiovascular
P274 What the Mouth has to say about Diabetes in a Nigerian Tertiary Hospital Ogunmuyiwa Stella, Adesina Olubiyi, Alalade Boladale, Otukoya Adedeji, Adewusi Titilope, Olukunle Oluwale, Bello Adejoke Obesity, diabetes, metabolism and cardiovascular
P275 ANTHROPOMETRIC INDEXES CORRELLATE OF BODY FAT PERCENTAGE AMONG NIGERIANS GBADEBO AJANI, MICHAEL OLAMOYEGUN Obesity, diabetes, metabolism and cardiovascular
P276 Lipid Profile In Apparently Healthy Nigerian Adults Mansur Ramalan, Andrew Uloko, Muhammad Fakhradeen, Ibrahim Gezawa Obesity, diabetes, metabolism and cardiovascular
P277 Overweight and Obesity in a rural Nigerian Adult Population Mansur Ramalan, Bage Aishatu, Muhammad Fakhrudeen Obesity, diabetes, metabolism and cardiovascular
P278 Comparison of glycaemic control in patients with Type-1 Diabetes Mellitus on CSII therapy with different basal rates. Saba Yunus Yunus, Hannah Forde, Sonya Browne, Anne Moore, Eimear Fanning, Diarmuid Smith Obesity, diabetes, metabolism and cardiovascular
P279 Effects of gypenoside on pancreatic beta cell function and insulin secretion Chinmai Patibandla, Steven Patterson, Xinhua Shu Obesity, diabetes, metabolism and cardiovascular
P280 GPR142 plays a critical role in Tryptophan-induced insulin and incretin secretion in mice Hua Lin, Alexander Efanov, Xiankang Fang, Lisa Beavers, Xuesong Wang, Isabel Gonzalez, Tianwei Ma Obesity, diabetes, metabolism and cardiovascular
P281 Inborn errors of metabolism and the endocrinologist Waiel A Bashari, Samson O Oyibo Obesity, diabetes, metabolism and cardiovascular
P282 An Unusual Case of Fish Odour Syndrome- Tabloid paper helped in diagnosis? Ambar Basu, Moulinath Banerjee Obesity, diabetes, metabolism and cardiovascular
P283 EGFR using CKD-EPI, MDRD and Cockcroft- Gault and glycaemic control among type 2 diabetics in an out- patient clinic in Nigeria amanda onwah, omotola ayandele, eunice chike- ezue, anthony kweki Obesity, diabetes, metabolism and cardiovascular
P284 CORRELATES OF DYSGLYCAEMIA AND IMPLICATIONS FOR DIABETES CARE IN CALABAR, NIGERIA. Ofem Enang, Akinyele Akinlade, Olufemi Fasanmade, Augustine Ohwovoriole Obesity, diabetes, metabolism and cardiovascular
P285 PREVALENCE AND RISK FACTORS FOR OBESITY AMONG HIV PATIENTS IN KANO, NORTH WESTERN NIGERIA FAKHRADDEEN MUHAMMAD, ANDREW ULOKO, MANSUR RAMALAN, ENIKUOMEHIN ADENIKE, RAHILA MUKHTAR, FAUZIYYAH MUHAMMAD Obesity, diabetes, metabolism and cardiovascular
P286 RELATIONSHIP BETWEEN INDICES OF CENTRAL OBESITY AND FASTING PLASMA GLUCOSE IN SOUTH-WESTERN NIGERIA Taiwo Raimi, Adesina Odewabi, Olatunde Odusan, Olufemi Fasanmade Obesity, diabetes, metabolism and cardiovascular
P287 How well do front line healthcare professionals understand type 2 diabetes? Xavier Boland, Rhys Martin, Suzannah Yarwood, Duncan Browne Obesity, diabetes, metabolism and cardiovascular
P288 ACCURACY AND RELIABILITY OF GLUCOSE METERS USED AT DIABETES CLINIC OF OAUTHC, ILE IFE, OSUN STATE, NIGERIA. Funmilayo Owolabi, Oluwatomi Yusuff, Amina Lawal-Bello, Oluwabukola Ala, Oluwadamilola Amjo, Adenike Raiyemo, Tewogbade Adedeji, Babatope Kolawole, Rosemary Ikem Obesity, diabetes, metabolism and cardiovascular
P289 BEHAVIOURAL RISK FACTORS FOR DIABETES MELLITUS: A STUDY OF SECONDARY SCHOOL STAFF IN A COMMUNITY IN SOUTH WEST NIGERIA Olubukola Ojo, Olayinka Ilesanmi, Bridget Omotoso, Olalekan Ojo, Oladimeji Junaid Obesity, diabetes, metabolism and cardiovascular
P290 Influence of deuterium depleted water on indicators of prooxidant-antioxidant and detoxifying systems in experimental diabetes Stepan Dzhimak, Alexander Basov, Lilia Fedulova, Elena Kotenkova Obesity, diabetes, metabolism and cardiovascular
P291 RENAL FUNCTION IN TYPE 2 DIABETES PATIENTS AT PRESENTATION IN A TERTIARY HOSPITAL IN NIGERIA- A PRELIMINARY REPORT Olalekan Ojo, Olubukola Ojo Obesity, diabetes, metabolism and cardiovascular
P292 Blood Glucose Monitoring in Diabetic Inpatients - Hyperglycaemia Anita Phung, Nathan Brown, Christina Micanovic, Isaac Aloysius Obesity, diabetes, metabolism and cardiovascular
P293 CASE REPORT OF A TYPE 2 DM PATIENT WITH VITAMIN B12 DEFICIENCY ANEMIA Akinyele Akinlade, Michael Olamoyegun, Ofem Enang Obesity, diabetes, metabolism and cardiovascular
P294 RELATIONSHIP BETWEEN ANTHROPOMETRIC INDICES AND INSULIN RESISTANCE IN NIGERIANS WITH TYPE 2 DIABETES MELLITUS CHIKEZIE ONWUKWE, NKIRU CHIKEZIE Obesity, diabetes, metabolism and cardiovascular
P295 ASSESSMENT OF THE RELATIONSHIP BETWEEN OBESITY INDICES AND LIPID PARAMETERS AMONG NIGERIANS WITH HYPERTENSION Michael Olamoyegun, Ajani David, Akinyele Akinlade, Babajide Gbadegesin, Clement Aransiola, Rotimi Olopade, Olujide Ojo, Ofem Enang, Stella Adetokunbo Obesity, diabetes, metabolism and cardiovascular
P296 HYPERURICAEMIA AND PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH DIABETES MELLITUS Anthonia Ogbera, Victor Osagie Obesity, diabetes, metabolism and cardiovascular
P297 Similia similibus curantur: using DPP-IV inhibitor to treat reactive hypoglycaemia. Marisa Clemente, Moulinath B Obesity, diabetes, metabolism and cardiovascular
P298 CLINICAL PROFILE OF PERSONS WITH DIABETES MELLITUS ATTENDING  AN ENDOCRINOLOGY CLINIC IN  RURAL NIGERIA PATRICK ADUNBIOLA, ORE OLUGBEMIDE, IDOWU BANKOLE, KENNEDY AKHUEMOKHAN Obesity, diabetes, metabolism and cardiovascular
P299 A role for 11C-methionine PET/CT-MRI in the management of de novo and residual acromegaly Olympia Koulouri, Andrew Hoole, Andrea Steuwe, Daniel Gillett, Andrew Powlson, Scott Akker, Simon Aylwin, Antonia Brooke, Harit Buch, Will Drake, Miles Levy, Ayesha Siddiqi, Helen Simpson, Krishna Chatterjee, Neil Burnet, Nagui Antoun, Heok Cheow, Richard Mannion, John Pickard, Mark Gurnell Pituitary
P300 The effect of AIP on AHR transcriptional activity – implications for AIP mutations pathogenicity Matheus de Oliveira Andrade, Dan Sebastian Soare, Serban Radian, Márta Korbonits Pituitary
P301 Investigation of the invasive phenotype of AIP-mutated pituitary adenomas Craig Stiles, Sayka Barry, Emanuela Gadaleta, Claude Chelala, Carol C Shoulders, Marta Korbonits Pituitary
P302 Menin regulates the expression of miR-15a, which is downregulated and inversely correlates with cyclin D1 expression in mouse Men1-associated pituitary tumours. Kate E Lines, Paul J Newey, Chris J Yates, Gerard V Walls, Rajesh V Thakker Pituitary
P303 An Association Between Visual Morphometric Changes and Psychiatric Outcomes in Patients With Acromegaly Syed Imran, Michael Vallis, Jitske Tiemesma, Ferhan Siddiqi, Churn-Ern Yip, Barna Tugwell, Thomas Ransom, Lisa Tramble, Ebad Abidi, David Clarke, Stephanie Kaiser Pituitary
P304 The founder R304* AIP mutation is prevalent in Irish acromegaly and gigantism patients as well as in the general population of Ireland Serban Radian, Yoan Diekmann, Plamena Gabrovska, Brendan Holland, Lisa Bradley, Helen Wallace, Karen Stals, Anna-Marie Bussell, Karen McGurren, Martin Cuesta, Anthony W. Ryan, Maria Herincs, Laura Cristina Hernández-Ramírez, Aidan Holland, Jade Samuels, Elena Daniela Aflorei, Sayka Barry, Judit Dénes, Ida Pernicova, Craig E. Stiles Pituitary
P305 In vitro effect of Imatinib on somatotropinoma cell line Prakamya Gupta, Ashutosh Rai, Naresh Sachdeva, Bishan Das Radotra, Anil Bhansali, Kanchan Kumar Mukherjee, Debashish Hota, Márta Korbonits, Pinaki Dutta Pituitary
P306 Unique clinical picture in patients with X-linked acrogigantism (X-LAG) Donato Iacovazzo, Sian Jose, Benjamin Bunce, Richard Caswell, Laura Cristina Hernández-Ramírez, Francisca Caimari, Francesco Ferraù, Sonal Kapur, Plamena Gabrovska, Mary N Dang, Celia Rodd, Mary Lee Vance, Claudia Ramírez, Moises Mercado, Anthony P Goldstone, Michael Buchfelder, Christine Burren, Pinaki Dutta, Catherine Choong, Timothy Cheetham Pituitary
P307 Silencing of Aryl Hydrocarbon Receptor Protein (AIP) up-regulates the small Rho GTPase, CDC42 Nadira B. Mothojakan, Craig E. Stiles, Sayka Barry, Carol C. Shoulders, Márta Korbonits Pituitary
P308 Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels Peter Trainer, John Newell-Price, John Ayuk, Simon Aylwin, Aled Rees, Will Drake, Philippe Chanson, Thierry Brue, Susan Webb, Carmen Fajardo, Javier Aller, Ann McCormack, David Torpy, Lynne Atley, George Tachas Pituitary
P309 Developing a pituitary Distress Thermometer (PDT) - a means to improve patient quality of life Sue Jackson, Alyson Norman, Anna Crown Pituitary
P310 Mortality of patients with non-functioning pituitary macroadenoma is significantly elevated: systematic analysis of 546 cases in a tertiary referral centre in the UK Georgia Ntali, Cristina Capatina, Violet Fazal-Sanderson, James V Byrne, Simon Cudlip, John AH Wass, Ashley B Grossman, Niki Karavitaki Pituitary
P311 The burden of AIP mutations in pituitary adenoma patients from the UK F. Caimari, M.N Dang, P. Gabrovska, L.C Hernández-Ramírez, K. Stals, A.M. Bussell, T. Cranston, N. Karavitaki, A.V. Kumar, S. Hunter, T. Kearney, P.J. Trainer, I. Izatt, J. Bevan, R. Quinton, J. Grieve, S.E. Baldeweg, A.B. Grossman, P. Morrison, M. Korbonits Pituitary
P312 ACTH and gonadotrophin deficiency predict mortality in patients treated for non-functioning pituitary adenomas (NFPAs) in the UK and Republic of Ireland: long-term follow-up of 519 patients across two tertiary referral centres Michael O'Reilly, Raoul Reulen, Saket Gupta, Rosemary Dineen, C Thompson, Harriet Pearce, Gabriella Bugg, Andrew Toogood, Neil Gittoes, Christopher Thompson, John Ayuk Pituitary
P313 A prospective observational study of the causation and management of SIADH in a tertiary referral hospital. Saba Yunus, Martin Questa, David Slattery, Saket Gupta, William Tormey, CJ Thompson Pituitary
P314 Biochemical assessment of disease activity in acromegaly; a comparison of single GH, GH day series mean, OGTT nadir and IGF-1 in 51 patients Kirupakaran Arun, Andrew S Powlson, Afzal N Chaudhry, David J Halsall, Mark Gurnell Pituitary
P315 Expression of MGMT in a large series of pituitary adenomas: lactotroph  and corticotroph adenomas are more likely to be MGMT-negative than somatotroph and gonadotroph adenomas Danielle A Dixon, Paraskevi Xekouki, Paola Salaris, Omar Mustafa, Julia Prague, Nadeem Abbas, Benjamin Whitelaw, Istvan Bodi, Simon JB Aylwin Pituitary
P316 Does basal post-operative early morning cortisol measurement predict HPA axis integrity as assessed by an insulin tolerance test in patients who have undergone pituitary surgery? Syed Mustafa Ali Ahmad, Debbie Papadopoulou, Emma Hatfield, Nigel Mendoza, Ramesh Nair, Karim Meeran, Niamh M Martin Pituitary
P317 Patient experiences of living with acromegaly in the UK. Antonia Brooke, Jacqui Lyttle, Lynne Goss, Lou Pobereskin, Peninsula Endocrinology Network Pituitary
P318 An Association between Self-Drawing, Morphometric Changes and Psychological Outcomes in Patients with Acromegaly versus Non-functioning Pituitary Adenoma Stephanie Kaiser, Jitske Tiemensema, Michael Vallis, Ferhan Siddiqi, Churn-Ern Yip, Barna Tugwell, Thomas Ransom, Lisa Tramble, Ebad Abidi, David Clarke, Syed Ali Imran Pituitary
P319 The Accuracy of Bilateral Inferior Petrosal Sinus Cannulation and Usefulness of Prolactin Adjustment in One Scottish Centre Kerri Devine, Karen Smith, Iain Robertson, Colin Perry, Marie Freel Pituitary
P320 Neuronatin emerges in the rat pituitary stem/progenitor cells and terminates its role in the terminally differentiating cells Naoko Kanno, Masahi Higuchi, Saishu Yoshida, Hideji Yako, Mo Chen, Hiroki Ueharu, Naoto Nishimura, Hiroto Nishihara, Takako Kato, Yukio Kato Pituitary
P321 Current clinical management of acromegaly in the UK; a survey of endocrinologists Joanne Edwards, Vathani Siva, Laura Baldock, John Ayuk Pituitary
P322 Traditional Cardiac Risk Factors in a Cohort of Hypopituitary Patients: A Preliminary Look at the Utility of QRISK2 Score Rasheeta Sivapackianathan, Jayani Suriyakumaran, Scott Akker, William Drake, Mona Waterhouse, Maralyn Druce Pituitary
P323 Long term follow up of patients with craniopharyngioma. Nigel Glynn, Raquel Sanchez Windt, Mona Waterhouse, Scott Akker, William Drake, Maralyn Druce Pituitary
P324 Metabolic  state  in  ACTH insufficient & ACTH sufficient patients with hypopituitarism not treated for growth hormone deficiency (GHD): a comparative study Dragana Miljic, Sandra Pekic, Mirjana Doknic, Marko Stojanovic, Milan Petakov, Vera Popovic Pituitary
P325 Using modified clamp study to replicate insulin stress test Horng Kai Tan, Gina Twine, Daniel Flanagan Pituitary
P326 Impaired quality of life in patients with acromegaly despite long-term disease control: results from a longitudinal study Nikolaos Kyriakakis, Julie Lynch, John O'Dwyer, Stephen G. Gilbey, Robert D. Murray Pituitary
P327 Pituitary Incidentaloma: Features and outcomes - Recent experience at a tertiary centre Gurmit Gill, Biju Jose Pituitary
P328 DEVELOPMENT OF A PATIENT-REPORTED OUTCOME MEASURE (PROM) FOR PITUITARY SURGERY Ali Nikzad Suren, Anna Crown, Sue Jackson Pituitary
P329 Management of Pituitary Apoplexy - The Greater Manchester Experience Sumithra Giritharan, Kanna Gnanalingham, Tina Karabatsou, Tara Kearney Pituitary
P330 Feedback and Gonadotropin releasing hormone (GnRH) pulse frequency decoding: a mathematical model for GnRH signalling in gonadotrophs Amitesh Pratap, Than Pham, Kathryn Garner, Krasi Tsaneva-Atanasova, Craig McArdle Pituitary
P331 Keep Calm and Give Cabergoline: A giant prolactinoma presenting with seizures Su Ann Tee, Paul Peter, Giridhar Tarigopula, Praveen Partha, Shafie Kamaruddin Pituitary
P332 Loperamide-induced hypopituitarism Catherine Napier, Simon HS Pearce Pituitary
P333 An unusual case of pituitary pathology and the utility of whole body 18F-FDG PET-CT imaging in identifying extraneural biopsy targets Jenna Deakin, Michelle Siu, Harriet Cunningham, Nikhil Patel, Thomas Osborne, Vineet Prakash, Ahmed Yousseif Pituitary
P334 Clinically Non-Functioning Pituitary Macroadenomas:  Presenting Features and Outcomes - Recent Experience at a Tertiary Centre Mahender Yadagiri, Arun Vijay, Mark Pritchard, Ananth Nayak, Simon Shaw, Natarajan Saravanappa, John Ayuk, Biju Jose Pituitary
P335 Pituitary Service Review in a District General Hospital - A Case for Nationally Agreed Guidelines? Eveleigh Nicholson, Jana Bujanova, Nadia Zarif, Partha Kar Pituitary
P336 A case of pituitary functional recovery in a patient with Langerhan's Cell Histiocytosis following chemotherapy with chlorodeoxyadenosine and Mercaptopurine. ANDREW GHABBOUR, ROSELLE HERRING, DAVID RUSSELLL-JONES Pituitary
P337 Unusual features in a case of hypophysitis following ipilimumab therapy  Ali Rathore, Charlotte Siegler, Hafiz Algurafi, James Ahlquist Pituitary
P338 EVOLUTION IN ACROMEGALIC PATIENTS WITH DISCORDANT GH - IGF1 LEVELS DURING MEDICAL TREATMENT Monica Livia Gheorghiu, Iulia Vargatu, Raluca Alexandra Trifanescu, Anda Dumitrascu, Andra Caragheorgheopol Pituitary
P339 Frontal Bone Recurrent Ectopic Craniopharyngioma after transfrontal resection: case report Ana Maria Hilma, Ana-Maria Codreanu, Sergiu Stoica, Corin Badiu, Camelia Procopiuc Pituitary
P340 An unusual case of acromegaly Mia Sheridan, Emma Turtle, Liesbeth Van Look Pituitary
P341 How common is Ipilimumab induced Hypophysitis leading to cortisol deficiency? Sid McNulty, Fareha Bawa, Dhanya Kalathil Pituitary
P342 TSH secreting Pituitary Adenoma with negative TSH Staining Amber Khan, Khai Leow, Jan Hoong Ho, Kalpana Kaushal, Simon Howell Pituitary
P343 An Unusual  Cause of Headache in Pregnancy T Htay, J Bedford, M Harvie, P Dassan, S R Mehta Pituitary
P344 The  Aggressive Clinical Course Of Silent Corticotroph Pituitary Adenomas -  A case series Mehjabeen Beebeejaun, Eswari Chinnasamy, Philip Rich, Leslie Bridges, Gul Bano Pituitary
P345 Intrasellar Meningioma Faisal Ozair, Eswari Chinnasamy, Gul Bano Pituitary
P346 Silent corticotroph adenoma presenting with severe visual loss Laura Rich, Julia Thomas, Joan Grieve Pituitary
P347 Analysis of the human fetal gonadal proteome at 13-14 weeks of gestation. Rebecca Matthews, Panagiotis Filis, Peter O'Shaughnessy, Paul Fowler Reproduction
P348 Development of a single-injection non-surgical sterilant via modification of Measles Virus pseudotyped particles. Cornelia Roesl, Nathan Jeffery, Sarah Smith, Laura Milne, Pamela Brown, Lee Smith Reproduction
P349 Decoding gonadotrophin receptor signalling via spatial regulation of the luteinizing hormone receptor Silvia Sposini, Frederic Jean-Alphonse, Aylin Hanyaloglu Reproduction
P350 IGF-I action in trophoblast involves endocytic and post-endocytic pathways Magda Karolczak-Bayatti, James Horn, Patrick Case, Lynda Harris, John Aplin, Melissa Westwood Reproduction
P351 Intracrine Androgens Enhance Decidualisation and Modulate Expression of Human Endometrial Receptivity genes. Douglas Gibson, Ioannis Simitsidellis, Hilary Critchley, Philippa Saunders Reproduction
P352 Intravenous and subcutaneous infusions of kisspeptin-54 stimulate gonadotrophin release similarly in healthy women Shakunthala Narayanaswamy, Channa Jayasena, Noel Ng, Risheka Ratnasabapathy, Deborah Papadopoulou, Julia Prague, Ali Abbara, Alexander Comninos, Stephen Bloom, Waljit Dhillo Reproduction
P353 Assessment of Reproductive Parameters and Oxidative Stress Following Treatment With Alcohol and/or Cannabinol in Male Wistar Rats Christopher Akintayo, Moyo Ayodele, Shimile Karga Reproduction
P354 Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis Thozhukat Sathyapalan, Rhiannon David, Nigel J Gooderham, Stephen L Atkin Reproduction
P355 Vitamin D regulates extravillous trophoblast migration by inhibiting sphingosine-1-phosphate (S1P) signalling via S1P receptor-2 Edward Johnstone, Khiria Al-Saghir, Cherlyn Tan, Daman Adlam, Melissa Westwood Reproduction
P356 Visceral fat drives 5alpha-reductase activity independent of body mass index in women with polycystic ovarian syndrome Punith Kempegowda, Michael W. O'Reilly, Nicola J. Crabtree, Angela E. Taylor, Beverly A. Hughes, Jeremy W. Tomlinson, Wiebke Arlt Reproduction
P357 Impact of male cholestasis on the sperm epigenome and consequences for the health of the offspring Vanessa Pataia, Georgia Papacleovoulou, Lucilla Poston, Catherine Williamson Reproduction
P358 Isoform-specific knockdown of PKC isoforms reveals PKCβ2 is required for Epidermal Growth Factor stimulated expression of the prostaglandin synthase COX2 in human myometrium. Claire Hudson, Andres Lopez Bernal Reproduction
P359 Information Transfer in Gonadotropin-Releasing Hormone (GnRH) Signalling: ERK-mediated feedback loops control hormone sensing. Kathryn Garner, Rebecca Perrett, Margaritis Voliotis, Thanh Pham, Krasimira Tsaneva-Atanasova, Craig McArdle Reproduction
P360 Whole Exome Sequencing in Congenital Hypogonadotropic Hypogonadism Louise Izatt, Paul Carroll, Suzanne Lillis, Lina Brodd, Kristina Stone, Kevin Ryan, JooWook Ahn, Michael Simpson, Michael Yau Reproduction
P361 Implantation and Pregnancy Outcome of Rats Fed With Low and High Salt Diet Iranloye Bolanle, Oludare Gabriel Reproduction
P362 Vitamin D metabolic profiling across pregnancy  Radhika Susarla, Carl Jenkinson, Jennifer Tamblyn, Brian Keevil, Shiao-Yng Chan, Mark Kilby, Martin Hewison Reproduction
P363 Vitamin D and Fetomaternal Immunity: Effects on Uterine Natural Killer Cells Jennifer Tamblyn, Louisa Jeffery, Radhika Susarla, Paul Moss, Martin Hewison, Mark Kilby Reproduction
P364 Use of an animal model to identify the origin and validity of the testicular dysgenesis syndrome hypothesis in humans Sander van den Driesche, Karen Kilcoyne, Ida Wagner, Ashley Boyle, Chris McKinnell, Sheila Macpherson, Rod Mitchell, Richard Sharpe Reproduction
P365 Investigation into the Effects of Glucocorticoids in a Mouse Model of Induced Menstruation Alison A Murray, Gregory M Armstrong, Reena Murgai, Alexandra E Gray-Renfrew, Rebecca EA Vere, Karen E Chapman, Hilary OD Critchley Reproduction
P366 Structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome: SUCCESS-RCT improved physical activity and illness perception Hamidreza Mani, Kamlesh Khunti, Miles Levy, Danielle Bodicoat, Laura Gray, Janette Barnett, Heather Daly, Trevor Howlett, Melanie Davies Reproduction
P367 Characterization of a GnRH-type signaling system in an echinoderm Shi Tian, Meet Zandawala, Michaela Egertová, Isabel Beets, Susan E. Slade, James H. Scrivens, Maurice R. Elphick Reproduction
P368 Low-dose gonadotrophin therapy for induction of ovulation: comparison of results in women with PCOS or hypothalamic amenorrhoea Suzie Lovelock, Kate Hardy, Davinia White, Stephen Franks Reproduction
P369 Characterisation of bile acid pathways in steroidogenic tissues Sheba Jarvis, Raffaela. M Gadaleta, Elizabeth. J Want, Nicola Gray, Shadi Abu-Hayyeh, Lord Robert Winston, Catherine Williamson, Charlotte. L Bevan Reproduction
P370 Food, drink and medical plants and their molecules can affect female hormones and reproductive functions Alexander V. Sirotkin, Attila Kadasi, Aneta Stochmalova, Richard Alexa, Andrej Balazi, Abdel Halim Harrath Reproduction
P371 Regulation of Cyp17a1 expression in mouse ovarian theca cells in vivo and in vitro Hanako Kakuta, Tomomi Sato Reproduction
P372 Maternal Insulin-Like Growth Factor-1 and Transforming Growth Factor Beta-1 levels during Pregnancy in Rats Fed with Low and High Salt Gabriel Oludare, Bolanle Iranloye Reproduction
P373 Identification of novel transcription factors that may regulate transcription of the equine chorionic gonadotrophin beta subunit Jordan Read, Victoria Cabrera-Sharp, Samantha Mirczuk, Robert Fowkes, Amanda de Mestre Reproduction
P374 A Rare Form Genetic Abnormality in Turner Syndrome Mariana-Cristina Costache-Outas, Camelia Procopiuc, Oana Popa, Madalina-Aura Vintila, Cosmina-Raluca Costache, Danai Stambouli Reproduction
P375 Long-term monitoring of hypogonadal men receiving intramuscular testosterone replacement: a retrospective audit Andrzej Rys, Jonathan Candan, Sue Cox, Jamie Smith Reproduction
P376 PREVALENCE AND CORRELATES OF PREMATURE EJACULATION AMONG NIGERIANS IN A TERTIARY HEALTH CENTRE: A PRELIMINARY CROSS-SECTIONAL STUDY Michael Olamoyegun, Akinyele Akinlade, David Ajani, Clement Aransiola, Ofem Enang, Babajide Gbadegesin, Rotimi Olopade, Olujide Ojo Reproduction
P377 EFFECTS OF ORAL, INJECTABLE, AND IMPLANT HORMONAL CONTRACEPTION ON SERUM LEVELS OF IRON, FERRITIN, COPPER, CERULOPLASMIN AND VITAMIN E TITILOLA SAMUEL, OLUFEMI MORAKINYO, ADEPEJU BALOGUN, JO OLAMIJULO, OLUBUNMI MAGBAGBEOLA Reproduction
P378 Importance of social support and implications of gender reassignment in congenital adrenal hyperplasia due to 3-beta hydroxysteroid deficiency Leelavathy Kandaswamy, Rajeev Raghavan, Vijay Nandini Cherukuri, Harit Buch Reproduction
P379 Testicular regression syndrome and severe psychiatric disorder - a  rare association preventing the optimal management of the endocrine condition Cristina Capatina, Adela Ghinea, Diana Deciu, Catalina Poiana Reproduction
P380 Self medication in transpeople is not associated with deterioration in cardiovascular risk factors but is associated with reduced vitamin D levels and antidepressant use. Leighton Seal, Fahmin Khaleque, James Barrett Reproduction
P381 A pragmatic review of patient satisfaction and testosterone replacement therapy Adam Smith, Sarah Dickinson, Michael Arber Reproduction
P382 Spontaneous resolution of hypothalamic amenorrhea post diagnostic GnRH test. GK Dimitriadis, MO Weickert, TM Barber, HS Randeva Reproduction
P383 Adrenocortical function in glucocorticoid receptor deficient mice Ghazaleh Mohammadi-Zaniani, Rachel Richardson, Steve Morley, Karen Chapman, Chris Kenyon Steroids
P384 TNFα regulates Steroid Sulphatase Activity in Healthy and Malignant tissue. Lorna Gilligan, Mai Nguyen, Anne-Marie Hewitt, Kirsty Burnell, Habibur Rahman, Rowan Hardy, Paul Foster Steroids
P385 Genome-wide binding analysis of glucocorticoid receptors in the rat hippocampus in response to corticosterone and stress. Benjamin P. Flynn, John R. Pooley, Yvonne M. Kershaw, Songjoon Baek, Lars Grontved, Michael J. Guertin, Gordon L. Hager, Stafford L. Lightman, Becky L. Conway-Campbell Steroids
P386 Impact of 5α-Dihydrotestosterone (DHT) on Glandular Epithelial Proliferation in the Mouse Uterus Ioannis Simitsidellis, Fiona L. Cousins, Douglas A. Gibson, Lee B. Smith, Philippa T. K. Saunders Steroids
P387 Plasma Corticosteroid-Binding Globulin: Biomarker of inflammation onset and severity in a rat arthritis model Lesley Hill, Tamara Bodner, Joanne Weinberg, Geoffrey Hammond Steroids
P388 A novel animal model to explore the whole-organism response to 21-hydroxylase deficiency Andreas Zaucker, Tulay Guran, Nazia Thakur, Angela Taylor, Aliesha Griffin, Nils Krone Steroids
P389 Regulation of Glucocorticoid Receptor Action by ARID subunits of SWI/SNF Felicity Ellen Russell, Becky L. Conway-Campbell, Matthew Birnie, Simon Biddie, Stafford Lightman Steroids
P390 Alpha-MSH secretion from a gastro-intestinal stromal tumour leading to ACTH-independent Cushing’s syndrome. Dominic Cavlan, William Drake, Phil Lowry, Andrew Bicknell, Christopher Evagora, Peter King Steroids
P391 Involvement of the TORC isoforms in adrenal responsiveness to basal and stress-induced HPA activity Lorna Smith, Zidong Zhao, George Hazell, Greti Aguilera, Stafford Lightman, Francesca Spiga Steroids
P392 Exploring metabolomic changes due to cortisol deficiency in early development using the ferredoxin (fdx1b) null-allele zebrafish Meltem Weger, Aliesha Griffin, Benjamin Goerling, Angela E. Taylor, Burkhard Luy, Ferenc Mueller, Nils Krone Steroids
P393 The effects of chronic administration of the synthetic glucocorticoid dexamethasone on memory and learning in the rat Emma Earl, Yvonne Kershaw, Stafford Lightman, Becky Conway-Campbell Steroids
P394 Synthetic glucocorticoid treatment induces prolonged activation of glucocorticoid receptors in discrete brain regions and impairs memory and learning processes in the rat. Matthew Birnie, Rebecca Demski-Allen, Ben Flynn, Yvonne Kershaw, Gareth Barker, Clea Warburton, Stafford Lightman, Becky Conway-Campbell Steroids
P395 Vitamin D2 vs vitamin D3: effects of total and free 25D on immune cells in vivo Ivan Hernandez, Rene Chun, Dean Larner, Carl Jemkinson, Louisa Jeffery, John S Adams, Martin Hewison Steroids
P396 Model systems to define the role of AKR1D1 in metabolic liver disease Nikolaos Nikolaou, Laura Gathercole, James Dunford, Wenhwa Lee, Reina Lim, Jane McKeating, Udo Oppermann, Leanne Hodson, Jeremy Tomlinson Steroids
P397 Molecular and immunohistochemical analysis of aldosterone producing adenomas Rea Ganatra, Lewis Saunders, Candy Sze, Ashley Parker, Philip Hall, Dominic Cavlan, Peter King Steroids
P398 Discrimination of adrenocortical carcinoma from other adrenal lesions: use of a new 13 steroid serum panel based on LC-MS/MS David Taylor, Lea Ghataore, Royce Vincent, Roy Sherwood, Ben Whitelaw, Dorota Dworakowska, Klaus-Martin Schulte, Salvadore Diaz-Cano, Dylan Lewis, Simon Aylwin, Norman Taylor Steroids
P399 Glucocorticoid-induced lipolysis across human ageing and the relationship to fat mass and androgens Zaki Hassan-Smith, Angela Taylor, Beverly Hughes, Theresa Brady, Pamela Jones, Stuart Morgan, Gareth Lavery, Jeremy Tomlinson, Paul Stewart Steroids
P400 Rapid Equilibriation of Cortisol Between the Free and Total Plasma Pools Anna Anderson, Carolynn Cairns, Roland Stimson, Ruth Andrew, Nor Mohd-Shukri, Rebecca Reynolds, Brian Walker Steroids
P401 Do Androgens Lead to Increased Erythropoiesis in Women with Congenital Adrenal Hyperplasia (CAH)? Nayananjani Karunasena, Meredith Elman, Ashwini Mallappa, Deborah P. Merke, Richard Ross, Eleni Daniel Steroids
P402 Bioinformatic analysis of microRNAs associated with aldosterone secretion. Nur Izah Ab Razak, Scott M. MacKenzie, Louise A. Diver, Martin M. McBride, Eleanor Davies Steroids
P403 Immunogenicity in AAD patients treated with depot tetracosactide Joanna L Davis, Catherine Napier, Anna L Mitchell, Earn H Gan, Simon HS Pearce Steroids
P404 Unveiling the complexity of the Undifferentiated Zone in the human adrenal cortex. Irene Hadjidemetriou, Gerard Ruiz-Babot, Celso Gomez-Sanchez, Peter King, Leonardo Guasti Steroids
P405 Cytosolic innate immune receptor RIG-I amplifies glucocorticoid action within lung epithelial cells Shuji Sai Steroids
P406 Quantitative analysis of an adrenal steroid profile, canrenone and mifepristone in plasma by triple quadrupole mass spectrometry Catriona Kyle, Gregorio Naredo, Ruth Andrew, Brian Walker, Natalie Homer Steroids
P407 Conventional versus modified release hydrocortisone in mitotane treated patients with adrenocortical cancer Marianne Weigel, Stefanie Hahner, Daniela Beier, Kathrin Zopf, Marcus Quinkler Steroids
P408 Effects of diet and gender on postprandial salivary glucocorticoid levels and bile acid excretion in healthy volunteers Graham Anderson, Christopher Kenyon, Emad A S AL-DUJAILI Steroids
P409 Shocking? A systematic review of adrenal insufficiency in adults on oral steroids Louise Hunter, Rebecca M Joseph, David W Ray, William G Dixon Steroids
P410 Hormone replacement therapy with prednisolone in adrenal insufficiency (AI) patients - data from the European Adrenal Insufficiency Registry (EuAIR) Marcus Quinkler, Bertil Ekman, Claudio Marelli, Sharif Uddin, Pierre Zelissen, Robert Murray Steroids
P411 The effect of adrenalectomy on cardiovascular morbidity in adrenal tumor patients with Subclinical Cushing's Syndrome: Systematic review and meta-analysis Irina Bancos, Fares Alahdab, Rachel Crowley, Vasileios Chortis, Dana Erickson, Neena Natt, Massimo Terzolo, Wiebke Arlt, Mohammad Murad Steroids
P412 DHEA reduces the palmitate-induced apoptosis in L6 myotubes Vitor Felitti, Gabriela Spiazzi, Caio Teixeira, Carla Carvalho Steroids
P413 Profiling of multiple vitamin D metabolites in a healthy human cohort by high-throughput LC-MS/MS analysis Carl Jenkinson, Angela Taylor, Radhika Susarla, Jennifer Tamblyn, Zaki Hassan-Smith, Brian Keevil, Martin Hewison Steroids
P414 Support from clinical audit data for liberal minimum 9am cortisol cut-off to avoid Short Synacthen Tests. Bernard Freudenthal, Daniel Beder, Arla Ogilvie Steroids
P415 Lineage conversion of human cells to an adrenocortical phenotype: a new technology to study the adrenal gland. Gerard Ruiz Babot, Irene Hadjidemetriou, Sharon Jane Ajodha, David Taylor, Norman Taylor, Leonardo Guasti Steroids
P416 Steroid-dependent patients with multiple co-morbidities are more vulnerable to adrenal crisis Katherine White, John Wass Steroids
P417 Comorbidities are the norm for steroid-dependent patients and predispose to adrenal crisis Katherine White, John Wass Steroids
P418 Lack of awareness contributes to delayed diagnosis and inappropriate management in men with low testosterone: findings from a UK study of men diagnosed with hypogonadism David Edwards, Laurence Olding Steroids
P419 Heterogeneity in the clinical management of adrenal insufficiency - data from EU-AIR Robert Murray, Bertil Ekman, Sharif Uddin, Claudio Marelli, Marcus Quinkler, Pierre Zelissen Steroids
P420 PHAEOCHROMOCYTOMA RELATED REVERSIBLE TAKOTSUBO CARDIOMYOPATHY                                      ZEENAT BANU, PATRICK CHONG Steroids
P421 Iatrogenic Cushing's syndrome secondary to Combined Oral Contraceptive Pill in a patient with Congenital Adrenal hyperplasia Satish Artham, Yaasir Mamoojee, Simon Ashwell Steroids
P422 Bilateral adrenal haemorrhage in a patient with anti-phospholipid syndrome Taofeek Ojewuyi, Akram Alkrekshi, Teng Teng Chung Steroids
P423 Transient Adrenal Insufficiency following Acute Bilateral Adrenal Haemorrhage Jan Hoong Ho, Khai Leow, Amber Khan, Simon Howell, Kalpana Kaushal Steroids
P424 X-linked Adrenoleukodystrophy- How to improve identification in the Addison's populatation Louis Tapper, Sarah Hogg, Graham Wood, Karen Harrison, Alasdair Parker Steroids
P425 Primary testicular lymphoma with bilateral adrenal masses and adrenal insufficiency Satish Artham, Yaasir Mamoojee, Sath Nag Steroids
P426 Adrenal Insufficiency from bilateral adrenal haemorrhage in a postoperative patient on warfarin Emily Tafadzwa Mudenha, Manjusha Rathi Steroids
P427 Cushing's syndrome secondary to bilateral functioning adrenocortical adenoma zeenat banu, Saiful kassim Steroids
P428 Complications of CAH in pregnancy Natasha Archer, Chandrima Roy, Miles Levy Steroids
P429 Liquorice induced hypermineralocorticoidism – A Case report from Midyorkshire Hospitals NHS trust Vani Shankaran, Mark Freeman Steroids
P430 Autoimmune Polyendocrine Syndrome Type 4 Shang Shaho Steroids
P431 A severe case of Ectopic ACTH presenting with Cushing's Syndrome with Hypokalemia, Hypomagnesemia, Hypophosphatemia, Hyponatremia and Hypocalcemia. Sheharyar Qureshi, Anna Gray, Nisha Adjmal, Junaid Farooq, Noushad Padinjakara Steroids
P432 PERIPHERAL BLOOD MICRORNA MARKERS IN PATIENTS WITH PAPILLARY THYROID CANCER Petros Perros, Ujjal Mallick, Simon Pearce Thyroid
P433 Effect of hypothyroidism on pancreatic β-cell mass and circulating insulin concentration in the ovine fetus Shelley E Harris, Miles J De Blasio, FB Peter Wooding, Abigail L Fowden, David Meredith, Alison J Forhead Thyroid
P434 Thyroid hormones and mitochondrial development in skeletal muscle of fetal sheep near term K.L. Davies, A.J. Forhead, M.J. De Blasio, A.J. Murray, A.L. Fowden Thyroid
P435 The natural history of subclinical hyperthyroidism due to Graves' disease. Sviatlana Zhyzhneuskaya, Caroline Addison, Jola Weaver, Vasileios Tsatlidis, Salman Razvi Thyroid
P436 Epitopes, Specificity, Functional Effects and Immunoglobulin G Subclasses of Anti-Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 Mahmoud Habibullah, Nicolas Kluger, Annamari Ranki, Kai Krohn, Anthony Weetman, Helen Kemp Thyroid
P437 Reliability of Thyroid Ultrasounds in assessment of thyroid nodules Salini Sumangala, Gurmit Gill, Paul Wilson, Zafar Hashim, Muthukumarasamy Balasubramaniam, Lakshminarayanan Varadhan Thyroid
P438 Subclinical and overt hypothyroidism in pregnancy: what happens next? David Carty, Flora Doogan, Sarah-Jane Duffus, Elaine Butler, Paul Welsh, Christian Delles Thyroid
P439 Soy protein with isoflavones impairs thyroid function Thozhukat Sathyapalan, Mo Aye, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin Thyroid
P440 Increased rehospitalisation rate and cardiovascular morbidity in inpatients with hyperthyroidism - a matched case-control study Barbara Torlinska, James Hodson, Jayne Franklyn, Jamie Coleman, Kristien Boelaert Thyroid
P441 Small fibre dysfunction in Hypothyroidism - a prospective study using methods of small fibre function and structure Sanjeev Sharma, Gerry Rayman Thyroid
P442 A cross-sectional survey to determine iodine status of school girls living in Northern Ireland. Paul McMullan, Lesley Hamill, Jayne Woodside, Katie Dolan, Karen Mullan Thyroid
P443 Thyroid abnormalities during anti-PD1 cancer immunotherapy Cathrine Mace, Stefan Diem, Martin Gore, James Larkin, Daniel Morganstein Thyroid
P444 The effect of isoflavone-free soy protein supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized double blind crossover study. Thozhukat Sathyapalan, Zeeshan Javed, Natalie J Thatcher, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin Thyroid
P445 A cross sectional survey of dietary iodine intake in pregnant women living in Northern Ireland. Paul McMullan, Jayne Woodside, Lesley Hamil, Karen Mullan Thyroid
P446 Is One Benign Thyroid FNA Cytology Sufficient To Out rule Malignancy? : A University Teaching Hospital Experience. Mohamed Ahmed, Michael Jeffers, John Feeney, Pardeep Govender, Mark Sherlock, James Gibney Thyroid
P447 The value of second fine needle aspiration cytology tests when investigating benign thyroid nodules (Thy2/Thy2c) Alan Muhyaldeen, Angelos Kyriacou, Jonathan Schofield, Anisa Ali, Sunethra Ghattamaneni, Sakinah Thiryayi, Rana Durgesh, Narine Nadira, Steve Lee, Akheel Syed, Neil Parrott, Handrean Soran Thyroid
P448 Managemenet of amiodarone induced thyrotoxicosis within the United Kingdom: is it time for a consensus guideline? A single centre retrospective review. Mie Mie Tisdale, Francesca Swords, Rupa Ahluwalia Thyroid
P449 Serum thyroid stimulating hormone concentration after withdrawal of  thionamides as a predictor of Graves’ disease outcome Preethi Nalla, Mohamed Adlan, Lakdasa D Premawardhana Thyroid
P450 Maternal thyroid function in pregnancy and risk of Breech presentation. Bridget Knight, Beverly Shields, Rachel Sturley, Bijay Vaidya Thyroid
P451 Ultrasound Guided Thyroid FNA with Cytopathology In-attendance Significantly Improved Accuracy in a University Teaching Hospital. Mohamed Ahmed, Michael Jeffers, John Feeney, Pardeep Govender, Mark Sherlock, James Gibney Thyroid
P452 Diagnostic and therapeutic challenges in medullary thyroid carcinoma Ruxandra Dobrescu, Ionela Baciu, Dumitru Ioachim, Corin Badiu Thyroid
P453 Less is more: superior efficacy and tolerability of 400 MBq radioactive iodine for management of thyrotoxicosis Joannis Vamvakopoulos, Laura Guest, Alexandra Paul, Emily Austin, Lisa Shepherd, Andrew Bates Thyroid
P454 Incidental thyroid malignancy in Grave's thyrotoxicosis. Nazia Rashid, Tom Kurzawinski, Teng-Teng Chung Thyroid
P455 Management of thyroid cancer: a 5-year retrospective audit Lavanta Farouk, Nisha Kaimal Thyroid
P456 Thyroid Eye Disease Audit – The Wolverhampton experience Feaz Babwah, Ananth Viswanath, Soupramanien Sandramouli Thyroid
P457 R438H Missense Mutation Related Generalized Resistance to Thyroid Hormone (GRTH): A Case Series Report in Three Generations Jawad Bashir, Tamar Saeed, Khaliq Hamdan, Hadeel Bashir, Irfan Khan Thyroid
P458 Imaging in subclinical hyperthyroidism Anne DeBray, Amar Puttanna Thyroid
P459 Qualitative analysis of ultrasound reports assessing radiological descriptors of thyroid nodules - a retrospective pilot audit Satish Artham, Yaasir Mamoojee, Sue Jones, Vikram Lal, Sath Nag Thyroid
P460 An audit of Hyperthyroidism in Pregnancy Eswari Chinnasamy, Faisal Ozair, Sidrah Khan, Emmanuel Ofori-Asare, Carolyn Romer, Ingrid Watt-Coote, Arshia Panahloo Thyroid
P461 Thyroxine administration: a challenging case P. Loumpardia, S. Wordsworth, G. Curtis, C.M. Bellamy, N. Waterfield, S.P.Y. Wong Thyroid
P462 Thyroid deficiency refractory to treatment: Is this a case for DOT? Emily Tafadzwa Mudenha, Devaka Fernando Thyroid
P463 Recurring thyroid eye disease: a diagnostic dilemma. Pauline McAleer, Emma Turtle, Jan Kerr, Karen Adamson Thyroid
P464 Timing of food intake and L-thyroxine replacement - a cost saving simple change of phrasing in the British National Formula (BNF) Rajendran Bellan Kannan Thyroid
P465 The value of thyroxine absorption test followed by weekly thyroxine administration in determining the cause of persistent hypothyroidism despite high dose levothyroxine treatment: A case report Khaliq Hamdan, Mohammad Rahman, Priya Mohan-Babu, Kofi Obuobie Thyroid
P466 Resistance to thyroid hormone in a family of Bangladeshi extraction Muhammad Asam Thyroid
P467 More Than Meets the Eye: A case of longstanding hypothyroidism due to Hashimoto's thyroiditis presenting with unilateral thyroid eye disease (TED) Su Ann Tee, Paul Peter, Praveen Partha, Shafie Kamaruddin, Giridhar Tarigopula Thyroid
P468 TSH Receptor antibodies Testing In Hypothyroid Pregnant Women Nabeel Saeed, Shakir Ahmed, Firas Haddadin Thyroid
P469 Thyroid dysfunction secondary to antiviral therapy: a simple management protocol Saher Tariq, Waiel A Bashari, Katherine Barry, Mary Ninkovic, Samson O Oyibo Thyroid
P470 Propylthiouracil induced ANCA associated vasculitis (AAV). Laxmi Manohar Rao Balmuri, Komal Imtiaz Thyroid
P471 Odd TFTs: when it doesn’t fit, it probably isn’t right! Khyatisha Seejore, Thet Koko, Andrew Pettit Thyroid
P472 Primary radioactive iodine ablation for TSH secretingadenoma - an uncommon treatment for a rare disease. Farheen Raza, Haider Khan, Paula Chattington Thyroid
P473 An unusual cause of hypercalcemia Sushuma Kalidindi, Mussarat Riaz, Alexandra Lubina-Solomon Thyroid
P474 Buying time: a unique case of delayed thyroidectomy post thyroid storm Gautam Sen, Marc Atkin Thyroid
P475 A disputable but effective therapy in neutropenia associated with Graves' disease. Isuri Kurera, Mehjabeen Beebeejaun, Emma Bingham Thyroid
P476 Late stage Hashimato’s or Riedel’s? A case report illustrating this diagnostic conundrum. Charlene Tang, Sanjaya Dissanayake, Varadarajan Baskar Thyroid
P477 Investigating pyrexia whilst awaiting thyroidectomy for Thy3, Hurthle cell nodule. P. Loumpardia, T. Dacruz, H. Zeitoun, S.P.Y. Wong Thyroid
P478 The roller-coaster ride of thyroid function before, during and after pregnancy Sian Wynne, Stella Mwenechanya, Moulinath Banerjee Thyroid
P479 Metastatic differentiated thyroid cancer with undetectable serum thyroglobulin: diagnostic, management and follow-up challenges Pedro Marques, Teresa Ferreira, Lucília Salgado, Rafael Cabrera, Valeriano Leite Thyroid
P480 Thionamides resistant Graves' Disease - It's not always poor compliance. Sajjad Ahmad, Ijaz Farooq, Stephen Stanaway Thyroid
P481 Recurrent Hashimoto's Encephalopathy: A case report of reversible coma and status epilepticus Adnan Agha, Htwe Htun, Adeeba Ahmed Thyroid
P482 Hyperthyroidism in a elderly patient intolerant to carbimazole Sushuma Kalidindi, Stephanie Bailey, Shakeel Mohammed, Alexandra Lubina-Solomon Thyroid
P483 Audit - Radioiodine therapy in benign thyroid disease Jill Nicholson, Finn Catling, Myuri Moorthy, Anukul Garg, Nethaji Chidambaram Thyroid
P484 Severe Myxoedema complicated by peri-orbital oedema, gum oedema, SIADH and ECG changes Aye Aye Min, Deirdre Maguire Thyroid
P485 Inadequate TSH - resistance to thyroid hormones: 2 case reports Adriana Gogoi, Simona Jercalau, Corin Badiu Thyroid
P486 Management of Hypothyroidism in Pregnancy with Armour Thyroid Tolulope Shonibare, Alia Munir Thyroid
P487 A case of thyroid hormone resistance with unusually elevated free thyroxine Louise Curtis, Georgina Page, Helen Partridge, Helen Holt, Tristan Richardson Thyroid
P488 Hypercalcaemia - Look beyond the usual. Mohammad M Rahman, Thomas R Hickin Thyroid
P489 If it feels like Myxoedema Coma, then it probably is! Heechan Kang, Waiel A Bashari, Samson O Oyibo Thyroid
P490 Preoperative parathyroid imaging: a retrospective audit Natalie Winfield Thyroid
FP1 Inhibition of NFAT signalling in vivo improves microvascular endothelial function in a mouse model of chronic diabetes Alison McNeilly, Eliana Garcia-Vaz, Jennifer Gallagher, Rory McCrimmon, Maria Gomez, Faisel Khan Featured Posters
FP2 Corticosterone in human saliva is highly abundant and lacks a diurnal rhythm Catriona Kyle, Rita Upreti, Anna Anderson, Shaoyun Chen, Natalie Homer, Ruth Andrew, Roland Stimson, Brian Walker Featured Posters
FP3 Maternal genotype is an important determinant of the outcome of antenatal glucocorticoid treatment in GR<sup>+/+</sup> and GR<sup>+/-</sup> fetal mice Emma Batchen, Rachel Richardson, Adrian Thomson, Carmel Moran, Gillian Gray, Karen Chapman Featured Posters
FP4 GLP-1 reduces cerebrospinal fluid secretion and intracranial pressure: A novel treatment for idiopathic intracranial hypertension? Hannah Botfield, Maria Uldall, James Mitchell, Ana Maria Gonzalez, Rigmor Jensen, Alexandra Sinclair Featured Posters
FP5 <sup>Generation of GnRH neurons from human Embryonic Stem Cells (hESCs) and induced Pluripotent Stem Cells (iPSCs) of healthy individuals and patients with Kallmann's Syndrome</sup> Ariel Poliandri, Duncan Miller, Leo Dunkel Featured Posters
FP6 The role of 11beta-Hydroxysteroid dehydrogenase type 2 in the central regulation of blood pressure and salt appetite Julie McNairn, Matthew Bailey, Carmel Moran, Lorraine Work, Megan Holmes Featured Posters
FP7 Regulation of adipogenesis by wnt10b signalling in cultured human adipocytes taken from an obese patient with a WNT10B-C256Y mutation. Sahar Azharian, Philip D.Voyias, Alice Murphy, Lucia Martinez de la Escalera Clapp, Antonysunil Adaikalakoteswari,, Ponnusamy Saravanan, Milan K.Piya, Philip G.McTernan, Gyanendra Tripathi Featured Posters
FP8 Reduced circulating levels of kisspeptin, human chorionic gonadotropin, placental-like growth factor, soluble fms-like tyrosine kinase-1 and soluble endoglin but not prokineticin-1 are associated with miscarriage risk Ali Abbara, Channa Jayasena, Alexander Comninos, Shakunthala Narayanaswamy, Juan Gonzalez Maffe, Chioma Izzi-Engbeaya, Jaimie Oldham, Zubair Sarang, Zainab Malik, Richard Harvey, Mandish Dhanjal, Catherine Williamson, Stephen Bloom, Waljit Dhillo Featured Posters
FP9 How well can we measure oestradiol? Laura Owen, Phillip Monaghan, Brian Keevil Featured Posters
FP10 A dedicated Turners clinic improves adherence to UK recommended best practice and is well liked by patients. Jean Munday, Anjana Siva, Huw Thomas, Lisa Cross, Michelle Evans, Kim Page, Eleni Karathanasi, Lorraine Albon Featured Posters
FP11 Potential molecular mechanism of AIP-mediated cellular invasion Sayka Barry, Eivind Carlsen, Jumana A Saleh, Emanuela Gadaleta, Claude Chelala, Márta Korbonits Featured Posters
FP12 Characterising the functional significance of the first reported mutations in the pituitary tumor-transforming gene binding factor (PBF) Waraporn Imruetaicharoenchoke, Rachel Watkins, Bhavika Modasia, Vikki Poole, Alice Fletcher, Rebecca Thompson, Kristien Boelaert, Vicki Smith, Martin Read, Christopher McCabe Featured Posters
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 75
Mon 02 09:00
Registration
Strathblane Hall
Mon 02 10:30
Skills 1: Working with the media
Sidlaw
Chair: Saffron Whitehead (London)
Mon 02 10:30
SK1.1
Skills 1: Working with the media
Why should we engage with the media?
London, UK
Mon 02 10:52
SK1.2
Skills 1: Working with the media
Working with press officers to promote your research
Mon 02 11:14
SK1.3
Skills 1: Working with the media
What journalists need from scientists
Mon 02 11:37
SK1.4
Skills 1: Working with the media
When hormones hit the headlines
Mon 02 10:30
Symposium 1: Endocrinology meets the environment
Nutrition and habits meet hormones
Supported by Endocrine Connections
Fintry
Chairs: Matthew Simmonds (Oxford) & Martin Read (Birmingham)
Mon 02 10:30
S1.1
Symposium 1: Endocrinology meets the environment
Later life consequences of maternal vitamin D deficiency - MAVIDOS Study
Mon 02 11:00
S1.2
Symposium 1: Endocrinology meets the environment
Iodine deficiency
Mon 02 11:30
S1.3
Symposium 1: Endocrinology meets the environment
Environmental influences on autoimmunity
Amsterdam, The Netherlands
Mon 02 10:30
Symposium 2: Zoning in on adrenal tumours
Illuminating the recent advances in genetic causes of adrenal tumours and hypertension
Supported by Endocrine-Related Cancer
Main Hall, Pentland
Chairs: Marie Freel (Glasgow) & Scott MacKenzie (Glasgow)
Mon 02 10:30
S2.1
Symposium 2: Zoning in on adrenal tumours
Somatic mutations and adrenal remodelling in hyperaldosteronism
Mon 02 11:00
S2.2
Symposium 2: Zoning in on adrenal tumours
Advances in genetic causes of adrenal Cushing’s
Zürich, Switzerland
Mon 02 11:30
S2.3
Symposium 2: Zoning in on adrenal tumours
The new genetics of phaeochromocytoma
Paris, France
Mon 02 10:30
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial decline and dysfunction is a common theme in many disease states. Identifying strategies that improve mitochondrial function
Moorfoot & Kilsyth
Chairs: Paul Chapple (London) & Craig Doig (Birmingham)
Mon 02 10:30
S3.1
Symposium 3: Fanning the flames of mitochondrial function
Novel regulation of fat metabolism in cancer
Boston, USA
Mon 02 11:00
S3.2
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial protein homeostasis in the control of metabolism and aging
Amsterdam, The Netherlands
Mon 02 11:30
S3.3
Symposium 3: Fanning the flames of mitochondrial function
Mitochondrial disease: problems and solutions
Mon 02 12:15
Meet the Expert 1: Cutting edge imaging of whole endocrine organs
Supported by Clinical Endocrinology
Sidlaw
Chair: Julian Davis (Manchester)
Mon 02 12:15
MTE1
Meet the Expert 1: Cutting edge imaging of whole endocrine organs
Cutting edge imaging of whole endocrine organs
Mon 02 12:15
Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
Supported by Clinical Endocrinology
Main Hall, Pentland
Chair: Graham Leese (Dundee)
Mon 02 12:15
MTE2
Meet the Expert 2: T4 vs T4/T3 – evidence vs expectations?
T4 vs T4/T3 – evidence vs expectations?
Mon 02 12:15
Futures 1: Branching out with endocrinology
Making the most out of your degree(s) – matching your skills to academic careers
Fintry
Chairs: Ruth Andrew (Edinburgh) & Samantha Mirczuk (London)
Mon 02 12:15
FUT1.1
Futures 1: Branching out with endocrinology
Insights into career patterns for graduates of a biological sciences degree
Mon 02 12:25
FUT1.2
Futures 1: Branching out with endocrinology
From postdoc to P.I. – transition to independence
London, United Kingdom
Mon 02 12:35
FUT1.3
Futures 1: Branching out with endocrinology
The secret life of a core facilities manager
Edinburgh, UK
Mon 02 12:45
FUT1.4
Futures 1: Branching out with endocrinology
Panel discussion
Mon 02 12:15
Futures 2: Overcoming the consultancy hurdle
Shaping the future of endocrinology and diabetes
Moorfoot & Kilsyth
Chairs: Miles Levy (Leicester) & Sheba Jarvis (London)
Mon 02 12:15
FUT2.1
Futures 2: Overcoming the consultancy hurdle
Perspective of a next generation consultant
Portsmouth, UK
Mon 02 12:25
FUT2.2
Futures 2: Overcoming the consultancy hurdle
Perspective of an established consultant
Leeds, UK
Mon 02 12:35
FUT2.3
Futures 2: Overcoming the consultancy hurdle
Research pathways in endocrinology – a UK and global perspective
London, UK
Mon 02 12:45
FUT2.4
Futures 2: Overcoming the consultancy hurdle
Panel discussion
Mon 02 13:00
Lunch & poster viewing
Exhibition Hall, Lennox Suite
Mon 02 13:00
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Sidlaw
Chair: Ashley Grossman (Oxford)
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Current thinking in the management of hyponatraemia and SIADH
Cardiff University, United Kingdom
Mon 02
Otsuka Satellite: Which way now in hyponatraemia? Reviewing new consensus guidelines
Interactive case studies
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 02 13:00
Pfizer Satellite: Treatment resistance in Acromegaly
Moorfoot & Kilsyth
Chair: John Ayuk (Birmingham)
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Challenges in acromegaly - resistance to somatostatin analogues
Birmingham, UK
Mon 02
Pfizer Satellite: Treatment resistance in Acromegaly
Managing treatment resistance in Fimilial Isolated Pituitary Adenomas

Unknown speaker

London, UK
Mon 02 14:15
Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
Main Hall, Pentland
Chair: Steve O'Rahilly (Cambridge)
Mon 02 14:15
PL1
Plenary Lecture 1: Society for Endocrinology Starling Medal Lecture
Hyperactive PI-3-Kinase signalling without hormone excess: between cancer and endocrinology
Edinburgh, UK
Mon 02 14:45
Plenary Lecture 2: Society for Endocrinology Medal Lecture
Main Hall, Pentland
Chair: Barbara McGowan (London)
Mon 02 14:45
PL2
Plenary Lecture 2: Society for Endocrinology Medal Lecture
Kisspeptin - a vital trigger of puberty with therapeutic potential
London, UK
Mon 02 15:30
Oral Communications 1:Early Career Prize Session
Six oral communications from selected abstracts submitted by Early Career endocrinologists
Moorfoot & Kilsyth
Chairs: Brian Walker (Edinburgh) & Gerard Conway (London)
Mon 02 15:30
OC1.1
Oral Communications 1:Early Career Prize Session
A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901
Mon 02 15:45
OC1.2
Oral Communications 1:Early Career Prize Session
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
London, UK
Mon 02 16:00
OC1.3
Oral Communications 1:Early Career Prize Session
RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
Mon 02 16:15
OC1.4
Oral Communications 1:Early Career Prize Session
Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome
Dublin, Ireland
Mon 02 16:30
OC1.5
Oral Communications 1:Early Career Prize Session
Interaction of the MR and GR in the Nucleus and at DNA
Mon 02 16:45
OC1.6
Oral Communications 1:Early Career Prize Session
Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Munich, Germany
Mon 02 15:30
Clinical Management Workshop 1: How do I do it? (I)
Clinical tips from the experts
Supported by Clinical Endocrinology and Endocrinology, Diabetes & Metabolism Case Reports, Thyroid Eye Disease Charitable Trust and British Thyroid Foundation
Main Hall, Pentland
Chairs: John Bevan (Aberdeen) & Tristan Richardson (Bournemouth)
Mon 02 15:30
CMW1.1
Clinical Management Workshop 1: How do I do it? (I)
How do I report and interpret a DXA scan?
Sheffield, UK
Mon 02 15:45
CMW1.2
Clinical Management Workshop 1: How do I do it? (I)
How do I treat osteoporosis after bisphosphonates?
Birmingham, United Kingdom
Mon 02 16:00
CMW1.3
Clinical Management Workshop 1: How do I do it? (I)
How do I investigate and manage gynaecomastia?
Mon 02 16:15
CMW1.4
Clinical Management Workshop 1: How do I do it? (I)
How do I manage adrenal suppression?
Oxford, UK
Mon 02 16:30
CMW1.5
Clinical Management Workshop 1: How do I do it? (I)
How do I prevent thyroid eye disease after radioiodine?
United Kingdom
Mon 02 16:45
CMW1.6
Clinical Management Workshop 1: How do I do it? (I)
How do I manage suspected non compliance for thyroxine replacement?
Mon 02 15:30
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Exploring dynamic systems with different timescales and mechanisms
Supported by Journal of Endocrinology
Sidlaw
Chairs: Gordon Hager (Bethesda, MD, USA) & Lorna Smith (Bristol)
Mon 02 15:30
S4.1
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Sleep: what endocrinologists should know about the body clock
Mon 02 16:00
S4.2
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Rhythms of adrenal glucocorticoid secretion
Bristol, United Kingdom
Mon 02 16:30
S4.3
Symposium 4: It's all in the timing: rhythms underlying endocrine systems
Dynamics In Hypothalamic-Pituitary Function Over Multiple Time-scales
Mon 02 15:30
Symposium 5: Premature ovarian insufficiency
Ovarian follicle reserve: sequelae and management of premature depletion
Fintry
Chairs: Stephen Franks (London) & Kim Jonas (London)
Mon 02 15:30
S5.1
Symposium 5: Premature ovarian insufficiency
Determinants of ovarian follicle reserve: implications for the ageing ovary
Mon 02 16:00
S5.2
Symposium 5: Premature ovarian insufficiency
Neurological and psychological effects of premature ovarian insufficiency
Mon 02 16:30
S5.3
Symposium 5: Premature ovarian insufficiency
Management of oestrogen replacement and potential for fertility in young women with premature ovarian insufficiency
London
Mon 02 17:00
Tea & coffee
Exhibition Hall, Lennox Suite
Mon 02 17:30
Early Career Prize Lectures
The Society awards two prizes to Early Career Endocrinologists, one basic science and one clinical
Main Hall, Pentland
Chairs: Karen Chapman (Edinburgh) & Wiebke Arlt (Birmingham)
Mon 02 17:30
ECP1.1
Early Career Prize Lectures
Basic Science - The Physiology and Pharmacology of the Fasting-Induced Hormone, FGF21
London, UK
Mon 02 18:00
ECP1.2
Early Career Prize Lectures
Clinical: Kisspeptin- A ‘Key Regulator' of Reproductive Physiology, Integrating Limbic Circuits with the Regulation of Reproductive Hormones
London, UK
Mon 02 18:30
Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
Main Hall, Pentland
Chair: David Ray (Manchester)
Mon 02 18:30
PL3
Plenary Lecture 3: Society for Endocrinology Transatlantic Medal Lecture
An integrated view of nuclear receptor/chromatin interactions
Bethesda, USA
Mon 02 19:00
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
Main Hall, Pentland
Chair: Mark Vanderpump (London)
Mon 02 19:00
D1.1
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
FOR
Cardiff, Wales
Mon 02 19:20
D1.2
Debate: This house believes that patients with hypothyroidism should be offered combination treatment with T3 and T4 if they do not respond to Levothyroxine
AGAINST
Mon 02 19:45
Welcome Reception
Exhibition Hall, Lennox Suite
Mon 02 20:00
Futures 3: Why endocrinology and diabetes?
Drink and nibbles will be available
Fintry
Chairs: Karim Meeran (London) & Dominic Cavlan (London)
Mon 02 20:00
FUT3.1
Futures 3: Why endocrinology and diabetes?
What endocrinology did for me – from a consultant’s perspective
Sheffield, UK
Mon 02 20:10
FUT3.2
Futures 3: Why endocrinology and diabetes?
Let me tell you how it is – from a trainee’s perspective
Mon 02 20:20
FUT3.3
Futures 3: Why endocrinology and diabetes?
An Endocrinology Club in your medical school - from concept to reality
Mon 02 20:30
FUT3.4
Futures 3: Why endocrinology and diabetes?
Panel discussion
Mon 02 20:45
Early Career Quiz
Ticketed event
Moorfoot & Kilsyth
Tue 03 08:00
Registration
Strathblane Hall
Tue 03 09:00
Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
Main Hall, Pentland
Chair: Graham Williams (London)
Tue 03 09:00
PL4
Plenary Lecture 4: Society for Endocrinology Dale Medal Lecture
Calcium regulation: from rhinos to molecules
Oxford, United Kingdom
Tue 03 09:30
Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
Main hall - Pentland
Chair: Mark Vanderpump (London)
Tue 03 09:30
PL5
Plenary Lecture 5: British Thyroid Association Pitt-Rivers Lecture
New insights into thyroid hormone action
Boston, USA
Tue 03 10:00
Tea & coffee
Exhibition Hall, Lennox Suite
Tue 03 10:30
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Update on advanced neuroendocrinology
Main Hall, Pentland
Chairs: Helen Spoudeas (London) & Andrew Lansdown (Cardiff)
Tue 03 10:30
CMW2.1
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Weird and wonderful pituitary imaging
London
Tue 03 11:00
CMW2.2
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
How to improve management of craniopharyngioma
Manchester, United Kingdom
Tue 03 11:30
CMW2.3
Clinical Management Workshop 2: Management of pituitary disease: beyond the adenoma
Inflammatory and autoimmune pituitary disease
London, UK
Tue 03 10:30
Symposium 6: Clinical implications of thyroid genomics
Genome variations in thyroid regulation and disease
Supported by Journal of Molecular Endocrinology
Moorfoot & Kilsyth
Chairs: Mark Gurnell (Cambridge) & Vicki Smith (Birmingham)
Tue 03 10:30
S6.1
Symposium 6: Clinical implications of thyroid genomics
Thyroid genomics - relevance to thyroid hormone therapy
Cardiff, Wales
Tue 03 11:00
S6.2
Symposium 6: Clinical implications of thyroid genomics
Genetic underpinning of thyroid function in health and disease
Rotterdam, The Netherlands
Tue 03 11:30
S6.3
Symposium 6: Clinical implications of thyroid genomics
TCGA genomic characterisation of papillary thyroid carcinoma
Ann Arbor, USA
Tue 03 10:30
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Successfully conveying science to the general public
Supported by Addison’s Disease Self-Help Group
Sidlaw
Chairs: Anna Mitchell (Newcastle upon Tyne) & Kate Lines (Oxford)
Tue 03 10:30
SK2.1
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Engaging with the public: conveying the wonders of science
Tue 03 10:45
SK2.2
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
The battles of writing a lay summary
Southborough, UK
Tue 03 11:00
SK2.3
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making science cool for kids
Tue 03 11:15
SK2.4
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making your impact statement pack a punch
Oxford, United Kingdom
Tue 03 11:30
SK2.5
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Making social media work for promoting and recruiting science
Tue 03 11:45
SK2.6
Skills 2: Early Career Symposium: Effective communication: get involved, get engaged!
Panel discussion
Tue 03 10:30
Nurse Session 1: Multiple Endocrine Neoplasia
Holistic approach of the MEN patient
Supported by AMEND
Fintry
Chairs: Morag Middleton (Aberdeen) & Alison Milne (Aberdeen)
Tue 03 10:30
N1.1
Nurse Session 1: Multiple Endocrine Neoplasia
Overview of MEN
Birmingham, UK
Tue 03 11:00
N1.2
Nurse Session 1: Multiple Endocrine Neoplasia
Genetics and MEN
London , UK
Tue 03 11:30
N1.3
Nurse Session 1: Multiple Endocrine Neoplasia
Psychological support of the MEN patient
Tue 03 12:15
Meet the Expert 3: Optimising fertility in teenage cancer survivors
Supported by Clinical Endocrinology
Main Hall, Pentland
Chair: Richard Quinton (Newcastle upon Tyne)
Tue 03 12:15
MTE3
Meet the Expert 3: Optimising fertility in teenage cancer survivors
Optimising fertility in teenage cancer survivors
Edinburgh, UK
Tue 03 12:15
Meet the Expert 4: Investigation and management of TSHoma
Supported by Clinical Endocrinology
Sidlaw
Chair: Neil Gittoes (Birmingham)
Tue 03 12:15
MTE4
Meet the Expert 4: Investigation and management of TSHoma
Investigation and management of TSHoma

Unknown speaker

Cambridge, UK
Tue 03 12:15
Meet the Expert 5: What every endocrine researcher should know about genome editing
Fintry
Chair: Vicki Smith (Birmingham)
Tue 03 12:15
MTE5
Meet the Expert 5: What every endocrine researcher should know about genome editing
What every endocrine researcher should know about genome editing
Boston, USA
Tue 03 12:15
Meet the Expert 6: Frontiers in the management of hypoparathyroidism
Supported by Clinical Endocrinology and Hypopara UK
Moorfoot & Kilsyth
Chair: Bill Fraser (Norwich)
Tue 03 12:15
MTE6
Meet the Expert 6: Frontiers in the management of hypoparathyroidism
Frontiers in the management of hypoparathyroidism
Bethesda, USA
Tue 03 13:00
Lunch & poster viewing
Exhibition Hall, Lennox Suite
Tue 03 13:00
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Moorfoot & Kilsyth
Chair: Ashley Grossman (Oxford)
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
The experience of acromegaly: patients’ perspectives
Exeter, UK
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Somatostatin analogue therapy for acromegaly; what matters to patients?
Tue 03
Ipsen Satellite: Treatment of pituitary patients: What are the clinical and patients’ needs?
Thyrotropinomas (TSHomas) – do symptoms correlate with disease activity?

Unknown speaker

Cambridge, UK
Tue 03 14:15
Oral Communications 2: Translational pathophysiology and therapeutics
Six oral communications from selected abstracts submitted by delegates
Sidlaw
Chairs: Anne White (Manchester) & Jyothis George (Oxford)
Tue 03 14:15
OC2.1
Oral Communications 2: Translational pathophysiology and therapeutics
Dual 5-alpha reductase inhibition promotes hepatic lipid accumulation in man as a result of changes to lipid metabolism in adipose tissue and the liver
Birmingham, United Kingdom
Tue 03 14:30
OC2.2
Oral Communications 2: Translational pathophysiology and therapeutics
Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism
Tue 03 14:45
OC2.3
Oral Communications 2: Translational pathophysiology and therapeutics
Further advances in diagnosis of adrenal cancer: a high-throughput urinary steroid profiling method using liquid chromatography tandem mass spectrometry (LC-MS/MS)
Tue 03 15:00
OC2.4
Oral Communications 2: Translational pathophysiology and therapeutics
Development of a long-acting growth hormone antagonist for the treatment of acromegaly
Tue 03 15:15
OC2.5
Oral Communications 2: Translational pathophysiology and therapeutics
Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and one year mortality

Unknown speaker

Holbæk, Denmark
Tue 03 15:30
OC2.6
Oral Communications 2: Translational pathophysiology and therapeutics
Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1 (MEN1)
Oxford, UK
Tue 03 14:15
Symposium 7: The rise and rise of the FGFs in endocrinology
The increasing understanding of FGFs in pathogenesis and treatment of diverse endocrine disease
Moorfoot & Kilsyth
Chairs: Steve O'Rahilly (Cambridge) & Andrew Lansdown (Cardiff)
Tue 03 14:15
S7.1
Symposium 7: The rise and rise of the FGFs in endocrinology
FGFs and hypogonadism
Lausanne, Switzerland
Tue 03 14:45
S7.2
Symposium 7: The rise and rise of the FGFs in endocrinology
FGF21: Starvation hormone to clinical drug?
Bloomington, USA
Tue 03 15:15
S7.3
Symposium 7: The rise and rise of the FGFs in endocrinology
Targeting FGF23 in bone disease
Indianapolis, USA
Tue 03 14:15
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Thyroid and metabolic control during pregnancy
Main Hall, Pentland
Chairs: Karen Adamson (Edinburgh) & Shareen Forbes (Edinburgh)
Tue 03 14:15
S8.1
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Revolutionising Type 1 diabetes metabolic control in pregnancy
Cambridge, UK
Tue 03 14:45
S8.2
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Pregnancy and obesity
Edinburgh, United Kingdom
Tue 03 15:15
S8.3
Symposium 8: Fine-tuning of metabolic state for optimal pregnancy outcome
Autoimmune thyroid disease before and during pregnancy
Exeter
Tue 03 14:15
Nurse Session 2: Nurse-led clinics
Why, how and other considerations of nurse led clinics
Fintry
Chairs: Dianne Wright (Bradford) & Sadaf Ulnasah (Birmingham)
Tue 03 14:15
N2.1
Nurse Session 2: Nurse-led clinics
Development of a nurse-led hyperparathyroidism clinic
London, UK
Tue 03 14:45
N2.2
Nurse Session 2: Nurse-led clinics
Running a general endocrine nurse-led clinic
Tue 03 15:15
N2.3
Nurse Session 2: Nurse-led clinics
Medicolegal aspects of endocrine nursing
Oxford, UK
Tue 03 15:45
Tea & coffee
Exhibition Hall, Lennox Suite
Tue 03 16:15
Oral Communications 3: Steroids and adrenal
Six oral communications from selected abstracts submitted by delegates
Sidlaw
Chairs: John Connell (Dundee) & Mick O'Reilly (Birmingham)
Tue 03 16:15
OC3.1
Oral Communications 3: Steroids and adrenal
Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
London, UK
Tue 03 16:30
OC3.2
Oral Communications 3: Steroids and adrenal
Glucocorticoids stabilise the microtubule network to inhibit cell migration
Tue 03 16:45
OC3.3
Oral Communications 3: Steroids and adrenal
11β-HSD1-mediated decrease in COX-2 expression is abrogated by hypoxia in human dermal fibroblasts
Leeds, United Kingdom
Tue 03 17:00
OC3.4
Oral Communications 3: Steroids and adrenal
Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma
Birmingham, United Kingdom
Tue 03 17:15
OC3.5
Oral Communications 3: Steroids and adrenal
Glucocorticoid pattern-dependent gene regulation in the rat hippocampus
Tue 03 17:30
OC3.6
Oral Communications 3: Steroids and adrenal
Female 5β-reductase knockout mice are protected from diet induced obesity, insulin resistance and glucose intolerance
Tue 03 16:15
Oral Communications 4: Diabetes and cardiometabolic complications
Six oral communications from selected abstracts submitted by delegates
Fintry
Chairs: Terence Pang (Dudley) & Jonathan Hazlehurst (Oxford)
Tue 03 16:15
OC4.1
Oral Communications 4: Diabetes and cardiometabolic complications
Acute intense exercise restores defective counter-regulation in Type 1 Diabetes through a process of dis-habituation
Tue 03 16:30
OC4.2
Oral Communications 4: Diabetes and cardiometabolic complications
Thermal imaging as a novel non-invasive method to measure human brown adipose tissue activity in humans
London, UK
Tue 03 16:45
OC4.3
Oral Communications 4: Diabetes and cardiometabolic complications
5α-Tetrahydrocorticosterone exhibits topical anti-inflammatory action with limited adverse effects on angiogenesis
Tue 03 17:00
OC4.4
Oral Communications 4: Diabetes and cardiometabolic complications
Hyperinsulinaemia due to inhibition of 5α-reductases is ameliorated by liver-selective glucocorticoid receptor antagonism in diet-induced obesity
Tue 03 17:15
OC4.5
Oral Communications 4: Diabetes and cardiometabolic complications
Glucagon Increases Energy Expenditure Independently of Brown Adipose Tissue Activation in Humans
Tue 03 17:30
OC4.6
Oral Communications 4: Diabetes and cardiometabolic complications
Cardiac fibrosis and the balance between glucocorticoid and mineralocorticoid receptor signalling
Tue 03 16:15
Symposium 9: The endocrinology of the thin
Mechanisms and therapies at unhealthily low body mass states
Supported by Endocrine Connections
Moorfoot & Kilsyth
Chairs: Daniel Morganstein (London) & Clare McFadden (Edinburgh)
Tue 03 16:15
S9.1
Symposium 9: The endocrinology of the thin
Endocrine dysfunction in anorexia nervosa
Boston, USA
Tue 03 16:45
S9.2
Symposium 9: The endocrinology of the thin
Paradoxical metabolism neutralizes immunity in cachexia
Tue 03 17:15
S9.3
Symposium 9: The endocrinology of the thin
Ghrelin in frailty
Philadelphia, USA
Tue 03 16:15
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Immunotherapy for the clinical endocrinologist
Main Hall, Pentland
Chairs: Paul Newey (Dundee) & Anna Mitchell (Newcastle upon Tyne)
Tue 03 16:15
CMW3.1
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
The thyroid and rituximab
Alessandria, Itay
Tue 03 16:45
CMW3.2
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Endocrine sequelae of biological therapies
Dublin, Ireland
Tue 03 17:15
CMW3.3
Clinical Management Workshop 3: Biological therapies - cause and cure of endocrine diseases
Biological agents in pancreatic neuroendocrine tumours
Tue 03 18:00
Plenary Lecture 6: Clinical Endocrinology Trust Lecture
Main Hall, Pentland
Chair: Steve Ball (Manchester)
Tue 03 18:00
PL6
Plenary Lecture 6: Clinical Endocrinology Trust Lecture
Mining the steroid metabolome in adrenal hormone excess
London, UK
Tue 03 18:30
Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
Main Hall, Pentland
Chair: John Connell (Dundee)
Tue 03 18:30
PL7
Plenary Lecture 7: Clinical Endocrinology Trust Visiting Professor Lecture
The expanding universe of mineralocorticoids in hypertension
Michigan, USA
Tue 03 19:30
Conference Dinner
Ticketed event
The Hub, Edinburgh
Wed 04 07:30
Registration
Strathblane Hall
Wed 04 07:30
Breakfast
Tea, coffee and pastries available
Main Hall, Foyer
Wed 04 08:30
Society for Endocrinology AGM
Main Hall, Pentland
Wed 04 09:15
Clinical Management Workshop 4: How do I do it? (II)
Clinical tips from the experts
Supported by Clinical Endocrinology and Endocrinology, Diabetes & Metabolism Case Reports
Main Hall, Pentland
Chairs: Colin Johnston (London) & Helen Simpson (Cambridge)
Wed 04 09:15
CMW4.1
Clinical Management Workshop 4: How do I do it? (II)
How do I prep a thyrotoxic patient for urgent surgery?
Wed 04 09:30
CMW4.2
Clinical Management Workshop 4: How do I do it? (II)
How do I manage refractory hypocalcaemia
Wed 04 09:45
CMW4.3
Clinical Management Workshop 4: How do I do it? (II)
How far do I investigate chronic fatigue?
Manchester, UK
Wed 04 10:00
CMW4.4
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hirsutism?
Wed 04 10:15
CMW4.5
Clinical Management Workshop 4: How do I do it? (II)
How do I manage hormone replacement in teenagers/young adults with learning difficulties?
Wed 04 10:30
CMW4.6
Clinical Management Workshop 4: How do I do it? (II)
How do I manage men who have used anabolic steroids?
Wed 04 09:15
Applied Physiology Workshop 1: Evolving model systems for complex tissues
From cells to organs in the lab
Sidlaw
Chairs: Kevin Docherty (Aberdeen) & Shareen Forbes (Edinburgh)
Wed 04 09:15
APW1.1
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Modelling human diseases with stem cell derived hypothalamic neurones
Wed 04 09:45
APW1.2
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Regeneration in the hypothalamus
Sheffield, UK
Wed 04 10:15
APW1.3
Applied Physiology Workshop 1: Evolving model systems for complex tissues
Cell replacement and regeneration of beta cells as novel therapy for diabetes
Wed 04 09:15
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
How does food talk to the gut?
Supported by Journal of Endocrinology
Moorfoot & Kilsyth
Chairs: Robert Semple (Cambridge) & Ben Challis (Cambridge)
Wed 04 09:15
S10.1
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Incretin hormones as regulators of appetite: from concept to clinical use
Liverpool, United Kingdom
Wed 04 09:45
S10.2
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Gut lipid sensing and energy homeostasis
Toronto, Canada
Wed 04 10:15
S10.3
Symposium 10: Blood and guts: how the intestine transduces nutritional cues to endocrine signals
Short chain fatty acids in the regulation of energy homeostasis
Wed 04 11:00
Plenary Lecture 8: Society for Endocrinology European Medal Lecture
Main Hall, Pentland
Chair: Karen Chapman (Edinburgh)
Wed 04 11:00
PL8
Plenary Lecture 8: Society for Endocrinology European Medal Lecture
Repositioning of the mineralocorticoid receptor antagonists: pathophysiological basis and therapeutic issues 
Paris, France
Wed 04 11:30
Tea & coffee
Exhibition Hall, Lennox Suite
Wed 04 12:00
Oral communications 5: Thyroid and parathyroid
Six oral communications from selected abstracts submitted by delegates
Sidlaw
Chairs: Duncan Bassett (London) & Peter Taylor (Cardiff)
Wed 04 12:00
OC5.1
Oral communications 5: Thyroid and parathyroid
Functional consequences of germline mutations in a novel non-RET medullary thyroid cancer susceptibility gene
Birmingham, UK
Wed 04 12:15
OC5.2
Oral communications 5: Thyroid and parathyroid
A novel, missense, mutation (P81R) in the thyrotropin-releasing hormone receptor gene in congenital central hypothyroidism
Wed 04 12:30
OC5.3
Oral communications 5: Thyroid and parathyroid
Use of 11-C-Methionine PET to loacliase parathyroid adenoma/hyperplasia-a single centre experience
Wed 04 12:45
OC5.4
Oral communications 5: Thyroid and parathyroid
A novel modulator of cellular invasion and metastasis in endocrine cancer
Wed 04 13:00
OC5.5
Oral communications 5: Thyroid and parathyroid
Investigating the genetic architecture of gland-in-situ congenital hypothyroidism by comprehensive screening of eight known causative genes
Cambridge, United Kingdom
Wed 04 13:15
OC5.6
Oral communications 5: Thyroid and parathyroid
Safety review of liothyronine use: a 20 year observational follow up study
Wed 04 12:00
Oral communications 6: Advances in reproduction and signalling
Six oral communications from selected abstracts submitted by delegates
Moorfoot & Kilsyth
Chairs: Ruth Andrew (Edinburgh) & Konstantinos Manolopoulos (Birmingham)
Wed 04 12:00
OC6.1
Oral communications 6: Advances in reproduction and signalling
Neurokinin B receptor antagonist limits kisspeptin-10 induced LH secretion in women
Wed 04 12:15
OC6.2
Oral communications 6: Advances in reproduction and signalling
Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)
London, United Kingdom
Wed 04 12:30
OC6.3
Oral communications 6: Advances in reproduction and signalling
Mutations in HS6ST1 are causal in self-limited delayed puberty, as well as idiopathic hypogonadotropic hypogonadism
London, UK
Wed 04 12:45
OC6.4
Oral communications 6: Advances in reproduction and signalling
Calcium-sensing receptor internalisation is impaired in cells expressing FHH3-associated AP2σ mutations
Birmingham, UK
Wed 04 13:00
OC6.5
Oral communications 6: Advances in reproduction and signalling
Pituitary tumor transforming gene binding factor (PBF): a novel modulator of iodide uptake and target for Src phosphorylation in breast cancer
Wed 04 13:15
OC6.6
Oral communications 6: Advances in reproduction and signalling
Glucocorticoids induce rapid and persistent chromatin remodelling at a glucocorticoid receptor bound locus in macrophages
Wed 04 12:00
Symposium 11: Epigenetics in endocrine-related cancers
Evolving manifestations of epigenetic signalling and nuclear hormone receptors in breast, prostate and ovarian tumourigenesis
Supported by Endocrine-Related Cancer
Fintry
Chairs: Simon Langdon (Edinburgh) & James Thorne (Leeds)
Wed 04 12:00
S11.1
Symposium 11: Epigenetics in endocrine-related cancers
Oestrogen receptors and epigenetics in breast cancer aetiology and outcome
London, UK
Wed 04 12:30
S11.2
Symposium 11: Epigenetics in endocrine-related cancers
Regulation of androgen receptor function in prostate cancer
Buffalo, USA
Wed 04 13:00
S11.3
Symposium 11: Epigenetics in endocrine-related cancers
Epigenetic signalling and acquired drug resistance in ovarian cancer
Wed 04 12:00
Symposium 12: Corticosteroids - getting to the heart of the matter
This symposium will address the role of corticosteroids and therapeutic approaches in cardiovascular disease and the potential for cardio-selective therapeutic interventions
Supported by Journal of Molecular Endocrinology
Main Hall, Pentland
Chairs: Frederic Jaisser (Paric France) & Rachel Richardson (Edinburgh)
Wed 04 12:00
S12.1
Symposium 12: Corticosteroids - getting to the heart of the matter
Glucocorticoids and the control of cardiac function
Wed 04 12:30
S12.2
Symposium 12: Corticosteroids - getting to the heart of the matter
Selective targeting of the mineralocorticoid receptors (MR) and cardiovascular disease
Clayton, Australia
Wed 04 13:00
S12.3
Symposium 12: Corticosteroids - getting to the heart of the matter
MR antagonists - lessons from clinical trials
Nancy, France
Wed 04 12:00
Senior Endocrinologists Session
Tinto
Chairs: Paul Belchetz (Leeds) & Ian Mason (Edinburgh)
Wed 04 12:00
SE1.1
Senior Endocrinologists Session
The new tachykinin, endokinin: its role in emesis, sialorrhea and smoking in pregnancy
Wed 04 12:18
SE1.2
Senior Endocrinologists Session
What is visual art, why is it made, and for whom?
Wed 04 12:36
SE1.3
Senior Endocrinologists Session
Steroid mass spectrometry: a 50 year history
Oakland, USA
Wed 04 12:54
SE1.4
Senior Endocrinologists Session
A crackpot ejection theory about China's unique natural glass
Rome, Italy
Wed 04 13:12
SE1.5
Senior Endocrinologists Session
Understanding the biochemistry underpinning hypoglycaemia of the Insulin Autoimmune Syndrome (IAS) is paramount for diagnosis and management
Wed 04 13:30
Lunch & poster viewing
Exhibition Hall, Lennox Suite
Wed 04 13:30
Internis Satellite
Fintry
Wed 04 13:45
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Sidlaw
Chair: Ashley Grossman (Oxford)
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Assessing disease burden in AI: data from the real world
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
Treatment and management of AI: insights from a German cohort
Berlin, Germany
Wed 04
Shire Satellite: Understanding adrenal insufficiency (AI): from disease burden to treatment evaluation
The economics of orphan drugs
Wed 04 14:45
Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Supported by Clinical Endocrinology
Sidlaw
Chair: Lora Heisler (Aberdeen)
Wed 04 14:45
MTE7
Meet the Expert 7: Designer Receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Designer receptors Exclusively Activated by Designer Drugs (DREADD) - Novel pharmacological handles on the endocrine system
Wed 04 14:45
Meet the Expert 8: Updated thyroid cancer guidelines
Supported by Clinical Endocrinology
Moorfoot & Kilsyth
Chair: Graham Williams (London)
Wed 04 14:45
MTE8
Meet the Expert 8: Updated thyroid cancer guidelines
Updated thyroid cancer guidelines
United Kingdom
Wed 04 14:45
Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
Supported by Clinical Endocrinology
Fintry
Chair: Guftar Shaikh (Glasgow)
Wed 04 14:45
MTE9
Meet the Expert 9: Endocrine and non-endocrine aspects of hypothalamic syndromes
Endocrine and non-endocrine aspects of hypothalamic syndromes

Unknown speaker

London, UK
Wed 04 14:45
Meet the Expert 10: Diagnosis and management of SIADH
Supported by Clinical Endocrinology
Main Hall, Pentland
Chair: Maralyn Druce (London)
Wed 04 14:45
MTE10
Meet the Expert 10: Diagnosis and management of SIADH
Diagnosis and management of SIADH
Dublin, Republic of Ireland
Wed 04 15:45
A year in...Type 2 diabetes
Big breakthroughs over the previous 12 months in the field of Type 2 diabetes research
Main Hall, Pentland
Chair: Chris McCabe (Birmingham)
Wed 04 15:45
AYI1
A year in...Type 2 diabetes
A year in...Type 2 diabetes
Wed 04 16:15
Plenary Lecture 9: Society for Endocrinology International Medal Lecture
Main Hall, Pentland
Chair: Steve O'Rahilly (Cambridge)
Wed 04 16:15
PL9
Plenary Lecture 9: Society for Endocrinology International Medal Lecture
Controlling the freedom of steroids in health and disease
Vancouver, Canada
Wed 04 16:45
Awards Ceremony
Main Hall, Pentland
Wed 04 17:15
Closing Remarks
Main Hall, Pentland

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract